User:QuackGuru/Sand 25

From WikiProjectMed
Jump to navigation Jump to search


Effects of vaping on the human respiratory system have been observed. Serious lung illnesses such as chronic obstructive pulmonary disease, asthma, and possibly lung cancer is associated with the use of e-cigarettes.
Effects of vaping on the human respiratory system have been observed.[1] Serious lung illnesses such as chronic obstructive pulmonary disease, asthma,[2] and possibly lung cancer[3] is associated with the use of e-cigarettes.[2]
Labeled and unlabeled constituents in e-cigarettes and identified effects on neurobiology and behavior. E-liquids and/or aerosols have been shown to contain nicotine, propylene glycol, carbonyls, flavorants, and metal particulates, all of which can induce effects on biological processes and/or behavior.
Labeled and unlabeled constituents in e-cigarettes and identified effects on neurobiology and behavior.[4] E-liquids and/or aerosols have been shown to contain nicotine, propylene glycol, carbonyls, flavorants, and metal particulates, all of which can induce effects on biological processes and/or behavior.[4]
Graphic from the Centers for Disease Control and Prevention's report entitled What Is in E-cigarette Aerosol?
Graphic from the Centers for Disease Control and Prevention's report entitled What Is in E-cigarette Aerosol?[5]

The benefits and the health effects of electronic cigarettes are uncertain.[6] There is considerable variation among e-cigarettes and in their liquid ingredients, and as a consequence, there are differences in the aerosol delivered to the user.[7] Regulated US Food and Drug Administration (FDA) products such as nicotine inhalers may be safer than e-cigarettes,[8] but e-cigarettes are generally seen as safer than combusted tobacco products[note 1][14] such as cigarettes and cigars.[15] Since vapor does not contain tobacco and does not involve combustion, users may avoid several harmful constituents usually found in tobacco smoke,[16] such as ash, tar, and carbon monoxide.[17] However, vaping is more dangerous in the short-term than smoking.[12][18] Because of the risk of nicotine exposure to the fetus and adolescent causing long-term effects to the growing brain, the World Health Organization does not recommend it for children, adolescents, pregnant women, and women of childbearing age.[19] Vaping itself has no proven benefits[12] and with or without nicotine it cannot be considered harmless.[20] Their indiscriminate use is a threat to public health.[21]

The long-term effects of e-cigarette use are unknown[22][23][24] and unclear.[25] Short-term use may lead to death.[12] Less serious adverse effects include abdominal pain, headache, blurry vision,[26] throat and mouth irritation, vomiting, nausea, and coughing.[7] They may produce similar adverse effects compared to tobacco use.[27] E-cigarettes reduce lung function, reduce cardiac muscle function, and increase inflammation.[28] In 2019 and 2020, there was an outbreak of severe lung illness linked to vaping in the US[29] and Canada,[30] with 68 confirmed deaths in the US,[note 2][29] and one confirmed death in Europe.[35] There are also risks from misuse or accidents[16] such as nicotine poisoning (especially among small children[36]),[37] contact with liquid containing nicotine,[38] fires caused by device malfunction,[7] and explosions resulting from extended charging, unsuitable chargers, design flaws,[16] or user modifications.[39] Battery explosions are caused by an increase in internal battery temperature and some have resulted in severe skin burns.[40] There is a small risk of a battery explosion in devices modified to increase battery power.[41]

The cytotoxicity of e-liquids varies,[42] and contamination with various chemicals have been detected in the liquid.[43] Metal parts of e-cigarettes in contact with the e-liquid can contaminate it with metal particles.[16] Many chemicals including carbonyl compounds such as formaldehyde can inadvertently be produced when the nichrome wire (heating element) that touches the e-liquid is heated and chemically reacted with the liquid.[44] The later-generation and "tank-style" e-cigarettes with a higher voltage (5.0 V[42]) may generate equal or higher levels of formaldehyde compared to smoking.[45] Nicotine is associated with cardiovascular disease, increased serum cholesterol levels, and possible birth defects.[46] Children, youth,[11] and young adults are especially sensitive to the effects of nicotine.[47] Several studies demonstrate nicotine is carcinogenic.[48] Public health authorities do not recommend nicotine use for non-smokers.[49] Propylene glycol, glycerin, volatile organic compounds, and free radicals can impair lung health.[50] Many flavors are irritants[51] and certain flavoring agents can induce respiratory toxicity.[52]

E-cigarettes create vapor that consists of fine and ultrafine particles of particulate matter, with the majority of particles in the ultrafine range.[7] The vapor contains propylene glycol, glycerin, nicotine, flavors, small amounts of toxicants,[7] carcinogens,[note 3][53] and heavy metals, as well as metal nanoparticles, and other substances.[7] Exactly what the vapor consists of varies significantly in composition and concentration across and within brands, and depends on the e-liquid contents, the device design, and user behavior, among other factors.[note 4][54] E-cigarette vapor potentially contains harmful chemicals not found in tobacco smoke[55] such as propylene glycol.[56] E-cigarette vapor contains fewer toxic chemicals,[7] and lower concentrations of potentially toxic chemicals than in cigarette smoke.[57] Concern exists that the exhaled e-cigarette vapor may be inhaled by bystanders, particularly indoors.[58] There is limited information available on the environmental issues around production, use, and disposal of e-cigarettes that use cartridges.[59] E-cigarettes that are not reusable may contribute to the problem of electronic waste.[60]

Health effects

Overview of benefits and effects

Graphic from the January 2015 California Department of Public Health's State Health Officer's Report on E-Cigarettes warning about harmful substances in e-cigarette vapor.
Graphic from the January 2015 California Department of Public Health's State Health Officer's Report on E-Cigarettes warning about harmful substances in e-cigarette vapor[61]
A 2015 Centers for Disease Control and Prevention video on e-cigarettes.[62]
E-cigarette device explodes in man's pocket while on bus in California.
E-cigarette device explodes in man's pocket while on bus in California[63]
Basic information on the health effects of using e-cigarettes.
Basic information on the health effects of using e-cigarettes.[64]

Reviews on the safety of electronic cigarettes, evaluating roughly the same studies, have reached significantly different conclusions.[65] Broad-ranging statements regarding their safety cannot be reached because of the vast differences of devices and e-liquids available.[66] A consensus has not been established for the benefits as well as the effects related to their use.[52] A substantial amount of research has been conducted in the past decade prior to 2020 to examine the health effects of e-cigarette use, often providing conflicting evidence and claims.[6] What will cause the most or least undesirable effects of various blends of solvents, flavoring, and nicotine in e-liquids is unknown.[47]

There is considerable variation in e-cigarette product technologies as well as differing amounts of chemicals in their liquid solution, including an assortment of nicotine strengths and a vast array of additives and flavors, and as a consequence, there are differences in the contents of the aerosol inhaled as well as exhaled by the user.[7] Due to the large variation in the quantities of each constituent across products and an ever-evolving product marketplace, it is challenging to fully understand the clinical relevance of e-cigarette use on the individual's health.[4] Although there is inconsistencies among the methodologies used (detection method, liquid or aerosol, animal models, conditions), the data generated by these investigations remains informative.[67] Moreover, due to various methodological issues, severe conflicts of interest, and inconsistent research, no firm views can be made regarding their effects.[68] However, e-cigarette use with or without nicotine cannot be considered harmless.[20] Nicotine-free e-cigarette aerosol contains chemicals that cause cancer as well as chemicals associated with severe lung damage.[25]

E-cigarettes cannot be considered absolutely safe because there is no safe level for carcinogens.[69] An uncountable amount of studies aimed at evaluating e-cigarette potential consequences on human health and the most updated panorama of scientific literature provides increasing evidence of vaping harmfulness.[70] Among e-cigarettes adverse health effects, respiratory impact is by far the most extensively studied.[70] Nicotine is the most studied biologically active chemical present in e-cigarettes, and several of the cardiovascular effects of e-cigarettes have been attributed to this alkaloid from the tobacco plant.[71] Nicotine has well-established effects on the metabolism and cardiovascular system.[71] In the same way as conventional cigarettes smokers, vapers' pulmonary epithelium is typically damaged and bronchial mucosa chronically inflamed.[70]

Vaping has been promoted as being safer than cigarette smoking, though users can be inhaling toxicants such as diacetyl and carcinogens such as formaldehyde[72] and users can be inhaling contaminants such as traces of arsenic and other heavy metals.[27] Because of the belief that vaping is less dangerous than traditional cigarettes, vapers may vape products at a more frequent pace than traditional cigarettes, and as a consequence, produce higher levels of second-hand contaminants.[73] Vaping itself has no proven benefits,[12] and it is a deliberate exposure in contrast to numerous other toxicological exposures.[74] The potential benefits of nicotine vaping are significantly outweighed by its unwanted effects, such as threat of addiction, cancer, heart disease, hypertension, respiratory infections, and gastrointestinal discomfort.[75]

E-cigarettes were initially positioned as a "healthy alternative", though they may produce similar adverse effects compared to tobacco use.[27] There is emerging evidence demonstrating adverse effects attributable to e-cigarette use on every single human organ system.[76] Whether e-cigarettes are helping smokers or creating a new source of addiction is extensively being debated.[77] The overall public health effect related to their use is actively debated.[78] Available evidence on the benefits and risks of e-cigarette use are mixed and interpreted differently.[79] Some believe that e-cigarettes have the potential to reduce the burden of disease in smokers while others worry about the impact on public health and do not recommend, and even ban, their use.[79]

Limited research

The long-term consequences from e-cigarette use on death and disease are unclear.[80] The risks from long-term use of nicotine as well as other toxicants that are unique to e-cigarettes are uncertain.[81] The potential long-term effects of e-cigarette consumption have been scarcely investigated.[82] Disease caused by tobacco has a latency period of no less than 25 years.[83] Therefore, as of 2019, it will conservatively take two decades until firm conclusions from long-term studies on using e-cigarettes are published.[83] Epidemiological data on cancer findings takes at least 20 to 40 years to become available.[84] As of 2023, evidence of the harms of e-cigarettes has been unfolding slowly and has been documented in many reviews and reports worldwide.[85] E-cigarettes have the potential for benefit and harm, the nature and scale of each being uncertain in the absence of ample evidence.[86]

The health effects related to e-cigarette use is mostly unknown.[87] Most of the available articles reported are limited in their design, methodology, and the used exposure time and had a lack of long-term follow-up.[88] There is insufficient data regarding the health benefits of vaping.[89] There is limited available research regarding their effects on vulnerable groups such as minors.[90] The effect on population health from e-cigarettes is unknown.[8] The chemical characteristics of the short-lived free radicals and long-lived free radicals produced from e-cigarettes is unclear.[91] The knowledge of possible acute and long-term health effects of aerosols inhaled from e-cigarettes is limited partially due to incomplete awareness of physical phenomena related to e-cigarette aerosol dynamics.[92] There is a significant absence of inhalational toxicity data regarding the majority of the ingredients in e-cigarettes.[93]

Alternative to smoking

Switching from tobacco to vaping may reduce weight gain after smoking cessation, increase exercise tolerance, reduce exposure to toxic chemicals, and reduce risk of death. Vaping may reduce shortness of breath, reduce coughing, reduce spitting, and reduce sore throat compared to tobacco.
Effects of vaping, compared to tobacco smoking.[94]

Tobacco companies have deliberately promoted the use of alternatives to traditional cigarettes with supposedly safer tobacco products, such as e-cigarettes, in an effort to reduce the harm caused by tobacco consumption.[note 5][97] There is a lack of evidence in favor of using e-cigarettes as a safe option to classical cigarettes and as a substitute to public health approaches that aim at curtailing tobacco use.[98]

A 2019 editorial in The Lancet stated that there is no solid proof showing that e-cigarettes is safer than cigarettes, but this conclusion was met with criticism by Professor JN Newton, Director of Health Improvement at Public Health England (PHE), who insisted that there is a worldwide consensus that their use is probably significantly less dangerous than smoking.[99] Clinical trials and other studies have demonstrated that e-cigarettes are not a safer option.[100] Since e-liquids and vaping aerosols contain nicotine and many of the same toxic chemicals and carcinogens as classical cigarettes do, it may be assumed, especially when taking into account the growing evidence of toxic tobacco inhalation that has been observed in the users of these devices, that there is the possibility that vaping may result in similar unwanted effects.[101]

Figure shows the comparison of the degree of harmful effects documented from e-cigarette and conventional cigarette consumption. According to a 2021 review, the human studies, in vivo mice exposure, and in vitro studies shows that the effects from e-cigarettes were documented to be lower than those exerted by conventional cigarettes, which may suggest that e-cigarette consumption could be a safer option than conventional tobacco smoking but not a clear safe choice.
Figure shows the comparison of the degree of harmful effects documented from e-cigarette and conventional cigarette consumption.[82] According to a 2021 review, the human studies, in vivo mice exposure, and in vitro studies shows that the effects from e-cigarettes were documented to be lower than those exerted by conventional cigarettes, which may suggest that e-cigarette consumption could be a safer option than conventional tobacco smoking but not a clear safe choice.[82]
Figure shows the effect of the heating process on aerosol composition. Herein, the main harmful effects are documented. Several compounds detected in e-cigarette aerosols are not present in e-liquids and the device material also seems to contribute to the presence of metal and silicate particles in the aerosols. The heating conditions especially on humectants, flavorings, and the low-quality material used have been identified as the generator of the new compounds in aerosols. Some compounds generated from humectants (propylene glycol and glycerin) and flavorings, have been associated with clear airways impact, inflammation, impairment of cardiovascular function, and toxicity. In addition, some of them are carcinogens or potential carcinogens.
Figure shows the effect of the heating process on aerosol composition.[82] Herein, the main harmful effects are documented.[82] Several compounds detected in e-cigarette aerosols are not present in e-liquids and the device material also seems to contribute to the presence of metal and silicate particles in the aerosols.[82] The heating conditions especially on humectants, flavorings, and the low-quality material used have been identified as the generator of the new compounds in aerosols.[82] Some compounds generated from humectants (propylene glycol and glycerin) and flavorings, have been associated with clear airways impact, inflammation, impairment of cardiovascular function, and toxicity.[82] In addition, some of them are carcinogens or potential carcinogens.[82]

Vaping long-term is anticipated to raise the risk of developing some of the diseases linked to smoking.[51] Since vapor does not contain tobacco and does not involve combustion, users may avoid several harmful constituents usually found in tobacco smoke,[16] such as ash, tar, and carbon monoxide.[note 6][17] The public health community is divided, even polarized, over how the use of these devices will impact the tobacco epidemic.[103] Some tobacco control advocates predict that e-cigarettes will increase rates of cigarette uptake, especially among youth.[103] Others envision that these devices have potential for aiding cessation efforts, or reducing harm among people who continue to smoke.[103] Scientific studies advocate caution before designating e-cigarettes as beneficial but vapers continue to believe they are beneficial.[104]

E-cigarette vapor contains higher levels of carcinogens and toxicants than in an US Food and Drug Administration (FDA) regulated nicotine inhaler, which suggests that regulated US FDA devices may deliver nicotine more safely.[8] E-cigarettes are generally seen as safer than combusted tobacco products[15][105][14] such as cigarettes and cigars.[15] Due to the lack of long-term toxicological and safety studies on humans, stating with conviction that e-cigarettes are less hamaul than traditional cigarettes is "impossible".[1]

Early research seemed to indicate that vaping might be safer than traditional cigarettes and provide a different method to give up smoking, though mounting evidence does not substantiate this.[9] Evidence has not been presented to demonstrate that e-cigarettes are less dangerous than tobacco.[10] The short-term health effects of e-cigarettes can be severe[11] and the short-term harms of e-cigarettes is greater than tobacco products.[12] E-cigarettes are frequently viewed as a safer alternative to conventional cigarettes; however, evidence to support this perspective has not materialized.[13] This appears to be due to the presence of toxicants in e-liquid composition, their adverse effects in animal models, association with acute lung injury and cardiovascular disease, and ability to modulate different cell populations in the lung and blood towards pro-inflammatory phenotypes.[13] Short-term e-cigarette use may lead to death.[12]

The surge in vaping among youth and the vaping-induced lung illness epidemic has increased the controversy surrounding vaping and casts doubt about their feasibility for public health gains as an alternative to traditional cigarettes.[99] E-cigarette vapor potentially contains harmful substances not found in tobacco smoke[55] such as propylene glycol and/or glycerin and various flavoring agents along with other unknown chemicals.[56]

Opinions that e-cigarettes are a safe substitute to traditional cigarettes may compromise tobacco control efforts.[106] While quitting smoking may be firmly recommended for smokers who have asthma, it is not clear whether replacing e-cigarettes for cigarettes is a universally safer alternative.[93]

Studies evaluating whether e-cigarettes are less harmful than cigarettes are inconclusive.[88] As of 2020, there is still a lack of evidence that they are safe during repeated inhalation in long-term use.[88] Long-term data showing that vaping is a "healthier alternative" than cigarette smoking does not exist.[8]

Effects on increased availability of vaping products

A serious concern regarding e-cigarettes is that they could entice children to initiate smoking, either by subjecting them to nicotine that leads to smoking or by making smoking appear more acceptable again.[107] Concerns surrounding adolescent e-cigarette use stem from research indicating that nicotine use could potentially result in detrimental effects to the brain.[108]

The medical community is concerned that increased availability of e-cigarettes could increase worldwide nicotine dependence, especially among the young as they are enticed by the various flavor options e-cigarettes have to offer.[109] Since vaping does not produce smoke from burning tobacco, the opponents of e-cigarettes fear that traditional smokers will substitute vaping for smoking in settings where smoking is not permitted without any real intention of quitting traditional cigarettes.[109] Furthermore, vaping in public places, coupled with recent e-cigarette commercials on national television, could possibly undermine or weaken current antismoking regulations.[109] Fear exists that wide-scale promotion and use of e-cigarettes, fueled by an increase in advertising of these products, may carry substantial public health risks.[110] Public health professionals have voiced concerns regarding vaping while using other tobacco products - particularly combustible products.[111]

The increased dominance of the vaping market by global tobacco giants has raised concerns within the public health sector, due to the industry's well-documented history of deceiving the public with dubious claims, including that low-tar and "light" cigarettes would decrease the health risks linked to smoking.[111] While tobacco companies now tout their interest in these products as a move toward harm reduction, numerous observers suspect that their real motivation is financial gain.[111] E-cigarettes are expanding the tobacco epidemic by bringing lower-risk youth into the market, many of whom then transition to smoking cigarettes.[112] A 2016 review recommended the precautionary principle to be used for e-cigarettes because of the long history of the tobacco crisis, in order to assess their benefits and long-term effects and to avoid another nicotine crisis.[113]

Effects on dual vaping and smoking use

Overview

The figure shows the known and unknown health effects of vaping in comparison to cigarette smoke. The major toxic effects of compounds found in cigarette smoke (right lung) and in vaping aerosols (left lung) are lung inflammation, oxidative stress, cell death, impaired immune response, DNA damage, and epigenetic modifications. The respiratory diseases caused by cigarette smoke (lung cancer, COPD [emphysema and/orobstruction of airways]) are not yet established to be caused by vaping (represented by question marks in the left lung). There is an association with the presence of lipid-laden macrophages and the use of vaping products. E-cigarettes containing THC and vitamin E acetate or nicotine can cause a vaping-induced lung injury disease.
The figure shows the known and unknown health effects of vaping in comparison to cigarette smoke.[114] The major toxic effects of compounds found in cigarette smoke (right lung) and in vaping aerosols (left lung) are lung inflammation, oxidative stress, cell death, impaired immune response, DNA damage, and epigenetic modifications.[114] The respiratory diseases caused by cigarette smoke (lung cancer, COPD [emphysema and/orobstruction of airways]) are not yet established to be caused by vaping (represented by question marks in the left lung).[114] There is an association with the presence of lipid-laden macrophages and the use of vaping products.[114] E-cigarettes containing THC and vitamin E acetate or nicotine can cause a vaping-induced lung injury disease.[115]

The entrance of large US tobacco manufacturers, such as Altria Group, Reynolds American, and Lorillard, into the e-cigarette sector raises many potential public health issues.[116] Instead of pushing for quitting smoking, the tobacco industry may promote e-cigarettes as a way to get around clean indoor air laws, which promotes dual use and the increased sale of traditional cigarettes.[116] A 2015 review recommended the precautionary principle to be used because dual use could end up being an additional risk.[65] The industry could also lead vapers to tobacco products, which would increase instead of decrease overall addiction.[116] Concerns exist that the emergence of e-cigarettes may benefit Big Tobacco to sustain an industry for tobacco.[117]

Evidence on the effects of dual e-cigarette and traditional cigarette use compared to using one product alone is limited.[6] The long-term research on the effects of dual use of tobacco smoking and vaping are not available.[118] Many continue to use both, exposing themselves to the harms of tobacco smoking and e-cigarette use.[119] A 2018 study found that both e-cigarette and cigarette users had similar levels of metals toluene, benzene, and carbon disulfide, while dual users had the greatest amount of exposure to nicotine, tobacco biomarkers, metals toluene, benzene, and carbon disulfide.[101]

Dual use offers no significant advantages.[111] Vaping can hinder smokers from trying to quit, resulting in increased tobacco use and associated health problems.[120] Compared to just smoking, dual use of smoking and vaping may increase the chance of developing heart disease, lung disease, and cancer.[121] Quitting smoking entirely would probably have much greater beneficial effects to overall health than vaping to decrease the number of cigarettes smoked.[7]

Metabolic effects

Ten large, good-quality surveys, including between 3,400 and almost 450,00 persons from the general population, investigated the cardiovascular and metabolic health effects of dual use.[79] The best available of these studies had adjusted for tobacco consumption and found higher HbA1c levels in dual users than in exclusive smoking of conventional cigarettes, but significance levels were not tested.[79]

Four of the good-quality surveys investigated cardiovascular risk factors and found that dual users had a significantly higher unadjusted and adjusted odds ratios of cardiovascular disease, significantly higher prevalence unadjusted and adjusted odds ratios of cardiovascular risk factors and diagnosis of metabolic syndrome, significantly higher unadjusted and adjusted odds ratios of elevated human c-reactive protein, significantly higher risk of stroke, significantly higher prevalence of arrythmia, significantly higher unadjusted and adjusted odds ratios of elevated c-reactive protein, and significantly higher unadjusted and adjusted odds ratios of abdominal obesity than exclusive smoking of conventional cigarettes.[79]

The two remaining surveys found higher unadjusted and adjusted odds ratios of myocardial infarction and stroke, but significance level was not tested, and higher but not significant unadjusted and adjusted odds ratios of hypertension in dual users than in exclusive smoking of conventional cigarettes.[79] Furthermore, one survey found that dual users had similar fasting glucose as exclusive smoking of conventional cigarettes, and another study found the same levels of insulin resistance.[79]

Asthma

In a large survey, homeless persons with dual use reported significantly higher rates of asthma and cancer compared to exclusive smoking of conventional cigarettes.[79] A positive association between dual use and the prevalence of asthma was reported in one systematic review in 2021, while a 2021 meta-analysis found that the association with asthma prevalence was even stronger for dual use than for traditional cigarette use alone.[6] Temporality and a dose–response relationship were not determined due to the cross-sectional nature of the associations and lack of information on the intensity and duration of use.[6]

Breathing and heart effects

E-cigarette use, as compared to traditional cigarette use, contributes independently to respiratory risk.[6] Dual users reported a lower general health score, and more difficulty in breathing in the past month, compared to cigarette-only users.[122] Additionally, a significant difference was observed in the history of arrhythmia between cigarette-only users (14.2%) and dual users (17.8%).[122] More respiratory symptoms were found in dual smokers than in smokers who did not use e-cigarettes, and the possibility of reversible cerebral vasoconstriction syndrome was more likely to be observed in dual users.[122]

There is a greater risk for a heart attack with the use of both e-cigarettes and traditional cigarettes.[123] Using e-cigarettes daily doubles the risk of heart attack according to research performed by the Center for Tobacco Control Research and Education at the University of California, San Francisco in 2018.[124] This study provided the first evidence of a substantial human health impact of electronic nicotine devices.[124] This new study with nearly 70,000 people found that the heightened risk of heart attack for e-cigarette users is similar to one of the main effects of c-cigarettes.[124] Together, in those who use both c- and e-cigarettes daily, the odds increase five times.[124]

Other effects

A 2020 clinical study performed vascular function testing in almost 500 young persons and reported that dual users had similar arterial stiffness as exclusive smoking of conventional cigarettes.[79] Large good-quality surveys (only one did not weight data) including adults found that dual users had significantly worse fitness and significantly higher levels of uric acid and prevalence of hyperuricemia compared with exclusive smoking of conventional cigarettes.[79] Large surveys including adolescent dual users reported insufficient sleep significantly more often than exclusive smoking of conventional cigarettes, and higher odds of dental problems.[79] Finally, in a small human clinical study in 2020, dual users had higher levels of most biomarkers of systemic inflammation than exclusive smoking of conventional cigarettes, but the difference was not significant.[79]

Effects on smoking cessation

Overview

General information on what are e-cigarettes from the Centers for Disease Control and Prevention.
General information on what are e-cigarettes.[64]

The safety of e-cigarette consumption and its potential as a smoking cessation method remain controversial due to limited evidence.[82] Moreover, it has been reported that the heating process itself can lead to the formation of new decomposition compounds of questionable toxicity.[82] There is concern that e-cigarettes may result in many smokers rejecting historically effective smoking quitting smoking methods.[125]

Concern exists that the majority of smokers attempting to quit with the help of vaping may stop smoking but will keep on using nicotine, because their long-term effects are not clear.[126] Many individuals use e-cigarettes as a way to quit smoking, but there is not clear evidence that e-cigarettes help people quit smoking entirely.[119] E-cigarettes may help smokers reduce the number of cigarettes they smoke, though decreasing daily cigarette use is still not safe.[119]

Effects

Since e-cigarettes are intended to be used repeatedly, they can conveniently be used for an extended period of time, which may contribute to increased adverse effects.[127] The most frequently reported less harmful effects of vaping compared to smoking were reduced shortness of breath, reduced cough, reduced spitting, and reduced sore throat.[104] More serious adverse effects frequently related with smoking cessation including depression, insomnia, and anxiety are uncommon with e-cigarette use.[26] Many health benefits are associated with switching from tobacco products to e-cigarettes including decreased weight gain after smoking cessation and improved exercise tolerance.[128] Reported in 2013, quitting smoking with the use of a vape alleviated chronic idiopathic neutrophilia in a smoker.[129] Vaping can be harmful by hindering efforts to quit smoking, serving as an entry point to tobacco use for non-smokers, or causing a relapse in those who have previously quit smoking.[130]

Toxicity

They are similar in toxicity to other nicotine replacement products,[131] but e-cigarettes manufacturing standards are variable, and many as a result are probably more toxic than nicotine replacement products.[132] E-cigarettes produce more toxicants than other forms of nicotine replacement products and are likely to be more harmful.[133]

Effects on vaping cessation

The short-term effects of vaping causing greater airway resistance and inflammation may not be permanent following quitting vaping.[24] A 2022 review states that a better choice for quitting smoking or quitting nicotine might be to immediately stop using e-cigarettes and smoking combustible cigarettes, which might be a better way to reduce organ injuries.[134] Cardiotoxicity can be irreversible, when necrosis or apoptosis of the myocardial cells occurs, or reversible, as in the case of short-term nicotine product consumption.[135]

Primary-care interventions

Research indicates that screening patients for e-cigarette usage in primary practice is not frequently undertaken by medical practitioners.[136] A 2015 study found a low prevalence of screening for e-cigarettes in primary-care practice relative to smoking screening (14% versus 86%) in a sample of 776 practitioners across the US.[136] This low uptake is concerning, given the serious health risks of e-cigarettes.[136] A 2016 qualitative study in the US further confirmed that there is insufficient knowledge of e-cigarettes among physicians, including both the potential benefits and health risks.[136] A 2017 study in US college students found that most students did not receive any form of counseling about risks from medical practitioners, including dental hygienists.[136] Studies have also shown that there is a need for stronger education on e-cigarettes in medical curricula, which will allow physicians to begin addressing e-cigarette use in teenagers.[136]

As of 2022, there is little information on primary-care interventions for e-cigarette use in teenagers and young adults.[136] A 2020 case study of a 23-year-old e-cigarette user shows promising results for tapering e-cigarette use with the assistance of a pharmacist, which suggests that different healthcare practitioners may play a role helping patients with gradually tapering off e-cigarettes.[136] A 2021 randomized controlled trial of asthmatic teenagers who attended one of four clinics found that physicians discussed smoking during 38.2% of thee visits, but vaping was never brought up as a topic.[136] According to a 2022 review, this emphasizes that physicians should discuss both smoking and vaping during appointments, in particular in youth presenting with asthma.[136]

Overall risk relative to smoking

Vaping is estimated to be 95% less harmful than smoking claims

A 2015 Public Health England report claimed that "e-cigarettes were 95% safer than cigarettes, and it was widely cited, as a definitive scientific consensus, despite its tobacco and e-cigarette funding source and lack of any specific empirical evidence supporting the estimate of relative safety."[97] Moreover, "The tobacco industry's history of funding scientific research to undermine the evidence of harms from tobacco is well documented."[97]

 —Yogi H Hendlin and colleagues, American Journal of Public Health[97]

A 2018 PHE report stated, "The previous estimate that, based on current knowledge, vaping is at least 95% less harmful than smoking remains a good way to communicate the large difference in relative risk unambiguously so that more smokers are encouraged to make the switch from smoking to vaping," but noted that this in no way means that vaping is safe.[137] They also noted it is associated with some risks as well as uncertainties.[12] A 2015 PHE report stated that e-cigarettes are estimated to be 95% less harmful than smoking,[138] but the studies used to support this estimate were viewed as having a weak methodology.[139] The estimate has been extensively disputed in published journals.[140] Many vigorously criticized the validity of the estimate that vaping is 95% less harmful than smoking.[111] The PHE's encouragement of using vaping products has been characterized as "a reckless and irresponsible decision".[12]

Influential health organizations in England, including PHE, the Royal College of Physicians, the Royal Society for Public Health, and the National Health Service, have unequivocally stated that e-cigarettes are 95% safer than traditional cigarettes.[112] This claim originated from a single consensus meeting of 12 people convened by D.J. Nutt in 2014.[112] They reached this conclusion without citing any specific evidence.[112] The Nutt et al. paper did include this caveat: "A limitation of this study is the lack of hard evidence for the harms of most products on most of the criteria", which has generally been ignored by those quoting this report.[112]

Funding for researchers and groups that are supportive of promoting tobacco use

(a) Figure shows health risks associated to chemical compounds found exclusively in e-cigarettes. (b) Figure also shows health risks associated to chemical compounds from conventional cigarettes.
(a) Figure shows health risks associated to chemical compounds found exclusively in e-cigarettes.[141]
(b) Figure also shows health risks associated to chemical compounds from conventional cigarettes.[141]

The Nutt et al. meeting was funded by Euroswiss Health and Lega Italiana Anti Fumo.[112] EuroSwiss Health is one of several companies registered at the same address in a village outside Geneva with the same chief executive, who was reported to have received funding from British American Tobacco for writing a book on nicotine as a means of harm reduction and who also endorsed British American Tobacco's public health credentials.[112] Another of Nutt's coauthors, Riccardo Polosa, was Chief Scientific Advisor to Lega Italiana Anti Fumo, received funding from Lega Italiana Anti Fumo, and reported serving as a consultant to Arbi Group Srl, an e-cigarette distributor.[112] He also received funding from Philip Morris International.[112]

Polosa, founder of the Center of Excellence for the Acceleration of Harm Reduction, has repeatedly and variously neglected to declare the money he was given for research came from Philip Morris International, his advisory costs from British American Tobacco, the Center of Excellence for the Acceleration of Harm Reduction's ties to the Foundation for a Smoke-Free World, and the Foundation for a Smoke-Free World's ties to Philip Morris International.[142] In regard to the Foundation for a Smoke-Free World, John Britton stated that this organization is the newest in a series of third-party entities established by the tobacco industry to further its agenda.[143] It serves as a financial conduit for researchers and groups that are supportive of tobacco use, thereby enhancing their careers or advancing pro-tobacco initiatives.[143]

Conflicts of interests and flawed and flimsy evidence

In 2015, The BMJ published an investigative report that raised broader issues surrounding potential conflicts of interest between individuals involved in the Nutt et al. paper.[112] The BMJ provided an infographic illuminating undisclosed connections between key people involved in the paper and the tobacco and e-cigarette industries as well as links between the paper and Public Health England via one of the coauthors.[112] Even so, as of June 2017, the "95% safer" figure remains widely quoted, despite the fact that evidence of the dangers of e-cigarette use has rapidly accumulated since 2014.[112] As of 2018, the evidence indicates that the risk of e-cigarette use is substantially higher than the "95% safer" figure would indicate.[112]

Several of the authors who came up with the "95% safer" assertion have ties to the tobacco industry.[139] A 2015 editorial in The Lancet identified financial conflicts of interest associated with Nutt et al., noting that "there was no formal criterion for the recruitment of the experts."[112] It was also criticized by the journal The Lancet for constructing its conclusions on "flimsy" evidence, which included citing literature with apparent conflicts of interest.[144] Some researchers consider that the 95% figure is flawed and confusing, by making opinions at odds with existing knowledge.[145] Despite this, most other health organizations have been more cautious in their public statements on the safety of e-cigarettes.[146]

Mortality

E-cigarette use induces an acute rise in cardiac sympathetic nerve activity.[147] This can trigger electrocardiogram abnormalities, and as a result, lead to a higher chance of sudden death in people with co-morbidities.[147] The risk of early death is anticipated to be similar to that of smokeless tobacco.[22] There is a significant risk of long-lasting lung injury from vaping that may contribute to or lead to death, in old people.[148]

Regulation

Guidelines for the design, manufacture, and assessment of the safety of e-cigarette devices has not been established.[149] Following years of regulatory discussions, suggested policies and directives, e-cigarettes mainly targeting the youth continue to be underregulated, as of 2020.[150] A 2020 meta-analysis states that e-cigarettes should not be available as consumer products, though they may be considered for sale as a prescription drug.[121] A 2015 review suggested that e-cigarettes could be regulated in a similar way as inhalation therapeutic medicine, meaning, they would be regulated based on toxicology and safety clinical trials.[41] A 2014 review recommended that e-cigarettes could be adequately regulated for consumer safety with existing regulations on the design of electronic products.[151] A 2015 review recommended that regulations provide detailed quality standards for products, policies to not allow chemicals of justifiable concern, and allocate testing for plausible contaminants.[65]

According to a 2020 review, regulation is needed to inform e-cigarette users of possible metal/metalloid exposure through vaping as well as to prevent metal/metalloid exposure during e-cigarette use.[152] A 2024 review showed that increasing taxation, banning flavors, sale licenses, and label warnings on e-cigarettes have decreased the incidences of youth vaping in affluent countries.[153] Although no single regulation has been found to be the most effective, having multiple regulations does make an impact in decreasing vaping among the youth in affluent countries.[153]

Regulation of the production and promotion of e-cigarettes may help lower some of the adverse effects associated with tobacco use.[154] Scientists are doing research to obtain more data regarding e-cigarettes and their usage.[155] This knowledge could result in additional regulations in the US.[155] E-cigarettes are permitted for sales in the US, though some organizations in the US have recommended they be completed banned.[77] The American Heart Association had urged a total ban on e-cigarette sales, stating that there is sufficient evidence linking e-cigarettes with adolescent's addiction to nicotine and with lure of never-smokers to smoking.[77]

In order to protect the public from both second-hand smoke and second-hand e-cigarette aerosol, the Surgeon General of the United States emphasized that smoke-free policies should be modernized to incorporate e-cigarettes, an approach that "will maintain current standards for clean indoor air, reduce the potential for renormalization of tobacco product use, and prevent involuntary exposure to nicotine and other aerosolized emissions from e-cigarettes."[156] A 2019 review states, it is imperative to establish regulations for e-cigarette construction, e-liquid and aerosol composition, health warnings, marketing, promotion, sales, taxation, and exposure to second-hand aerosol, with standards that are at least on par with those for traditional tobacco products.[157]

Public health consequences

The public health consequence of vaping is actively being debated.[158] The health community, pharmaceutical industry, and other groups have raised concerns about the emerging phenomenon of e-cigarettes, including the unknown health risks from their long-term use.[151] The rise in e-cigarette use among the general population raises concern.[119] E-cigarettes pose potential risks to the population as a whole.[159] Concerns have been raised that higher rates of never smokers initiating e-cigarettes would result in net public health harms via increased nicotine addiction.[160]

One of the serious concerns in public health is the increase in trying an e-cigarette among people who have not smoked, particularly children and adolescents, which can result in nicotine addiction and possible progression to smoking.[157] The prevalence of newer types of e-cigarettes, including Juul, with greater levels of nicotine is a public health catastrophe.[101] In December 2018, the US Surgeon General said vaping among youth is an epidemic.[101] Misinformation may downplay the risks of vape use and may be in part responsible for the recent youth vaping epidemic.[161] The rise in the rate of vaping among youth in Australia and New Zealand are a major public health concern.[25] The direct health risks, the association of e‐cigarette use with taking up tobacco smoking, and the uncertainty about their effects on major health outcomes mean that e‐cigarette use by non‐smokers, especially children and adolescents, is an important public health problem.[115] Their indiscriminate use is a threat to public health.[21]

E-cigarettes could cause public health harm if they: increase the number of youth and young adults who are exposed to nicotine, or lead non-smokers to start smoking conventional cigarettes and other burned tobacco products such as cigars and hookah, or sustain nicotine addiction so smokers continue using the most dangerous tobacco products – those that are burned – as well as e-cigarettes, instead of quitting completely, or increase the likelihood that former smokers will again become addicted to nicotine by using e-cigarettes, and will start using burned tobacco products again.[159] Many questions remain unanswered regarding their overall effect on public health.[7]

The range of e-liquid flavors available to consumers is extensive and is used to attract both current smokers and new e-cigarette users, which is a growing public health concern.[82] The widespread availability and popularity of flavored e-cigarettes is a key concern regarding the potential public health implications of the products.[162] A critical public health concern is the increased use among pregnant women.[163] E-cigarettes are not safe for youth, young adults, pregnant women, or adults who do not currently use tobacco products.[164] Because of the risk of nicotine exposure to the fetus and adolescent causing long-term effects to the growing brain, the World Health Organization does not recommend it for children, adolescents, pregnant women, and women of childbearing age.[19] E-cigarettes are an increasing public health concern due to the rapid rise among adolescents and the uncertainty of potential health consequences.[165]

Another area of concern is the public health consequences of second-hand e-cigarette vapor on bystanders.[166] Second-hand e-cigarette vapor is a significant public health issue because of the tremendous growth in the number of e-cigarette users.[58] The use of e-cigarettes in public areas poses a serious health risk considering the various toxic constituents that have been shown to affect both the primary user and bystanders of passive vaping.[166] It is pertinent to note that smoke-free laws in the US were passed before e-cigarettes entered the market and do not specifically mention the prohibition of e-cigarette vaping in many places.[166] As such, this non-clarity may lead to non-compliance or exploitation of smoke-free rules.[166] Greater e-cigarette vapor exposure to bystanders may undermine public policies to restrict second-hand smoke and may renormalize smoking habits.[167]

Adverse effects

Serious adverse effects of vaping include corneoscleral lacerations or ocular burns or death after e-cigarette explosion. Less serious adverse effects of vaping include eye irritation, blurry vision, dizziness, headache, throat irritation, coughing, increased airway resistance, chest pain, increased blood pressure, increased heart rate, nausea, vomiting, and abdominal pain.
Potential adverse effects of vaping.[168]

The short-term and long-term effects from e-cigarette use remain unclear.[25] The long-term health consequences from vaping is probably somewhat greater than nicotine replacement products,[81] They may cause long-term and short-term adverse effects, including airway resistance, irritation of the airways, eyes redness, and dry throat.[169] Serious adverse events related to e-cigarettes were hypotension, seizure, chest pain, rapid heartbeat, disorientation, and congestive heart failure but it was unclear the degree to which they were the result of e-cigarettes.[26] Less serious adverse effects include abdominal pain, dizziness, headache, blurry vision,[26] throat and mouth irritation, vomiting, nausea, and coughing.[7] There are no recognized benefits of vaping for youth.[170]

Nicotine poisoning associated with e-cigarettes may arise from inhalation, absorption, or ingestion via the skin or eyes.[37] Accidental poisoning can result from using undiluted concentrated nicotine when mistakenly used as prepared e-liquids.[171] There is a possibility that inhalation, ingestion, or skin contact can expose people to high levels of nicotine.[154] Concerns with exposure to the e-liquids include leaks or spills and contact with contaminants in the e-liquid.[172] E-liquid presents a poisoning risk, particularly for small children, who may see the colorful bottles as toys or candy.[156] The e-liquid can be toxic if swallowed, especially among small children.[36]

The possibility of injury caused by e-cigarette explosions is a concern for adults and children.[38] The exact causes of such incidents are not yet clear.[173] Some batteries are not well designed, are made with poor quality components, or have defects.[40] Major injuries have occurred from battery explosions and fires.[7] Direct harms from an e-cigarette blast include hand harms, face harms, waist/groin harms, and inhalation harms.[174] Indirect harms happened when the vaporing device set on fire another object and resulted in a house fire, followed by harm from fire burns or inhalation.[174] Several people have died as a result of e-cigarette blasts with parts of the device hitting the head and neck area.[11]

Toxicology

Limited understanding

Figure shows the role of reactive oxygen species (ROS) in the development of cancer. The increase in ROS in normal cells triggers stress responses and DNA repair to repair the ROS-mediated damage to genetic materials. However, the exposure to high levels of oxidants and the consequential redox imbalance leads to DNA damage, including base mismatch, single-strand break, or double-strand break. Moreover, ROS induce DNA mutations that could cause a loss of p53 function and DNA repair disfunction, leading to genomic instability, which further leads to the activation of oncogenes, aberrant metabolic stress, mitochondrial dysfunction, and a decrease in antioxidants. All these events activate a vicious cycle that amplifies oxidative stress and promotes cancer development.
Figure shows the role of reactive oxygen species (ROS) in the development of cancer.[175] The increase in ROS in normal cells triggers stress responses and DNA repair to repair the ROS-mediated damage to genetic materials.[175] However, the exposure to high levels of oxidants and the consequential redox imbalance leads to DNA damage, including base mismatch, single-strand break, or double-strand break.[175] Moreover, ROS induce DNA mutations that could cause a loss of p53 function and DNA repair disfunction, leading to genomic instability, which further leads to the activation of oncogenes, aberrant metabolic stress, mitochondrial dysfunction, and a decrease in antioxidants.[175] All these events activate a vicious cycle that amplifies oxidative stress and promotes cancer development.[175]

The long-term health impacts of e-cigarette use are unknown.[36] The long-term health impacts of the main chemicals nicotine and propylene glycol in the aerosol are not fully understood.[176] There is limited peer-reviewed data about the toxicity of e-cigarettes for a complete toxicological evaluation,[177] and their cytotoxicity is unknown.[178] A limited number of e-cigarettes in the marketplace have undergone a comprehensive toxicological examination.[89]

The chemicals and toxicants used in e-cigarettes have not been completely disclosed and their safety is not guaranteed.[154] While there is variability in the ingredients and concentrations of ingredients in e-cigarette liquids, tobacco smoke contains thousands of chemicals, most of which are not understood and many of which are known to be harmful.[151] Because there are numerous variations of vaping devices, diverseness in e‑liquids, and differences in usage behaviors, the potential toxicity of the inhaled emissions to the user is hard to quantify.[91] Many variables affect the levels of toxicants in the e-cigarette vapor, including the design, the type of liquid, and user behavior.[129]

Carcinogenicity

Concerns about the carcinogenicity of e-cigarettes arise from both nicotine[46] and from other chemicals that may be in the vapor.[54] There is no long-term research regarding the cancer risk related to the potentially small level of exposure to the identified carcinogens in the e-cigarette vapor.[8] Their long-term effect on risk of developing cancer is not known.[45] Heating the products in e-cigarettes produces condensed carcinogenic hydrocarbons and products toxic to the human body.[179] One example is the presence of nickel and ethylene oxide, substances linked to lung and sinus cancers, lymphomas, multiple myeloma, and leukemia.[179] In animal studies, nicotine alone causes sarcomas and leiomyomas.[180]

The International Agency for Research on Cancer does not consider nicotine to be a carcinogen, though several studies demonstrate it is carcinogenic.[48] Because it can form nitrosamine compounds (particularly N-Nitrosonornicotine (NNN) and nicotine-derived nitrosamine ketone (NNK)) through a conversion process, nicotine itself exhibits a strong potential for causing cancer.[3] About 10% of breathed in nicotine is estimated to convert to these nitrosamine compounds.[3] Nitrosamine carcinogenicity is thought to be a result of enhanced DNA methylation and may lead to an agonist response on the nicotinic acetylcholine receptors, which acts to encourage tumors to grow, stay alive, and penetrate into neighboring tissues.[3] Although nicotine in the form of nicotine replacement products is less of a cancer risk than with smoking,[181] there is evidence that nicotine may cause oral, esophageal, or pancreatic cancer.[182] Nicotine has a strong tumor-inducing effect on several kinds of cancers.[14] This is because "nicotinic receptors are expressed on the surface of tumor and immune cells, enabling nicotine to directly affect the tumor microenvironment."[14]

The World Health Organization has identified heated propylene glycol as a carcinogen, and the saliva of e-cigarette users has been found to contain carcinogens commonly associated with traditional smoking, including N-nitrosonornicotine and thiocyanates.[183] Therefore, e-cigarette vapors could still have cytotoxic, genotoxic, and inflammatory effects.[183] Many adverse effects could occur at the cellular level after long-term exposure to these harmful aerosols, including reduced cell proliferation and activity, changes in cell morphology and activity, cell apoptosis and necrosis, DNA damage, and increased transcription of pro-inflammatory cytokines, with an increased risk of carcinogenesis.[183]

Cancer cell proliferation and survival

FOXM1 upregulation may be enhanced by nicotine during malignant transformation. Nicotine may activate endogenous FOXM1 transcriptional activity and promoted FOXM1B-induced malignant transformation in human oral keratinocytes. Upregulation of FOXM1 may induce genomic instability.
FOXM1 upregulation may be enhanced by nicotine during malignant transformation.[184] Nicotine may activate endogenous FOXM1 transcriptional activity and promoted FOXM1B-induced malignant transformation in human oral keratinocytes.[184]

Evidence from experimental in vitro studies on cell cultures, in vivo studies on rodents as well as studies on humans inclusive of epidemiological studies indicate that nicotine itself, independent of other tobacco constituents, may stimulate a number of effects of importance in cancer development.[185]

Nicotine acts primarily by activation of nicotine acetylcholine receptors and nicotine binds to these receptors with a higher affinity than acetylcholine.[185] Nicotine can enhance cancer cell survival via attaching to nicotinic receptors.[14] It may also diminish cancer cell death resulting from chemotherapy, radiotherapy, or tyrosine kinase inhibitors.[14] Nicotine promotes metastasis by causing cell cycle progression, epithelial-to-mesenchymal transition, migration, invasion, angiogenesis, and avoidance of apoptosis in a number of systems.[186] Nicotine does promote the growth of blood vessels that supply tumors and it speeds tumor growth.[112]

Whether long-term vaping can raise the chance for malignancy in individuals with a susceptibility for tumor growth is unknown.[187] The effects of nicotine on the sympathoadrenal system could stimulate the advancement of cancer in people who have cancer.[14] The stimulation effects of nicotine on cancer development and growth may also be associated with other forms of nicotine use such as patch, nasal or mouth spray, inhalator, mouth strip, gum, and lozenge.[14]

The interaction of nicotine with nicotinic acetylcholine receptors activates signaling pathways that result in a number of reactions, such as increased cell proliferation and cell survival.[185] Although nicotinic acetylcholine receptors are the primary receptors, binding of nicotine to β-ARs and EGFRs may also be important.[185] Nicotine induces epithelial–mesenchymal transition, which is one of the vital steps for the acquisition of malignant phenotype.[185] This transition allows the cell to acquire migratory properties, which may facilitate cancer metastases.[185] Moreover, nicotine induces changes that mimic the effects of angiogenic growth factors.[185]

In mice studies with NNK as an initiator, nicotine acts as a promoter after injection or dermal absorption, but not after oral administration.[185] In drinking water experiments, there is considerable first-pass metabolism of nicotine before nicotine enters the systemic circulation.[185] As a result, serum concentration is much lower after ingestion than after intraperitoneal injection administration.[185] Nicotine enhanced tumor growth and progression after injection of malignant cells in mice.[185] Enhancements were found both after exposure of nicotine by intraperitoneal injection, oral, and skin administration.[185] Moreover, cotinine did also enhance tumor growth.[185] Nicotine may inhibit antitumor immune response.[185] It has also been reported that exposure to nicotine adversely affects dendritic cells, a cell type that has an important role in anticancer immunosurveillance.[185] Moreover, in studies on xenograft in mice, nicotine has been found to reduce the effect of radiotherapy and chemoradiotherapy.[185]

Upregulation of FOXM1 expression is an early event during cancer development.[188] The evidence suggests that FOXM1 plays a key role in cancer initiation.[188] FOXM1 also promotes cancer progression by facilitating cancer angiogenesis, invasion, and metastasis.[188] Upregulation of FOXM1 by itself can exacerbate genomic instability.[189] This is calculated by loss of heterozygosity and copy number variations in human oral keratinocytes.[189] Moreover, nicotine exacerbates FOXM1-induced genomic instability.[189]

DNA damage and oxidative stress

Chart showing various toxicants as measured in cigarette smoke and e-cigarette aerosol.
Chart showing various toxicants as measured in cigarette smoke and e-cigarette aerosol[190]
Figure shows the summary of described effects of nicotine e-cigarettes liquid and aerosols on neural stem cell mitochondria. E-cigarettes treatments led to altered mitochondrial membrane potential, induced aggregation of mitochondrial nucleoids and mitochondrial DNA, and induced calcium influx leading to plasma membrane retraction and intracellular calcium overload.
Figure shows the summary of described effects of nicotine e-cigarettes liquid and aerosols on neural stem cell mitochondria.[191] E-cigarettes treatments led to altered mitochondrial membrane potential, induced aggregation of mitochondrial nucleoids and mitochondrial DNA, and induced calcium influx leading to plasma membrane retraction and intracellular calcium overload.[191]

Nicotine has been shown to induce DNA damage in the Escherichia colipol A+/pol− test.[185] Low concentrations of nicotine stimulate cell proliferation, while high concentrations are cytotoxic.[185] Nicotine decreases the tumor suppressor Chk2, which is activated by DNA damage.[185] The decrease in Chk2 in cells exposed to nicotine suggests that nicotine may be capable of overriding DNA damage checkpoint activation, disrupting genetic surveillance, and increasing the risk of oncogenesis.[185] There is strong evidence that some substances found in e-cigarette vapors such as formaldehyde and acrolein can induce DNA damage and mutagenesis.[192]

Nicotine has been shown to induce chromosomal aberration, chromatid exchange, single-strand DNA strand breaks, and micronuclei in vitro.[185] Oxidative stress is probably involved since the effects are reduced in the presence of antioxidants.[185] The finding that the effects decrease after co-incubation with a nicotinic acetylcholine receptor antagonist indicates a receptor-dependent pathway for induction of oxidative stress.[185] All types of e-cigarettes, including non-nicotine ones, have been reported to induce oxidative stress, thereby increasing the risk of cognitive-related impairment in teenagers.[136]

The e-cigarette vapors triggered DNA strand breaks and lowered cell survival in vitro,[87] regardless of nicotine content.[193] A 2013 study found some samples of e-cigarette vapors had cytotoxic effects on cardiac muscle cells, though the effects were less than with cigarette smoke.[15] Studies demonstrate that e-cigarette vapor have adverse effects on primary airway epithelial cells and tumor cell lines, and other epithelial cell lines, that ranged from reducing viability, an increase in production of inflammatory mediators and oxidative stress, to reducing antimicrobial defences and pro-carcinogenic events.[194]

The potential effects of next-generation products on oxidative stress are being debated.[175] A deviation from the metabolic steady state leads to the concept of oxidative stress.[175] Oxidative stress describes an imbalance between oxidants, such as reactive oxygen species or reactive nitrogen species, and antioxidant species, in favor of oxidants.[175] The aerosols produced from next-generation products (such as e-cigarettes) can result in oxidative stress.[175] A 2017 study showed that e-cigarettes have a potent booster effect on phase I carcinogen bioactivation enzymes, including polycyclic aromatic hydrocarbon activators, and increase oxygen free radical production and DNA oxidation to 8-hydroxy-2'-deoxyguanosine.[175]

There is limited research examining the impact of nicotine exposure on neural stem cells and their mitochondria.[191] A 2019 study demonstrated a mitochondrial stress response in neural stem cells following exposure to e-liquids and their aerosols.[191] The study also reported that the effects of e-cigarettes on the mitochondria are mediated by nicotine and not by the transfer of volatile organic chemicals or solvents found in e-liquids (propylene glycol and glycerin).[191] This study also provided evidence that e-liquids and aerosols can cause significant, not-easily-reversible damage to the mitochondria of neural stem cells.[191]

E-cigarette treatments led to changes in the mitochondrial membrane potential, incited aggregation of mitochondrial nucleoids and mitochondrial DNA, and incited calcium influx, which resulted in plasma membrane retraction and intracellular calcium overload.[191] Nicotine appears to have differential effects on these immature cells of neural lineage, which depends on both location and maturation.[191] The mitochondria of neural stem cells appear to play an important role in these interactions between neural stem cells, glia, and nicotine.[191] Nicotine may have varying effects on neural stem cells which depends on the route of administration.[191]

Tobacco-specific nitrosamines and toxicants

Endogenous formation of tobacco-specific nitrosamines may occur after absorption of nicotine.
Endogenous formation of tobacco-specific nitrosamines may occur after absorption of nicotine.[185]

A range of chemicals and ultrafine particles are toxic and/or carcinogenic have been found in the e-liquids and inhaled and exhaled e-cigarette aerosols.[54] The majority of e-cigarettes evaluated included carcinogenic tobacco-specific nitrosamines; heavy metals such as cadmium, nickel, and lead; and the carcinogen toluene.[154] However, in comparison to traditional cigarette smoke, the toxic substance levels identified in e-cigarette vapor were 9- to 450-fold less.[154] E-liquid with tin was cytotoxic.[68] A 2018 study found significantly higher amounts of metals in e-cigarette vapor samples in comparison with the e-liquids before they came in contact with the customized e-cigarettes.[195] For example, nickel and tin were 600% higher in the e-cigarette vapor than in the e-liquid.[195]

Since nicotine-containing e-liquids are made from tobacco they may contain impurities like cotinine, anabasine, anatabine, myosmine and beta-nicotyrine.[36] The health implications of nicotine-related impurities are not known.[162]

The tobacco-specific nitrosamines NNN (N-nitrosonornicotine) and NNK (4-(metylnitrosamino)-1-(3-pyridyl)-1-butanone) may be formed from nicotine after oral administration.[185] After uptake of nitrosamines, including but not limited to NNK and NNN, they are metabolized by cytochrome P450s, and the resulting metabolites can subsequently breakdown into formaldehyde, methyldiazohydroxides, and pyridylic-butylic by-products.[180] All of these by-products are possible DNA harming substances, whereas the cancer-causing characteristics of nitrosamines are mainly associated with methyldiazohydroxides.[180] Methyldiazohydroxides can provoke the formation of mutagenic and carcinogenic O6-methyl-deoxyguanosines adducts, and can also form minuscule adducts of methylated thymine and methylated cytosine.[180] NNN and NNK are classified by International Agency for Research on Cancer as human carcinogens.[185]

Brain cancer

In a 2020 study, chronic administration of nicotine to mice (1 mg/kg every 3 days for a 60-day period) enhanced brain metastasis by skewing the polarity of M2 microglia, which increases metastatic tumor growth.[82] Nicotine can contribute to causing brain metastasis.[196] A 2021 review states that a 2020 study produced conclusive evidence that e-cigarette use may aid in sustaining malignancy.[13] Immunocompetent mice undergoing orthotopic breast tumor cell injection exposed to nicotine containing e-cigarette aerosol successfully developed tumors in all cases, whereas only one third of the control group did.[13]

Breast cancer

Nicotine may promote breast cancer initiation, development, angiogenesis, invasion, and metastasis, as well as possibly reducing the response to breast cancer treatment.[197] E-cigarette aerosol encourages breast carcinoma development in vitro by means of macrophage-tumor cells cross-talk, aided by both CCL5 and VCAM-1.[84]

Colorectal cancer

The use of alcohol with nicotine increases the likelihood of getting colorectal cancer.[198]

Gastrointestinal cancer

4-(metylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a nitrosated derivative of nicotine, has been implicated in its carcinogenic effects in promoting gastrointestinal cancers.[199]

Head and neck cancers

Schematic diagram of the biological role of FOXM1 in carcinogenesis. Research has shown that FOXM1 has a complex and diverse role in carcinogenesis. The effects of FOXM1 are mediated by numerous downstream targets as shown in this figure.
Schematic diagram of the biological role of FOXM1 in carcinogenesis.[200] Research has shown that FOXM1 has a complex and diverse role in carcinogenesis.[200] The effects of FOXM1 are mediated by numerous downstream targets as shown in this figure.[200]

Nicotine encourages the development of head and neck cancer by inducing endogenous activity of FOXM1 through loss of heterozygosity via participation in the entirety of chromosome 13 and by inducing copy number abnormality via participation in oral keratinocytes.[201][202] FOXM1 has been shown to possess the ability to cross-talk with other molecules that play a role in cancer development (like: NF-κB, prostaglandin-endoperoxide synthase 2, extracellular signal-regulated kinases, and matrix metalloproteinase).[203] In most human cancers, FOXM1 is overexpressed.[204] FOXM1 is a crucial regulator of many biological processes and tissues, and dysregulation of FOXM1 can significantly contribute to tumorigenesis and cancer progression.[204]

Because of the conflicting evidence, the role that vaping plays in the development of head and neck cancers is obscure and inconclusive.[205] There is just a minimal amount of literature that is applicable to vaping and head and neck cancers.[205] There is some evidence suggesting a potentially carcinogenic role of e-cigarettes in the pathogenesis of head and neck cancers.[206]

According to the International Agency for Research on Cancer, acrolein, which has been found in e-cigarette aerosol, is classified as a group 2A compound—probably carcinogenic to humans.[179] There is plenty of evidence from in vitro, in vivo, and human cohort studies that indicate this aldehyde’s cancer potential.[179] Moreover, the research shows that acrolein, by affecting specific signaling pathways, is not only directly involved in mutagenesis but also contributes to increasing the resistance of cancer cells to traditional cisplatin chemotherapy.[179] Clear evidence for the carcinogenic and cytotoxic properties of acrolein is provided by the studies of Matsumoto et al., where a 2-year inhalation of acrolein in both mice and rats induced, among others, squamous cell carcinomas in the nasal cavity.[179]

Lung and bladder cancers

There is growing concern that vaping may increase the likelihood of developing lung cancer.[3] The long-term effects of e-cigarette use on developing lung cancer is unknown,[3] though their long-term use is anticipated to raise the risk of developing lung cancer.[51] A 2021 review suggested that e-cigarette use may greatly increase the risk of developing lung cancer.[3] There is emerging evidence that indicates vaping could play a part in the development of other malignant tumors like lung and bladder cancers.[205]

A 2019 study showed that mice exposed to nicotine delivered by means of e-cigarette aerosol develop lung adenocarcinoma.[207] This suggests the need for caution when using nicotine replacement therapies and e-cigarettes.[207] A 2019 study showed that FVB/N mice exposed for 54 weeks to e-cigarette aerosol resulted in extensive DNA damage in the lungs, heart, and bladder mucosa and reduced DNA repair in the lungs.[175] Products derived from e-cigarette aerosol, such as nicotine and its derivatives, cause the same deleterious effects in human lung epithelial cells and bladder urothelial cells.[175]

Figure shows effects of e-cigarette aerosol exposure relating to cancer. Some e-cigarette aerosol-induced phenotypical changes are consistent with tumor-supporting processes and may indicate that e-cigarette use carries a risk of carcinogenesis; however, the severity of this risk has yet to be established.
Figure shows effects of e-cigarette aerosol exposure relating to cancer.[13] Some e-cigarette aerosol-induced phenotypical changes are consistent with tumor-supporting processes and may indicate that e-cigarette use carries a risk of carcinogenesis; however, the severity of this risk has yet to be established.[13]

Nicotine promotes endothelial cell migration, proliferation, survival, tube formation, and nitric oxide production in vitro, mimicking the effect of other angiogenic growth factors.[185] In 2001, it was found that nicotine was a potent angiogenic agent at tissue and plasma concentrations similar to those induced by light to moderate smoking.[185] Effects of nicotine on angiogenesis have been demonstrated for a number of tumor cells, such as breast, colon, and lung.[185] Similar results have also been demonstrated in in vivo mouse models of lung cancer, where nicotine significantly increased the size and number of tumors in the lung, and enhanced metastasis.[185]

In several in vitro experiments, it has been found that nicotine in concentrations as low as 1 μM decreased the anti-proliferative and pro-apoptotic effects exerted by chemotherapeutics on several different malignant cell lines.[185] These effects were partially reverted by exposure to α-bungarotoxin (α-BTX), an inhibitor of α7-nAChR.[185] In the case of radiotherapy (RT), nicotine administration increased survival of H460 and A549 lung cancer cells.[185] This effect was likewise reduced by addition of α-BTX prior to nicotine addition and radiation.[185] On this basis, it is expected that use of nicotine products during cancer treatment may reduce the effects due to reactions following interaction of nicotine with α7-nAChR.[185]

E-cigarettes deliver the potent lung carcinogen NNK.[112] Some evidence indicates that the NNK dose-response curve for cancer is highly nonlinear, with substantial increases in risk at low doses.[112] Known bladder carcinogens have been detected in the urine of e-cigarette users but not in non-users.[112] This included pyrene, naphthalene, fluorene, phenanthrene, and o-toluidine.[84] A 2015 study reported that the urine from users of e-cigarettes had very low levels of NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol), which may suggest that endogenous formation of TSNA after nicotine inhalation is negligible.[185] The data does indicate that TSNA may be formed internally after absorption of nicotine through the mucous membranes in the oral cavity and through the skin, while formation after lung absorption may be negligible.[185] Thus, the toxicokinetics of nicotine may depend on the route of administration.[185]

Mouth and throat cancers

Toxicological analysis of EC liquid and aerosol has revealed presence of several toxicants with known carcinogenicity. Oral cavity is the primary site of exposure of both cigarette smoke and EC aerosol. Role of EC in oral cancer is not as well-researched as that of traditional smoking. However, several recent studies have shown that it can lead to a wide range of potentially carcinogenic molecular events in oral cells.[208]

 —Meenu Maan and colleagues, Critical Reviews in Toxicology[208]

A 2015 study found carcinogenicity activity mainly occurred in the lungs, mouth, and throat, which may be associated with nitrosamines, propylene glycol and some flavoring additives.[209] No compelling evidence indicates that e-cigarette use directly causes oral cancer,[210] though several case studies have reported oral cancer development in people with a history of vaping.[13]

Stomach cancer

There is an association between long-term nicotine use and initiating the onset of gastric tumors.[199]

Urologic cancer

The long-term effects of vaping on urologic malignancy are not well understood but because of their likenesses to tobacco smoke, their possible consequences are worrying.[84]

Sarcoma

Nicotine can cause muscle sarcomas in A/J mice.[201] Long-term uptake of nicotine in A/J mice causes leiomyosarcomas and rhabdomyosarcomas.[201] This suggests nicotine directly participates in initiating cancer.[201]

Propylene glycol, glycerin, and other content

An image of the propylene glycol molecule.
The propylene glycol molecule

The primary base ingredients of the liquid solution is propylene glycol and glycerin.[7] About 20% to 27% of propylene glycol and glycerin-based liquid particles are inhaled.[211] A 2016 study found that 6% of nicotine, 8% of propylene glycol, and 16% of glycerin was breathed out by e-cigarette users.[212] The long-term effects of inhaled propylene glycol has not been studied,[213] and is unknown.[160] The effects of inhaled glycerin are unknown.[21] Being exposed to propylene glycol may cause irritation to the eyes and respiratory tract.[7] When propylene glycol is heated and aerosolized, it could turn into propylene oxide, which the International Agency for Research on Cancer states is possibly carcinogenic to humans.[7][193] Propylene glycol and glycerin have not been shown to be safe.[21]

Some research states that propylene glycol emissions may cause respiratory irritation and raise the likelihood to develop asthma.[125] Long-term inhalation of propylene glycol indoors could increase risk to children to develop asthma.[126] To lessen the risks, most e-cigarettes companies began to use water and glycerin as replacement for propylene glycol.[125] The inhaled glycerin could cause lipoid pneumonia.[214] Research indicates that the presence of propylene glycol and glycerin can boost the production of hydrogen peroxide.[215] E-cigarettes vapors have been found to contain propylene glycol, glycerin, volatile organic compounds, and free radicals, which can impair lung health.[50] A 2014 study showed that e-liquids from a specific manufacturer contained greater amounts of ethylene glycol than glycerin or propylene glycol, but ethylene glycol has not been permitted for use in products meant for human consumption.[216]

The toxicity of e-cigarettes and e-liquid can vary greatly, as there are differences in construction and materials in the delivery device, kind and origin of ingredients in the e-liquid, and the use or non-use of good manufacturing practices and quality control approaches.[177] If exposure of aerosols to propylene glycol and glycerin rises to levels that one would consider the exposure in association with a workplace setting, it would be sensible to investigate the health of exposed persons.[105] The short-term toxicity of e-cigarette use appears to be low, with the exception for some people with reactive airways.[43]

Acrolein

Some e-cigarette products had acrolein identified in the aerosol.[36] It may be generated when glycerin is heated to higher temperatures.[36] Acrolein may induce irritation to the upper respiratory tract,[7] and harm the lining of the lungs.[44] Acrolein induces oxidative stress and inflammation, leading to a disruption in the function of the endothelial cell barrier in the lung.[215] Acrolein may lead to chronic obstructive pulmonary disease.[215] Acrolein levels were reduced by 60% in dual users and 80% for those that completely switched to e-cigarettes when compared to traditional cigarettes.[36] Taking into account the typical 120 puffs per day as cited in the literature, the calculated acrolein levels released by e-cigarette users per day were identified to range between 0.00792 and 8.94 ppm.[209] Since these levels persist within the range that is harmful to cardiovascular health, acrolein emissions from e-cigarettes may inflict similar damage compared to that of tobacco smoking.[209]

Oxidants and reactive oxygen species

E-cigarettes vapor have been found to create oxidants and reactive oxygen species.[41] Oxidants and reactive oxygen species could react with other substances in the e-cigarette vapor because they are highly reactive.[41] Although e-cigarettes have been found to contain oxidants and reactive oxygen species at about 100 times less than in cigarette smoke, they probably induce meaningful biological effects.[41]

Ethanol

Different amounts of ethanol have been identified in e-liquids, even in instances when it is not disclosed as an ingredient.[217] There are flavoring chemicals that are sold in solvents.[218] For instance, vanilla extract is typically available in a liquid containing ethanol.[218] A 2017 study discovered the highest amounts of ethanol in testing various e-liquids were 7.7-fold greater than the restricted amount of 0.05% for pharmaceutical drugs.[217]

Ethanol is commonly included as a solvent.[52] For example, a 2016 study found that 30 of 42 of e-liquid brands were made up of ethanol, which is linked to an unfavorable impact on psychomotor performance.[52] A 2016 study found vaping using an e-liquid containing 23% alcohol was linked to reduced performance on the Purdue Pegboard Test.[219] E-liquids containing alcohol produce detectable levels of alcohol metabolites in the urine.[220] The amount of ethanol inhaled by the e-cigarette user is unknown.[217] The short-term pharmacodynamics of breathing in alcohol e-cigarette vapor is not known.[219]

Flavoring

Overview

The ingredients in an e-cigarette cartridge: Distilled water, Nicotine, FCC Grade Vegetable Glycerin, Natural Flavors, Artificial Flavors, Citric Acid. Nicotine content 6–8 mg per cartridge.
The ingredients in an e-cigarette cartridge: Distilled water, Nicotine, FCC Grade Vegetable Glycerin, Natural Flavors, Artificial Flavors, Citric Acid. Nicotine content 6–8 mg per cartridge.

The essential propylene glycol and/or glycerin mixture may consist of natural or artificial substances to provide it flavor.[43] Health effects of e-cigarette flavorings are not entirely known.[221] There is very limited toxicological data on inhaling flavoring additives.[93] Flavorings can be a significant part of toxicants in the e-cigarette vapor.[222] Each flavor has a different chemical composition, and therefore, probably, a distinct composition of toxicant emissions.[222] The precise ingredients in e-cigarettes are not known.[223]

The cytotoxicity of e-liquids varies,[42] and contamination with various chemicals have been detected in the liquid.[43] Some liquids were very toxic and others had little or no cytotoxicity.[42] The cytotoxicity is mostly due to the amount and number of flavors added.[42] The limited data available on their flavoring agents suggest that the majority of flavorings could lead to significant health risks from long-term use, particularly the ones that are sweet.[224] The majority of flavorings in e-liquids have not been investigated for toxicity by means of inhalation.[225]

Since nicotine has a bitter taste, nicotine e-liquids contain chemicals to cover up the nicotine taste.[41] The liquids contain aromatic substances like tobacco, fruit, vanilla, caramel, and coffee.[43] Generally, these additives are imprecisely described, using terms such as "vegetable flavoring".[43] Although they are approved for human consumption there are no studies on the short-term or long-term effects of inhaling them.[43] The safety of inhaling flavors is mostly unknown,[226] and their safety has not been determined by the Flavor and Extract Manufacturers Association.[87]

Contents

Certain flavorings contain diacetyl and acetyl propionyl which give a buttery taste.[55] Some sweet flavors containing diacetyl and acetyl propionyl include butter, chocolate, milk, or toffee.[227] Diacetyl occurs in a variety of e-cigarette flavorings such as caramel, butterscotch, watermelon, pina colada, and strawberry.[228] A 2016 Harvard study detected 39 of the 51 flavored e-cigarettes tested contained diacetyl.[229] Menthol flavorings could contain diacetyl.[228]

Many flavors are known aldehydes, such as anisaldehyde, cinnamaldehyde, and isovaleraldehyde.[41] Both diacetyl and acetyl-propionyl have been found in concentrations above those recommended by the US National Institute for Occupational Safety and Health.[55] Diacetyl is normally found at lower levels in e-cigarettes than in traditional cigarettes.[55] Saccharides in sweet e-liquid flavors break down and generate furans and aldehydes when vaporized.[230]

The Centers for Disease Control tested in 2015 36 e-cigarette products for 10 flavor compounds commonly used as additives in tobacco products.[162] Measurable levels of eucalyptol and pulegone were found in the menthol-flavored varieties for all manufacturers.[162] Menthol concentrations ranged from 3,700 to 12,000 μg/g in flavored e-liquids, levels similar to those found in the filler of traditional cigarettes.[162] Interestingly, menthol was found at low concentrations in 40% of the tobacco-flavored nonmenthol products tested.[162] Other flavor compounds found were camphor, methyl, salicylate, pulegone, cinnamaldehyde, and eugenol.[162]

Pharmacologic compounds

A 2010 study found rimonabant when examining e-liquids.[231] This weight loss drug has been linked to seizures and suicide.[231] The same study also determined e-liquid can contain amino-tadalafil which is a component of Cialis, used for erectile dysfunction.[231] Users are at risk of encountering negative health outcomes from the small possibility of being exposed to pharmacologic compounds in some e-liquids.[231]

Toxicity

Some flavors are regarded as toxic and a number of them resemble known carcinogens.[43] The cytotoxicity of some flavors such as strawberry seems to be greater than others.[232] A 2016 study of five flavors across six types of e-cigarettes found that flavors significantly affected the in vitro toxicity profile and the strawberry-flavored product was the most toxic.[233] Some artificial flavors are known to be cytotoxic.[43] Unflavored vapor is less cytotoxic than flavored vapor.[234] A 2012 study demonstrated that in embryonic and adult cellular models, some substances of the e-cigarette vapor such as flavoring not found in tobacco smoke were cytotoxic.[235]

Cinnamaldehyde has been described as a highly cytotoxic material in vitro in cinnamon-flavored refill liquids.[40] Cinnamaldehyde has also been detected in tobacco flavors, sweet flavors (e.g. caramel), and fruit flavors.[236] Cinnamaldehyde have been identified as cytotoxic at the amount of about 400 times less than those allowed for use by the US Environmental Protection Agency.[16] Compared to other flavors, coffee and cinnamon flavor are the most toxic.[227]

In sampling multiple e-cigarette delivery systems, a 2019 study found Juul pods were the only product to demonstrate in vitro cytotoxicity from both nicotine and flavor chemical content, in particular ethyl maltol.[237] Preliminary toxicological data suggests that synthetic coolants (e.g., WS-23 and WS-3) inhaled from the e-cigarette vapors are high enough to inflict adverse effects and possibly high enough to inflict toxicological effects.[238] E-liquids contain possibly toxic aldehydes and reactive oxygen species (ROS).[41] A 2012 study found butterscotch flavor was highly toxic with one liquid and two others had a low toxicity.[116]

Figure shows chemical compounds exclusively reported in e-liquids, as of 2019. When comparing with conventional cigarettes, a total of 50 chemical compounds were exclusively reported to be present in e-liquids.
Figure shows chemical compounds exclusively reported in e-liquids, as of 2019.[141] When comparing with conventional cigarettes, a total of 50 chemical compounds were exclusively reported to be present in e-liquids.[141]

The long-term toxicity is subject to the additives and contaminants in the e-liquid.[43] It is possible that flavors may worsen some of harmful effects in various cell types such as diminished cell viability, escalated rates of apoptosis, escalated DNA strand breaks, alterations in cell morphology and intensified inflammatory mediator production.[222] There is limited information available on the impact of flavors in the e-cigarette vapor on the DNA damage at the molecular scale.[180]

Because benzaldehyde can irritate the eyes and mucous membranes of the respiratory tracts with workplace exposure, concerns have been expressed regarding the toxicity of flavored e-cigarette vapor.[239] Various candy and fruit flavor e-liquids that are enticing to youth exhibit in cell culture cytotoxic or mutagenic effects.[240] Compared to other flavors, cherry contains a greater amount of benzaldehyde,[227] a main ingredient for a variety of fruit flavors.[228]

Irritants

Many flavors are irritants.[51] The irritants butyl acetate, diethyl carbonate, benzoic acid, quinoline, bis(2-ethylhexyl) phthalate, and 2,6-dimethyl phenol were present as undeclared ingredients in the e-liquid.[128] Chemical reactions may happen in e-liquids such as a reaction between aldehyde-containing flavors like vanillin and propylene glycol or glycerin.[218] This reaction happens at room temperature and creates new acetal substances which have a higher likelihood of causing irritation than the original substances they were created from.[218]

Respiratory effects

At least 65 unique flavor chemicals in e-cigarette aerosols trigger toxicity in the circulatory system, skeletal system, respiratory tract, and skin, as of 2021.[241] Many flavoring additives likely cause respiratory effects not typically seen in cigarette smokers.[93] Some flavorings could cause lung inflammation.[228] Fruity, sweet, and traditional tobacco flavorings may result in lung toxicity.[242] Flavorings can harm lung cells by producing free radicals and inflammation.[193] Some e-liquids containing cinnamaldehyde stimulate TRPA1, which might induce effects on the lung.[41] In human lung fibroblasts, cinnamon roll flavoring resulted in a noticeable rise in the amount of inflammatory cytokine IL-8.[215]

There is limited information on the effects of inhaling menthol.[93] The consequences of aldehyde-containing flavors on pulmonary surfaces are unknown.[41] An 18-year-old patient reported using a Juul device with mint flavored pods in the days leading to episodes of pneumothorax in January 2019.[237] Pulegone, a chemical for menthol and mint flavors, is a carcinogen that induces pulmonary metaplasia.[243]

In some cases e-liquids contain very large amounts of flavorings, which may cause irritation and inflammation on respiratory and cardiovascular systems.[171] A 2016 study of 30 e-cigarette products in the US market found that 13 were more than 1% flavor chemicals by weight, some of which were of potential toxicological concern (e.g., cause respiratory irritation).[233] The US Flavor and Extract Manufacturers Association, an organization representing flavor ingredient producers that assesses the safety of food flavorings, has pinpointed 1037 flavoring agents as plausible respiratory dangers due to their potential to become volatile and cause respiratory irritation.[93] The popular e-cigarette flavoring agents included in this list are: diacetyl, acetoin, 2,3-pentanedione (buttery flavors), camphor and cyclohexanone (minty flavors), benzaldehyde (cherry or almond flavors), cinnamaldehyde (cinnamon flavor), cresol (leathery or medicinal flavor), butyraldehyde (chocolate flavor), and isoamyl acetate (banana flavor).[93] The Flavor and Extract Manufacturers Association has declared the suggestion made by companies that flavor substances used in e-cigarettes and similar devices (such as hookahs) are safe to inhale due to their FEMA GRAS™ status for food use to be "false and misleading."[242]

Tierney and colleagues in 2016 analyzed 30 e-cigarette products on the US market and found 13 products contained more than 1% flavor chemicals by weight.[162] Among the chemicals identified were aldehydes (e.g., benzaldehyde and vanillin), which are categorized as primary irritants of the respiratory tract.[162] Tierney and colleagues also found that tobacco-flavored e-liquids were derived from confection-flavored chemicals (e.g., bubble gum and cotton candy flavoring) rather than tobacco extract.[162] In comparison to tobacco flavor, menthol created 330% higher levels of benzene and 120% higher levels of toluene.[83] Fruit flavor created 240% higher levels of benzene and 30% lower levels of toluene than tobacco flavor.[83]

The available evidence suggests that many aldehydes flavoring compounds, including vanillin, ethyl vanillin (vanilla), and benzaldehyde (berry/fruit), react in liquids with propylene glycol and glycerin solvents to form chemical adducts called flavor aldehyde propylene glycol/glycerin acetals.[175] Assessing the effect of these chemical flavors and their corresponding acetals on bronchial and alveolar epithelial cells, a 2020 preliminary study observed that propylene glycol acetals diminished key parameters of cellular energy metabolic functions, including basal respiration, adenosine triphosphate production, and spare respiratory capacity.[175]

2, 3-pentanedione, is a α-diketone that is chemically and structurally similar to diacetyl.[162] Although it has become a popular replacement for diacetyl, acute inhalation exposure to 2, 3-pentanedione has been shown to cause airway epithelial damage similar to diacetyl.[162] Some liquids use butyric acid instead of diacetyl and acetyl propionyl, but it could have negative health effects.[244] Respiratory toxicity resulting from flavoring agents primarily involving diacetyl and its alternatives raises concerns.[52] Concerns exist that the flavors and additives in e-cigarettes might lead to diseases, including popcorn lung.[145] Diacetyl and acetyl propionyl are associated with bronchiolitis obliterans.[55]

A 2014 in vitro study demonstrated that e-cigarette use of a "balsamic" flavor with no nicotine can activate the release of proinflammatory cytokine in lung epithelial cells and keratinocytes.[154] Some additives may be added to reduce the irritation on the pharynx.[21] A 2017 study found a variety of flavoring initiated inflammatory cytokines in lung cell cultures, of which acetoin and maltol were among the most strongest.[228]

The caffeine exposures from vaping is estimated to be considerably less than those found in caffeinated drinks.[245] There is very limited information available regarding the effects of breathing in caffeine.[245] The evidence is unclear that particular flavorings carry health risks, though there are indications that breathing in some may be a source of avoidable risks.[246]

Cardiovascular effects

The cardiovascular effects, including a vast range of flavorings and fragrances, is unknown.[247]

Asthma

There is a lack of evidence to directly associate inhalations of cinnamon with developing or aggravating asthma.[93]

Other effects

A 2014 in vitro study showed that menthol flavors have a damaging effect on human periodontal ligament fibroblast growth.[211] Being exposed to diacetyl produces morphological alterations in the liver according to animal studies.[169] Research indicates that the presence of methanol can boost the production of hydrogen peroxide.[215]

Regulations

The extensive and unregulated use of flavoring additives may pose health concerns.[93] A 2015 review recommended for specific regulation for diacetyl and acetyl propionyl in e-liquid, which are safe when ingested but have been associated with respiratory harm when inhaled.[65] The American Lung Association recommended in 2016 that the US FDA require that diacetyl and other unsafe chemicals be omitted from e-cigarettes.[229]

Flavoring enhancers

Flavoring enhancers are frequently used in e-liquids to improve flavor.[248] Flavoring enhancers used in e-liquid include monosodium glutamate, amino acids and hydrolyzed proteins such as inositol, leucine, and glutamic acid, ethyl pyrazine, caffeine, capsicum, ethylguaiacol, ethyl maltol, γ-Octalactone, isobutavan, malic acid, citric acid, sucralose, syringol, triacetin, vanillin, maltol, sucralose, and tartarazine.[248]

Some of these substances such as monosodium glutamate can lead to allergic reactions.[248] The toxicological profiles of them are unknown, though It is believed that some of these flavoring additives can function as oxidative and inflammatory mediators and result in pro-fibrotic, pro-atherogenic, pro-audiogenic, and pro-diabetic reactions such as insulin resistance as well as neurological, developmental and reproductive conditions.[248] It is unknown whether these additives may be carcinogenic - particularly when heating at high voltages with flavors.[248]

Formaldehyde

The International Agency for Research on Cancer has categorized formaldehyde as a human carcinogen, and acetaldehyde is categorized as a possible carcinogen to humans.[44] Formaldehyde induces DNA damage and inhibits DNA repair.[249] Acetaldehyde generated crosslinking of DNA-protein which impede with DNA metabolic functions, including replication, repair, recombination, transcription and chromatin remodeling.[249] Aldehydes may cause harmful health effects; though, in the majority of cases, the amounts inhaled are less than with traditional cigarettes.[44] A 2016 study found that e-liquids without flavoring generated no aldehydes, which indicated that the flavors were causing the creation of aldehydes, according to a 2018 PHE report.[250] Many chemical compounds can inadvertently be produced from e-cigarettes, especially carbonyl compounds like formaldehyde, acetaldehyde, acrolein, and glyoxal by the chemical reaction of the e-liquid when the nichrome wire (heating element) is heated,[44] to high temperatures.[154] These compounds are frequently identified in e-cigarette aerosols.[44]

Potentially hazardous carbonyls have been identified in e-cigarette aerosols produced at temperatures above 200 °C.[93] The propylene glycol-containing liquids produced the most amounts of carbonyls in e-cigarette aerosols.[44] The levels of toxic chemicals in the e-cigarette vapor were found to be 1 to 2 orders of magnitude smaller than with cigarette smoke but greater than from a nicotine inhaler.[7] Nearly all e-cigarettes evaluated, toxic and irritation-causing carbonyls were identified.[154] Reports regarding the levels of toxic chemicals were inconsistent.[154] This includes a study showing that the levels of toxicants in e-cigarettes may be higher than with cigarette smoke.[154]

Battery output voltage influences the level of the carbonyl substances in the e-cigarette vapor.[44] Some newer e-cigarette models let users boost the amount of vapor and nicotine provided by modifying the battery output voltage.[44] E-cigarettes that were modified to boost the vapor production are more dangerous to use.[149] High-voltage e-cigarettes could subject users to large amounts of carbonyls.[44] E-cigarettes with higher voltages (5.0 V[42]) can emit carcinogens including formaldehyde at levels comparable to cigarette smoke,[187] while reduced voltages (3.0 V[54]) generate aerosol with levels of formaldehyde and acetaldehyde roughly 13 and 807-fold less than in cigarette smoke.[44]

The average amount of formaldehyde in vapor from high-voltage devices is higher than the average amount of formaldehyde released from cigarettes.[120] "Dripping", where the liquid is dripped directly onto the atomizer, can create carbonyls including formaldehyde.[251] Formaldehyde, acetaldehyde, and acrolein have been detected at concentrations above those recommended for a brief period of exposure by the US National Institute for Occupational Safety and Health.[157]

Controversy exists regarding the specific amount of formaldehyde expected to be breathed in by the user.[222] Studies have established that free aldehydes are produced during regular use conditions, although formaldehyde hemiacetal production increases dramatically with battery output.[13] Initial studies reported that formaldehyde was formed during the vaping process under high heat conditions.[1] Although some of the more recent e-cigarette devices limit temperature in an attempt to minimize this, multiple reports have documented the formation of acetaldehyde, acrolein, diacetyl, and formaldehyde under a wide range of conditions.[1]

The metal heating coils in e-cigarettes can facilitate carbonyl formation, which allows it to occur at coil temperatures significantly below those linked to dry puffing.[83] A 2018 study on coil temperature and wicking measurements has shown that worrying amounts of formaldehyde can occur in habitual e-cigarette users at a somewhat low power setting, and within the operating temperature range perceived as sensorially pleasant by human subjects, rather than during dry-puff situations.[83]

Later-generation and "hotter" e-cigarettes may generate equal or higher levels of formaldehyde compared to smoking.[45] A 2015 study analyzing 10 puffs found that vaping at a high voltage (5.0 V) generates formaldehyde in e-cigarette vapor; they inferred from the finding that the user vaping at high voltage with 3 ml of e-liquid daily would inhale 14.4±3.3 mg of formaldehyde daily in formaldehyde-emitting chemicals.[42] This was estimated to be a lifetime cancer risk of 5 to 15 times greater than compared with long-term smoking.[42]

A 2015 study using a third-generation device, very low levels of formaldehyde were produced on lower power, although, when adjusted to a maximum power setting, levels were greater than with cigarette smoke.[234] Running at a higher power (temperature) not only increases nicotine delivery, but also increases the amount of formaldehyde and other aldehydes that are naturally produced by heating up propylene glycol or glycerin and other toxicants produced in the e-cigarette aerosol.[112] It has been suggested that e-cigarette users tend to stay clear of the harsh taste that is related to the creation of aldehydes during excessive heating or dry puffing (also known as a "dry hit"[252]).[41] However, e-cigarette users may learn to overcome the unpleasant taste due to elevated aldehyde formation, when the nicotine craving is high enough.[41]

Nicotine

Overview

Potential side effects of nicotine include increased clotting tendency, atherosclerosis, enlargement of the aorta, bronchospasm, muscular tremor and pain, gastrointestinal nausea, dry mouth, dyspepsia, diarrhea, heartburn, peptic ulcer, cancer, lightheadedness, headache, sleep disturbances, abnormal dreams, irritability, dizziness, blood restriction, increased or decreased heart rate, increased blood pressure, tachycardia, more (or less) arrhythmias, coronary artery constriction, coronary artery disease, high insulin, insulin resistance, and risks to child later in life during pregnancy include type 2 diabetes, obesity, hypertension, neurobehavioral defects, respiratory dysfunction, and infertility.
Potential side effects of nicotine[253]
A 2015 comparative risk analysis of drugs found the nicotine's margin of exposure (MOE) values were in a lower risk range than cocaine, heroin, and alcohol, whereas its MOE values was in a higher risk range than MDMA, methamphetamine, and methadone. Shown above is the MOE for daily drug use from the analysis.
A 2015 comparative risk analysis of drugs found the nicotine's margin of exposure (MOE) values were in a lower risk range than cocaine, heroin, and alcohol, whereas its MOE values was in a higher risk range than MDMA, methamphetamine, and methadone.[254] Shown above is the MOE for daily drug use from the analysis.[254]

Pregnant women, breastfeeding mothers, and the elderly are more sensitive to nicotine than other individuals.[226] There are safety issues with the nicotine exposure from e-cigarette use, which may cause addiction and other adverse effects.[54] Nicotine is regarded as a potentially lethal poison.[37] Concerns exist that vaping can be harmful by exposing users to toxic levels of nicotine.[37] At low amounts, it has a mild analgesic effect.[226] At sufficiently high doses, nicotine may result in nausea, vomiting, diarrhea, salivation, bradyarrhythmia, and possibly seizures and hypoventilation.[255] High doses can induce deleterious effects on the growth of osteoblasts.[256] Higher-doses leads to loss of nicotinic receptor specificity and induces cholinergic toxicity.[257] The highest-doses can lead to coma.[257] However, at the low amount of nicotine provided by e-cigarettes fatal overdose from use is unlikely; in contrast, the potent amount of nicotine in e-cigarettes liquids may be toxic if it is accidentally ingested or absorbed via the skin.[37] The health effects of nicotine in infants and children are unclear.[255]

Blood nicotine concentrations and speed of nicotine delivery

E-cigarettes provide nicotine to the blood quicker than nicotine inhalers.[104] The levels were above that of nicotine replacement product users.[37] E-cigarettes seem to have a pharmacokinetic nicotine profile closer to nicotine replacement products than with traditional cigarettes.[258] How efficiently different e-cigarettes give nicotine is unclear.[37] Serum cotinine levels are comparable to that of traditional cigarettes,[259] but are inharmonious and rely upon the user and the device.[8] Blood nicotine levels raised more gradually and took more time to get to peak concentration with e-cigarettes than with traditional cigarettes.[260] Vaping was found to have comparable levels of nicotine urinary metabolites to those who were tobacco and smokeless tobacco product users.[242] Though, the oxidative nicotine metabolites were less in those who were vaping.[242]

Addictiveness and reliance on other contributing factors

Evidence indicates that some vaping products may deliver the same amount of nicotine as traditional cigarettes.[261] A 2018 National Academies of Sciences, Engineering, and Medicine report states that there is fair evidence that chance and degree of dependence are less for e-cigarettes than traditional cigarettes.[262] According to a 2018 PHE report, it not clear the level of addictiveness of e-cigarettes, compared with traditional cigarettes.[263] The report also stated, "nicotine addictiveness depends on a number of factors including presence of other chemicals, speed of delivery, pH, rate of absorption, the dose, and other aspects of the nicotine delivery system, environment and behaviour."[264]

A 2019 study on highly educated young people found that a higher level of nicotine dependence was observed when using e-cigarettes compared with tobacco smoking.[265] In regards to the diversity of devices available, there is limited information available on the vulnerability of nicotine dependency.[266] Users vaping without using nicotine exhibited symptoms of dependence, according to a 2015 study.[267] E-cigarette packages and advertisements require health warnings under US law, stating "WARNING: This product contains nicotine. Nicotine is an addictive chemical."[261]

A 2020 study on habitual e-cigarette users shown that devices containing nicotine caused rapid increases in heart rate, systolic blood pressure, diastolic blood pressure, and mean blood pressure.[268] These effects were not observed with a nicotine inhaler or non-nicotine e-cigarettes.[268] This suggests that nicotine in e-cigarettes interacts with other environmental inhalants found in tobacco products.[268]

First-generation nicotine-containing devices

E-cigarettes resembling cigarettes typically produce much less blood nicotine levels.[221] When compared to traditional cigarettes older devices usually delivered low amounts of nicotine.[37] E-cigarette use can be associated with a substantial dispersion of nicotine, thus generating a plasma nicotine concentration which can be comparable to that of traditional cigarettes.[269] This is due to the minute nicotine particles in the e-cigarette vapor, which permit quick delivery into the bloodstream.[269] The nicotine delivered from e-cigarettes enters the body slower than traditional cigarettes.[60] Studies suggest that inexperienced users obtain moderate amounts of nicotine from e-cigarettes.[270] Concerns were raised over inconsistent amounts of nicotine delivered when drawing on a device.[271]

Later-generation nicotine-containing devices

Tank or adjustable e-cigarettes can raise nicotine levels as high as traditional cigarettes.[221] Later-generation e-cigarettes deliver higher doses of nicotine.[40] Later-generation models with concentrated nicotine liquids may deliver nicotine at levels similar to traditional cigarettes.[37] Some e-cigarette tank devices with stronger batteries heat solutions to greater temperatures, which may raise levels of nicotine in the blood similar to those of traditional cigarettes.[116] Research suggests that experienced e-cigarettes users are able to get as much nicotine from e-cigarettes as traditional cigarettes.[37] Later-generation e-cigarettes containing sufficient nicotine elevate heart rate comparable to traditional cigarettes.[247]

Later-generation devices delivery 35% to 72% more nicotine than compared with first‐generation devices.[209] Second-generation e-cigarettes raised the heart rate and blood pressure similar to traditional cigarettes.[272] As there are design changes, later-generation devices may provide nicotine similar to traditional cigarettes with a highly concentrated amount potential straight to the brain.[224] Such devices may largely reshape the effects on cardiac safety, misuse, and addiction.[224] There is not much research on fourth-generation devices.[111] Pod mods may provide nicotine at the same or higher concentration than traditional cigarettes which increases the possibility of addiction.[99] Minors using pod mods are more likely than traditional e-cigarette users to exhibit higher nicotine dependence symptoms.[273]

Intensity of use

Vaping requires more forceful sucking than smoking, and this action is unclear on increased uptake of harmful substances and the user's health.[269] E-cigarette use has an almost immediate effect on airway resistance, which decreases the ability to draw air in.[135] Sucking more forcefully may be harmful to the e-cigarette user.[224] A "cloud-chasing" competition or a presentation of a device might trigger an extra "performing" effort involving higher puff volume.[274] The health impacts of intensive vaping is unknown.[45] A range of possibly hazardous chemicals may be exhaled, including nicotine, while repeatedly puffing on a device.[269]

Some evidence indicates that vaping products that supply a lower level of nicotine may be more risky to use.[275] This is due to the devices that offer a low amount of nicotine require to be puffed with greater intensity to give users the amount of nicotine they desire, and greater intensive puffing results in, more breathing in of possible toxicants.[275] When compensating for reduced nicotine by puffing more intensely, e-cigarette users are exposed to higher concentrations of carbonyls.[276]

Growing evidence indicates that e-cigarette devices that deliver greater nicotine concentrations may reduce the number of puffs needed to reach adequate nicotine uptake in contrast to lower nicotine concentration ones.[277] By vaping longer, lower nicotine concentration devices can expose users to higher levels of hazardous emissions, notably carbonyls.[277] Furthermore, greater nicotine concentration devices may also possibly exacerbate nicotine dependency and other health issues.[277] Commercial e-cigarette products are continuing to evolve across time which may lead to increased intensity of use, for instance based on increasing nicotine levels, pH modifications, and potentially other design features.[4]

Nicotine concerns

An image of the human brain. The reinforcing effects of drugs of abuse, such as nicotine, is associated with its ability to excite the mesolimbic and dopaminergic systems. How do e-cigarettes affect the brain? The nicotine in e-liquids readily absorbs into the bloodstream when a person uses an e-cigarette. Upon entering the blood, nicotine stimulates the adrenal glands to release the hormone epinephrine (adrenaline). Epinephrine stimulates the central nervous system and increases blood pressure, breathing, and heart rate. As with most addictive substances, nicotine increases levels of a chemical messenger in the brain called dopamine, which affects parts of the brain that control reward (pleasure from natural behaviors such as eating). These feelings motivate some people to use nicotine again and again, despite possible risks to their health and well-being.
The reinforcing effects of drugs of abuse, such as nicotine, is associated with its ability to excite the mesolimbic and dopaminergic systems.[278]
How do e-cigarettes affect the brain?[279] The nicotine in e-liquids readily absorbs into the bloodstream when a person uses an e-cigarette.[279] Upon entering the blood, nicotine stimulates the adrenal glands to release the hormone epinephrine (adrenaline).[279] Epinephrine stimulates the central nervous system and increases blood pressure, breathing, and heart rate.[279] As with most addictive substances, nicotine increases levels of a chemical messenger in the brain called dopamine, which affects parts of the brain that control reward (pleasure from natural behaviors such as eating).[279] These feelings motivate some people to use nicotine again and again, despite possible risks to their health and well-being.[279]

The health effects of long-term nicotine use is unknown.[160] It may be decades before the long-term health effects of nicotine vapor inhalation is known.[280] It is not recommended for non-smokers.[16] Public health authorities do not recommend nicotine use for non-smokers.[49] The pureness of the nicotine differs by grade and producer.[281] The impurities associated with nicotine are not as toxic as nicotine.[281] The health effects of vaping tobacco alkaloids that stem from nicotine impurities in e-liquids is not known.[281] Nicotine affects practically every cell in the body.[226] The complex effects of nicotine are not entirely understood.[46] It poses several health risks.[48]

Short-term nicotine use excites the autonomic ganglia nerves and autonomic nerves, but chronic use seems to induce negative effects on endothelial cells.[282] Nicotine may have a profound impact on sleep.[283] The effects on sleep vary after being intoxicated, during withdrawal, and from long-term use.[283] Nicotine may result in arousal and wakefulness, mainly via incitement in the basal forebrain.[284] Nicotine withdrawal, after abstaining from nicotine use in non-smokers, was linked with longer overall length of sleep and REM rebound.[283] Nicotine's impact on the sleep-wake cycle via nicotine receptors could be significant, as receptor stimulation leads to increased wakefulness and decreased both overall sleep time and REM sleep.[285]

Nicotine can weaken antibacterial defenses and modify macrophage activation.[129] Nicotine can cause tremors,[193] high blood pressure, abnormal heart rhythms,[286] increased serum cholesterol levels,[46] and lower coronary blood flow.[247] Nicotine constricts blood vessels.[91] This includes coronary blood vessels and those in the skin.[287] However, blood vessels in the skeletal muscle dilate as a result of nicotine.[287] It can also cause nausea, sweating, and diarrhea.[224] In reaction to nitric oxide, it hinders endothelial-dependent widening of blood vessels.[46] It is associated with stroke, peripheral vascular disease, delayed wound healing, peptic ulcer disease, and esophageal reflux.[120] Vapers that get a higher amount of blood nicotine are probably correlated with increased heart rates.[129] Acute administration of nicotine causes a variety of well-characterized, dose- and route-dependent effects in adults, including cardiovascular effects, such as greater cardiac output, leading to an increase in myocardial oxygen demand.[162] Nicotine is correlated with lung inflammation in adults, which may be as a result of it chemotactic effects.[111]

Nicotine may have adverse effects on lipids,[288] cause insulin resistance,[116] and may cause pro-inflammatory effects that could impact beta cell function.[289] Nicotine lowers activity of free radical scavenging enzymes, resulting in more production of hydroxyl free radicals.[289] Nicotine impairs glucose homeostasis, indicating a major role in the development of type 2 diabetes.[289] Osseointegration is a pertinent part of the survival of implants.[290] Nicotine considerably impedes the regenerative capability of mesenchymal stem cells.[291] This includes impeding their proliferation, migration, and differentiation.[291] Nicotine has been correlated with vasoconstriction and a weakened ability to heal at the cellular level.[290] Thus, it apparently compromises implant osseointegration.[290] Nicotine lowers estrogen levels and has been associated with early menopause in women.[286] Nicotine is negatively associated with total sperm motility.[232]

Studies in animal models have conclusively shown that nicotine can aggravate tissue injuries and exacerbate diseases such as cancer, cardiovascular disease, stroke, pancreatitis, peptic ulcers, renal damage, and developmental disorders, including those affecting the lungs, reproductive system, and central nervous system.[292] The consequence of nicotine use in autoimmunity has been conflicting.[293] Nicotine could have cancer-promoting properties, therefore long-term use may not be harmless.[39] Nicotine may result in neuroplasticity variations in the brain.[294] Nicotine has been demonstrated to alter the amounts of brain-derived neurotrophic factor in humans.[295] Nicotine could make cancer therapies less effective.[26] Based on in vitro and in vivo effects of nicotine, patients should be advised not to use nicotine products during cancer treatment unless it is temporarily needed to stop tobacco smoking.[185] Nicotine can suppress appetite.[20] Nicotine users will probably gain weight after using less nicotine.[296] A long-term risk from vaping a base containing nicotine is nicotine dependence.[240]

Youth nicotine concerns

This video from the US Surgeon General advises parents to "Know the Risks," and highlights how e-cigarettes have the potential to cause lasting harm to the health of young users, especially their brain development, which continues until about age 25.[297]

Children are more sensitive to nicotine than adults.[226] The use of products containing nicotine in any form among youth, including in e-cigarettes, is unsafe.[162] Nicotine has more significant and durable damaging effects on adolescent brains compared to adult brains, the former causing more harmful effects.[162] Animal research offers strong evidence that the limbic system is particularly vulnerable to the long lasting effects of nicotine.[298] In youth, nicotine may result in cognitive impairment[298] as well as the chance of nicotine addiction for life.[286]

The adolescent's developing brain is especially sensitive to the harmful effects of nicotine.[299] A short period of regular or occasional nicotine exposure in adolescence exerts long-term neurobehavioral damage.[299] Risks of exposing the developing brain to nicotine include mood disorders and permanent lowering of impulse control.[300] The rise in vaping is of great concern because the parts encompassing in greater cognitive activities including the prefrontal cortex of the brain continues to develop into the 20s[255] Nicotine exposure during brain development may hamper growth of neurons and brain circuits, effecting brain architecture, chemistry, and neurobehavioral activity.[255]

Food and Drug Administration Commissioner Scott Gottlieb, announced on 28 July 2017 a comprehensive regulatory plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect youth and significantly reduce tobacco-related disease and death, including pursuing lowering nicotine in regular cigarettes to a minimally or non-addictive level.[301]

Nicotine changes the way synapses are formed, which can harm the parts of the brain that control attention and learning.[300] Preclinical studies indicate that teens being exposed to nicotine interferes with the structural development of the brain, inducing lasting alterations in the brain's neural circuits.[302] Each e-cigarette brand differs in the exact amount of ingredients and nicotine in each product.[302] Therefore, little is known regarding the health consequences of each brand to the growing brains of youth.[302] The use of e-cigarettes may contribute to the rise of nicotine addiction, which can have a significant impact on children.[116]

Whether there are subgroups of adolescents who are at greater risk of developing a nicotine dependence from vaping is not known.[240] One major public health concern is the targeting of children and young people by widespread e-cigarette advertising.[303] This could potentially result in non-smokers and young individuals developing a dependence on nicotine and start smoking.[303] Data from the US corroborates this concern.[303] Long-term studies on the safety of nicotine-only exposure (e.g., as with using e-cigarettes rather than smoking traditional cigarettes) among youth have not been conducted.[162]

In 2015 the psychological and behavioral effects of e-cigarettes were studied using whole-body exposure to e-cigarette vapor, followed by a series of biochemical and behavioral studies.[194] The results showed that nicotine-containing e-cigarette vapor induces addiction-related neurochemical, physiological and behavioral changes.[194] A 2015 study on the offspring of the pregnant mice, which were exposed to nicotine-containing e-cigarette liquid, showed significant behavioral alterations.[194] This indicated that exposure to e-cigarette components in a susceptible time period of brain development could induce persistent behavioral changes.[194] As indicated in the limited research from animal studies, there is the potential for induced changes in neurocognitive growth among children who have been subjected to e-cigarette vapors consisting of nicotine.[240] The US FDA stated in 2019 that some people who use e-cigarettes have experienced seizures, with most reports involving youth or young adult users.[304]

Graphic from the Centers for Disease Control and Prevention's report entitled Why Is Nicotine Unsafe for Kids, Teens, and Young Adults?
Graphic from the Centers for Disease Control and Prevention's report entitled Why Is Nicotine Unsafe for Kids, Teens, and Young Adults?[305]

Metals

There is limited evidence on the long-term exposure of metals.[16] Exposure to the levels and kinds of metals found in the aerosol relies upon the material and other manufacturing designs of the heating element.[116] E-cigarettes contain some contamination with small amounts of metals in the emissions.[16] The device itself could contribute to the toxicity from the small amounts of silicate and heavy metals found in the liquid and vapor,[251] because they have metal parts that come in contact with the e-liquid.[16]

Numerous studies have shown that e-liquids in contact with heating coils like Kanthal or nichrome facilitate leaching of metals/metalloids into the liquid present in the tank or cartomizer.[152] A 2019 study showed that metals were used in various device components, such as thick wires, wicks, sheaths, and joints.[152] These device components may also transfer metals/metalloids into the e-liquid because the presence of brass clamps and copper wires with silver coatings have been associated with higher zinc, copper, silver, and aluminum in the aerosol.[152] Furthermore, the presence of soldered joints of poor quality or with signs of fraying were associated with higher tin levels, emphasizing that poor manufacturing techniques make a notable contribution to potential metal impurities that may reach the user.[152] The e-cigarette user’s vaping regimen, which includes modifications in voltage, resistance, temperature, and puff duration, may also play a role in the degradation of the heating coils and other metal elements, and in turn modify the aerosol composition and degree of metal/metalloid exposure.[152] According to a 2018 PHE report, metals emissions no matter how small, are not needed.[246] They further stated, "EC [e-cigarettes] that generate minimal metal emissions should become an industry standard."[212]

Low levels of possibly harmful chromium, lead, and nickel metals have been found in the emissions.[116] Chromium and nickel nanoparticles have also been found.[7] Copper nanoparticles can induce mitochondrial and DNA injury in lung fibroblasts.[306] DNA repair can be impeded by titanium dioxide nanoparticles from the e-cigarette vapor.[90] This was demonstrated that the titanium dioxide nanoparticles induced single-strand breaks and produced oxidative stress in the DNA of A549 cells.[90] The risk of inhaling nanoparticles is an area of concern.[307] The toxicity of nanoparticles is unknown.[308] Nanoparticles can enter the brain and are associated with developmental neurotoxicity.[163] Metals including nickel, cadmium, lead, and silicate can found in the e-cigarette aerosols, and are thought to be carcinogenic, nephrotoxic, neurotoxic, and hemotoxic.[169] Heavy metals are correlated with serious health issues.[17] Inhaling lead can induce serious neurologic injury, notably to the growing brains of children.[17] No specific research is available on the consequences of vaping-associated metals on the brain.[163]

The presence of metals and metalloids (e.g., arsenic, chromium, lead, nickel) in e-cigarette aerosols is a major concern, given their serious health effects, including cancer, cardiovascular disease, renal damage, and neurotoxicity.[152] Metals may adversely affect the nervous system.[309] Metals found in the e-cigarette vapor may induce cell damage and initiate inflammatory cytokine such as in human lung fibroblasts.[228] Exposure to e-cigarette aerosols and copper nanoparticles results in the generation of mitochondrial ROS, causes mitochondrial stress by affecting the the OxPhos electron transport chain complex IV subunit, and leads to fragmentation of DNA in lung fibroblasts.[215] Metallic and nanoparticles are associated with respiratory distress and disease.[310]

A 2014 review found considerable amounts of tin, metals, and silicate particles that came from various components of the e-cigarette were released into the aerosol, which result in exposure that could be higher than with cigarette smoke.[154] Cadmium that have been found in the e-cigarette vapor is linked to low sperm density.[232]

Based on previous research, e-cigarette use is associated with increased levels of metal and adverse toxicity effects of human health.[311] However, the effects of metals in e-cigarette devices were examined in a small number of studies as of 2023, therefore, this is not sufficient to create a firm conclusion.[311] Additionally, information of user behavior other possible sources of exposure to metals were usually lacking in these studies.[311]

Neurotoxicity of e-cigarette aerosols diagram

Potential neurotoxicity of e-cigarette aerosols
alt=The diagram is titled Potential neurotoxicity of e-cigarette aerosols. The text states: The increased neuronal activity induced by nicotine is greater in the teenage brain than in the adult brain. Chronic nicotine use during the teenage years can cause reduced cognitive function, which may result in lower attention span and greater impulsivity in adulthood. Potential substances in e-cigarette aerosols: Nicotine Heavy metals Nanoparticles Free radicals Propylene glycol and/or glycerin Flavoring chemicals Potential side effects: Calcium dyshomeostasis Epigenetic alterations Hampered autophagy Hampered neurotransmission Mitochondrial damage Neuroinflammation Oxidative stress The final words states: Vaping can induce neurotoxic effects because of nicotine and other substances found in e-liquids and e-cigarette aerosols. Nicotine vaping can have a damaging impact on minors.

The increased neuronal activity
induced by nicotine is greater
in the teenage brain than
in the adult brain.[163]

Chronic nicotine use
during the teenage
years can cause
reduced cognitive
function, which
may result in lower
attention span and
greater impulsivity
in adulthood.[163]

Potential substances in
e-cigarette aerosols:

Potential side effects:

  • Calcium dyshomeostasis[163]
  • Epigenetic alterations[163]
  • Hampered autophagy[163]
  • Hampered neurotransmission[163]
  • Mitochondrial damage[163]
  • Neuroinflammation[163]
  • Oxidative stress[163]
Vaping can induce neurotoxic effects because of nicotine and other substances found in e-liquids and e-cigarette aerosols.[163] Nicotine vaping can have a damaging impact on minors.[163]

Pathogens

Microbial toxins

The existing research pertaining to the microbiomes of e-liquids and cartridges are sparse.[312] A 2019 study found popular US vape liquids were contaminated with B-D-glucan and endotoxin.[313] Asthma and hypersensitivity pneumonitis are connected with these two microbial toxins.[313] B-D-glucans and endotoxin may induce respiratory discomfort, but studies have not been conducted on the long-term effects at the levels detected in vape liquids.[72]

Virulence

E-cigarette exposure can enhance the virulence of certain pathogens.[314] This strengthens their potential to stay alive in the host.[314] Differing bacterial strains became more destructive in a larval infection model after exposure to e-cigarette vapor.[314] Methicillin-resistant Staphylococcus aureus colonized in e-cigarette vapor extract were more damaging in mice, and had an increased ability to create biofilms, permeate and occupy within epithelial cells, and withstand the antimicrobial LL-37.[314]

E-cigarette vapor rapidly augment biofilm formation on the polystyrene surface by various Gram-positive and Gram-negative pathogens in a dose- and bacterial-strain-dependent manner.[315] Reactive oxygen species and nicotine are the main chemical drivers of e-cigarette vapor-dependent biofilm augmentation.[315] Exposure to e-cigarette vapor induces adherence of Staphylococcus aureus and Porphyromonas gingivalis to host cells and proteins while the adherence of Streptococcus pneumoniae or Pseudomonas aeruginosa is unaffected by e-cigarette vapor exposure.[315]

The bioactive chemicals in e-cigarette vapor may affect pathogenic bacteria in the nasopharyngeal microflora, which may have implications on the pathophysiology of respiratory infections in e-cigarette users.[315] Research shows that the e-cigarette vapor-mediated alterations in bacterial virulence were dependent on the length of exposure and the strain of pathogen under examination and that reactive oxygen species and nicotine were the primary chemical drivers of e-cigarette vapor-mediated alterations in the pathogen virulence.[315] Exposure to e-cigarette vapor induces pleiotropic changes affecting the physiology of the host and the pathogens known to asymptomatically colonize the respiratory tract and the mouth.[315]

Effects on breathing and lung function

Respiratory effects

Overview

Figure shows mechanisms of e-liquid flavorings effects on the lung innate immunity and the respiratory microbiota in lung injury. The respiratory tract is lined by a pseudostratified columnar ciliated epithelium (nasal cavity through the bronchi) transitioning to cuboidal on the bronchioles and squamous on the alveoli (AEC). The apical junctional complexes (AJC), including tight and adherens junctions, maintain the airways epithelial integrity and contribute to prevent contact between the respiratory microbiota and the phagocytic cells therefore, providing an immunotolerant environment an immunotolerant environment. At the AJC, the tight junctions regulate paracellular permeability, and the adherens junctions provide cell-to-cell communication, while connecting to cellular cytoskeletal proteins. The airway mucus constitutes the water-based apical layer of the airway surface liquid and the periciliary layer is the second sol-based layer that bathes the epithelium. The respiratory microbiota (RM) resembles the oral microbiota (OM). Members of the RM relies on the airway mucus to access nutrients including mucins (MUC5AC and MUC5B) and avoid contact with the epithelium, professional antigen presenter cells (DCs) and phagocytic cells such as alveolar macrophages (AMs) and neutrophils (PMNs). The airway epithelium secretes β-defensins and other host defense peptides and proteins (HDPs). In addition to the airway's epithelium, the innate immune response within the respiratory tract involves phagocytic cells including dendritic cells, alveolar macrophages, neutrophils; eosinophils; innate lymphoid cells and natural killer cells. The airway surface liquid represents an ecological niche for the respiratory microbiota, provides a source of specialized nutrients, and plays a role in immunomodulation by regulating the interaction between the respiratory microbiota and the immune system. E-cigarette flavorings such as cinnamaldehyde, menthol, or vanillin can disrupt microbial clearance in the respiratory tract by disrupting the AEC integrity and decreasing the levels of mucus, decreasing mucus clearance and antimicrobial secretion, and eliciting and inflammatory response, eventually producing lung injury. E-cigarette flavorings also impair the phagocytic activity of AMs and PMNs.
Figure shows mechanisms of e-liquid flavorings effects on the lung innate immunity and the respiratory microbiota in lung injury.[316] The respiratory tract is lined by a pseudostratified columnar ciliated epithelium (nasal cavity through the bronchi) transitioning to cuboidal on the bronchioles and squamous on the alveoli (AEC).[316] The apical junctional complexes (AJC), including tight and adherens junctions, maintain the airways epithelial integrity and contribute to prevent contact between the respiratory microbiota and the phagocytic cells therefore, providing an immunotolerant environment an immunotolerant environment.[316] At the AJC, the tight junctions regulate paracellular permeability, and the adherens junctions provide cell-to-cell communication, while connecting to cellular cytoskeletal proteins.[316] The airway mucus constitutes the water-based apical layer of the airway surface liquid and the periciliary layer is the second sol-based layer that bathes the epithelium.[316] The respiratory microbiota (RM) resembles the oral microbiota (OM).[316] Members of the RM relies on the airway mucus to access nutrients including mucins (MUC5AC and MUC5B) and avoid contact with the epithelium, professional antigen presenter cells (DCs) and phagocytic cells such as alveolar macrophages (AMs) and neutrophils (PMNs).[316] The airway epithelium secretes β-defensins and other host defense peptides and proteins (HDPs).[316] In addition to the airway's epithelium, the innate immune response within the respiratory tract involves phagocytic cells including dendritic cells, alveolar macrophages, neutrophils; eosinophils; innate lymphoid cells and natural killer cells.[316] The airway surface liquid represents an ecological niche for the respiratory microbiota, provides a source of specialized nutrients, and plays a role in immunomodulation by regulating the interaction between the respiratory microbiota and the immune system.[316] E-cigarette flavorings such as cinnamaldehyde, menthol, or vanillin can disrupt microbial clearance in the respiratory tract by disrupting the AEC integrity and decreasing the levels of mucus, decreasing mucus clearance and antimicrobial secretion, and eliciting and inflammatory response, eventually producing lung injury.[316] E-cigarette flavorings also impair the phagocytic activity of AMs and PMNs.[316]

When vaping, hundreds to thousands of chemicals are inhaled into the lungs.[313] The risks to the lungs are not fully understood,[41] and concern exists regarding the negative effects on lung function.[317] The long-term effects on lung function is unknown.[8] There is limited evidence on the long-term health effects to the lungs.[45] The long-term effect from vaping a base containing nicotine on lung tissue is unknown.[318] Limited evidence suggests that e-cigarettes produce less short-term effects on lung function than with traditional cigarettes.[8] Many ingredients used in e-liquids have not been examined in the lung.[41] E-cigarettes increase the risk of developing asthma and chronic obstructive pulmonary disease.[319] Vaping may induce acute lung disease[45] and increase the risk of developing lung disease.[320] Vaping might cause sub-acute bronchial toxicity.[129] Little is known about the short- and long-term effects of e-cigarettes on the respiratory microbiota and their impact on the innate immune response.[316]

Effects

E-cigarette use can have deleterious effects on lung lipid metabolism regardless of nicotine content.[321] Lipid-laden macrophages, discovered in bronchoalveolar lavage fluid from e-cigarette users, suggest users are at risk for lipid-mediated lung injury and interfered pathogen clearance via macrophages.[220] The lipid concentrations may be related to aerosolization of propylene glycol and glycerin solvents in e-liquid.[220] Exposure to inhaled nicotine-containing e-cigarette fluids triggered effects normally associated with the development of a chronic obstructive lung disease-like tissue damage in a nicotine-dependent manner.[194] Preclinical research indicate that vaping escalates the virulence of drug resistant microorganisms and diminishes the capacity of lung cells to eliminate bacteria.[322] E-cigarettes have been correlated with pleural effusions.[306] A 2015 study found that e-cigarette vapors can induce oxidative stress in lung endothelial cells.[171]

Constant lung inflammation as a result of the e-cigarette vapor could result in lung pathogenesis and induce serious diseases, including chronic obstructive pulmonary disease and fibrosis.[87] There is strong evidence that e-cigarette vapors can result in acute endothelial cell injury, but the long-term effects regarding this matter on being exposed over a prolonged period of time to e-cigarette vapor is uncertain.[323] The use of nicotine-laden e-cigarettes can induce oxidative stress and disrupt autophagy due to nicotine exposure, which may act as a mechanism that causes to the onset of chronic obstructive pulmonary disease.[215] A 2014 case report observed the correlation between sub-acute bronchiolitis and vaping.[45] After quitting vaping the symptoms improved.[45] Vaping causes bronchospasm.[209] Adolescents who vaped had a higher frequency of chronic bronchitis symptoms.[228]

The long-term effects regarding respiratory flow resistance are unknown.[324] The available evidence indicates that e-cigarettes may result in respiratory effects that are like as well as unlike that of traditional cigarettes.[93] E-cigarettes, particularly the ones containing nicotine, decrease lung function, but to a considerable lower extent than with traditional cigarettes.[28] E-cigarette use lowers oxygen saturation.[325] E-cigarettes could harm the respiratory system.[43] Vaping induces irritation of the upper and lower respiratory system.[120] The immediate effects of e-cigarettes after five minutes of use on pulmonary function resulted in considerable increases in resistance to lung airflow.[40]

Vaping induces fundamental changes to the airway epithelial proteome and these changes, such as an altered look of the airways, are unique from what has been observed in smokers.[326] A 2013 review found an instant increase in airway resistance after using a single e-cigarette.[43] Higher levels of exhaled nitric oxide were found among test subjects in a 2014 study who vaped with a base of nicotine which was associated with lung inflammation.[327] Short-term usage of e-cigarettes results in an increase in respiratory resistance in a manner similar to that of tobacco smoking.[324] E-cigarette use could result in respiratory diseases among youth.[328] Evidence from animal studies indicate that children or adolescents exposed to second-hand vapor containing nicotine may impede their lung development.[329]

The figure shows the effects of flavors in e-liquids reported in different experimental models
The figure shows the effects of flavors in e-liquids reported in different experimental models[330]

Data suggest that e-cigarette users produce significantly more sputum than smokers and show increased markers of inflammation in their airways.[331] As airway inflammation and mucus hypersecretion are central features underlying asthma pathology, asthmatics might be at increased risk for e-cigarette-induced health effects.[331] Adolescents with asthma who vape could have greater odds of having a higher number of respiratory symptoms and aggravations in contrast to their peers who do not vape.[332] Adolescents and children with other respiratory ailments who vape may be at greater chance for aggravating of respiratory symptoms.[332]

Comparable to a traditional cigarette, e-cigarette particles are tiny enough to enter the alveoli, enabling nicotine absorption.[40] These particles are also tiny enough to go deep in the lungs and enter into the systemic circulation.[7] Research indicates that e‐cigarette vapor containing particulate matter with a diameter of 2.5 μm, just from one puff, enters the systemic circulation via the cardiopulmonary system, leading to a large amount being deposited in the respiratory tract.[209] Local pulmonary toxicity may occur because metal nanoparticles can deposit in the lung's alveolar sacs.[7] E-cigarettes companies state that the particulates produced by an e-cigarette are too tiny to be deposited in the alveoli.[104] Tinier particles deposit more nicotine in the alveoli.[129]

National Institute on Drug Abuse TV interview with Virginia Commonwealth University Professor of Psychology, Thomas Eissenberg, following his discussion on e-cigarette research.[333]
Vaping is an epidemic spreading amongst teenagers.[334] It can expose the lungs to acrolein, which can cause irreversible damage.[334]

Different devices generate different particle sizes and cause different depositions in the respiratory tract, even from the same nicotine liquid.[187] The aerosol production of e-cigarettes during vaping decreases, which requires a more forceful suction to create a similar volume of aerosol.[127] A more forceful suction could affect the deposition of substances into the lungs.[127] Compared to cigarette smoke, e-cigarettes produce on average smaller size particles, and the health effects of these smaller size particles is unclear.[335] Reports in the literature have shown respiratory and cardiovascular effects by these smaller size particles, suggesting a possible health concern.[336] Vaping is potentially harmful, especially to the critically ill, such as people with oncologic, lung, or cardiac diseases.[120] A 2019 case study of hard-metal pneumoconiosis was published in the European Respiratory Journal.[337] Researchers tested the patient's e-cigarette, which was used with cannabis.[337] Cobalt was found in the vapor, including other toxic metals-nickel, aluminum, manganese, lead, and chromium.[337] Metal-induced toxicity in the lung can result in long-term, if not, permanent scarring of the lungs.[337]

As with cardiovascular disease, evidence consistently indicates that exposure to e-cigarette aerosol has adverse effects on lungs and pulmonary function.[112] Repeated exposure to acrolein, which is produced by heating the propylene glycol and glycerin in e-liquids, causes chronic pulmonary inflammation, reduction of host defense, neutrophil inflammation, mucus hypersecretion, and protease-mediated lung tissue damage, which are linked to the development of chronic obstructive pulmonary disease.[112] E-cigarette aerosol also exposes users to highly oxidizing free radicals.[112] Animal studies have also shown that e-cigarettes increase pulmonary inflammation and oxidative stress while inhibiting the immune system.[112]

Consistent with these experimental results, people who used e-cigarettes experienced decreased expression of immune-related genes in their nasal cavities, with more genes suppressed than among cigarette smokers, indicating immune suppression in the nasal mucosa.[112] E-cigarette use upregulates expression of platelet-activating factor receptor (PAFR) in users' nasal epithelial cells; PAFR is an important molecule involved in the ability of S.pneumoniae, the leading cause of bacterial pneumonia, to attach to cells it infects (adherence).[112] In light of the immunosuppressive effects observed in nasal mucosa, there is concern that e-cigarette use will predispose users toward more severe respiratory infections, as has been demonstrated in mouse studies.[112]

Vaping is reportedly tied to a range of lung injuries which include hypersensitivity pneumonitis, diffuse alveolar hemorrhage, acute eosinophilic pneumonia, diffuse alveolar damage, organizing pneumonia, lipoid pneumonia, and giant cell interstitial pneumonia.[338]

Vaping cannabinoid plants may lead to lung injury similar to that of smoking tobacco.[339] Vaping poses unique risks, as contaminants and additives to the vape medium may cause significant lung damage apart from cannabinoids.[339]

Respiratory effects in youth and young adults

Overview

As of 2021, little information is available regarding the effect of e-cigarette exposure on children's respiratory health.[340] Available data on the respiratory effects among young people are mainly self-reported and may be subjected to recall bias, as of 2021.[340]

Effects

A 2016 survey conducted on 44,662 Chinese students (mean age 14.6 years), reported that e-cigarette use was significantly associated with respiratory symptoms, e.g., cough or phlegm for 3 consecutive months in the past 12 months.[340] Likewise, in a 2017 study on 2,086 adolescents aged 16–18 years who took part in the Southern California Children's Health Study, self-reported wheeze in the last 12 months was associated with current but not past use of e-cigarette.[340] In the same study, chronic bronchitis symptoms during the previous year were associated with both past and present use of e-cigarette.[340] The risk of bronchitis symptoms was directly proportional to the number of days of e-cigarette use in the past month, compared with non-e-cigarette users.[340] Vaping among 11th-grade and 12th-grade students in California was linked with twice the chance of respiratory complaints, and the chance went up with vaping more regularly.[165] In a 2020 cohort study of 7,049 adolescents, the association of e-cigarette use alone with wheezing in the past 12 months proved not to be significant.[340]

A 2017 cross-sectional study investigating the effects of active, passive, and e-cigarette vaping in Korean adolescents, including 4,890 with asthma in the last 12 months, reported significant associations between active and passive smoking and asthma.[340] In addition, the authors found that asthma was significantly more frequent in the e-cigarette group.[340] In a 2016 cross-sectional study on a large sample of 35,904 high school students (mean age 16.4 years) in South Korea, the authors found that e-cigarette users had an increased association with asthma diagnosis in comparison with non-e-cigarette users, suggesting that e-cigarette use may be a risk factor for asthma.[340] Of note, current e-cigarette users had the highest risk for severe asthma, defined as the number of days (greater than or equal to 4) absent from school in the past year due to asthma symptoms, compared to non-e-cigarette users.[340]

Similarly, in a 2017 survey on 6089 adolescents (mean age 15.8 years) in Hawaii, the authors reported that current use of e-cigarettes showed a significant association with current asthma and a marginal one with asthma at any time.[340] A 2020 study on 21,532 U.S. adolescents (age range: 14–18 years), in which use of an e-vapor product was associated with asthma, showed an additional harmful effect on asthma of the combined use of vapor products with marijuana and cigarette smoking: use of an e-vapor product was associated with asthma, and this association was even more evident when its use was coupled with marijuana, particularly when cigarette smoking was also involved.[340] When adjusting for frequent cigarette smoking and marijuana use, frequent use of an e-vapor product (greater than or equal to 10 days per month) was significantly associated with asthma.[340]

Asthma exacerbations were found to be associated with e-cigarette vaping.[340] Data from the 2012 Florida Youth Tobacco Survey, involving 36,085 high school students, reported that prevalence of ever having used e-cigarette and having used them in the past 30 days among those who reported asthma was 10.4 and 5.3%, and this was significantly higher than in those without asthma.[340] Among students with asthma, use of e-cigarette in the past 30 days was positively associated with an asthma attack in the past 12 months.[340]

E-cigarette use is associated with a doubling of the risk of symptoms of chronic bronchitis among US high school juniors and seniors with higher risk associated with higher use; these risks persisted among former users.[112] Similarly, current e-cigarette use was associated with an increased diagnosis of asthma among Korean high school students among current (e-cigarette users who were never cigarette smokers).[112] E-cigarette users were also more likely to have had days absent from school due to severe asthma symptoms.[112]

2019–2020 vaping lung illness outbreak

Some of the vaping products that contained exceedingly high amounts of vitamin E acetate, including Dank Vapes, pictured here.
Some of the vaping products analyzed by the Wadsworth Center contained exceedingly high amounts of vitamin E acetate, including Dank Vapes, pictured here.[341]
2020 CDC map of reported vaping-related lung illness cases in the US and US territories.
2020 CDC map of reported vaping-related lung illness cases in the US and US territories.[29]
CDC chart of the total weekly hospitalized vaping patients from February 2019 to January 2020.
CDC chart of the total weekly hospitalized vaping patients from February 2019 to January 2020.[342]
Vaping may result in acute lung injury and may cause mild, moderate, or severe lung injury. There is also a risk of unwanted effects, such as death, in young people.
Vaping may result in acute lung injury and may cause mild, moderate, or severe lung injury.[343] There is also a risk of unwanted effects, such as death, in young people.[12]

In 2019 and 2020, an outbreak of severe vaping-induced lung illness (called e-cigarette, or vaping, product use-associated lung injury[241]) had affected certain users of vaping products in the US[29] and Canada.[30] The first cases, which involved a cluster of lung illnesses, were first identified in Illinois and Wisconsin in April 2019.[344] Published case reports of vaping-related lung illnesses can be traced back to 2012.[345] Similar cases of vaping-induced lung injuries were reported in the UK and Japan before the outbreak occurred.[1][218] The prevalence of vaping-induced lung injuries ocurring worldwide remains unclear.[1] As of February 18, 2020, a total of 2,807 hospitalized cases have been reported to the Centers for Disease Control and Prevention (CDC) from all 50 states, the District of Columbia, and two US territories (Puerto Rico and US Virgin Islands).[29] 68 deaths in the US have been confirmed in 29 states and the District of Columbia, as of February 18, 2020.[29] Cases peaked in September 2019, and a slow decline followed.[note 7][29] Chief Public Health Officer of Canada announced on October 11, 2019 that they are aware of the initial cases of vaping-induced lung injury.[346] As of August 14, 2020, 20 cases of lung injuries have been reported to the Public Health Agency of Canada.[30] The majority of cases in Canada involving lung injuries do not seem to have been connected with the use of THC-infused products.[30]

Of the 2,807 reported cases, 2,022 hospitalized persons had data on substance use, as of January 14, 2020.[29] 82% reported THC use, 33% reported exclusive THC use, 57% reported using nicotine-containing products, and 14% reported exclusive use of nicotine-containing products.[29] Many of the samples tested by the states or by the US Food and Drug Administration (FDA) as part of the 2019 investigation have been identified as vaping products containing tetrahydrocannabinol (or THC, a psychoactive component of the cannabis plant).[347] Most of those samples with THC tested also contained significant amounts of vitamin E acetate.[347] The CDC reported that their findings suggest vaping products containing THC are linked to most of the cases and play a major role in the outbreak.[29] The CDC stated that the chemical vitamin E acetate is a very strong culprit of concern in the lung illnesses related to THC-based vaping products, but did not rule out other chemicals as possible causes.[note 8][348] The majority of those affected were young adults aged 18 to 34, which is the group with the greatest prevalence of cannabis use in the US.[31] Nicotine e-cigarette use has been linked to the vaping-induced lung injury cases in a small subset of users.[33]

Thickening agents were used to dilute vape oils.[349] There has been an increase in attention to companies that sell diluent products that are made with vitamin E acetate.[349] Previously, vitamin E acetate was used in low concentrations, or lower than 20% of the formula in vape cartridges.[349] As a result of a limited availability of cannabis in California as well as high demand, illicit sellers had used about 50% or higher of diluent thickeners in their formulas to bulk up tiny potency vape cartridges.[349] In September 2019, New York Governor Andrew Cuomo instructed the state health department to issue subpoenas against three sellers of thickening agents used in illicit vaping products.[350] The use of vitamin E acetate in vaping products is not banned in the US,[337] though Colorado,[351] Ohio,[351] and Washington have banned it in vaping products,[352] and Oregon has banned it in cannabis vaping products.[353] Health Canada does not permit vitamin E acetate in cannabis vaping products in Canada.[354] On November 18, 2022, six people involved in an elaborate criminal THC vape cartridge ring were convicted, and each one received fines or probation.[355] Jacob and Tyler Huffhines, and their mom Courtney, were convicted of criminal charges related to THC vape cartridges without receiving a prison sentence.[356] Wesley Webb, Hannah Curt, and Daniel Graumenz, were all fined.[355] Both Jordan Lynam and Tarail King were anticipated to be sentenced in November 2022.[357]

The e-cigarette industry is placing the blame on illicit vaping liquids for the lung injuries.[358] Juul Labs stated that some news agencies report that several cases of lung illness are associated with vaping THC, found in cannabis, "a Schedule 1, controlled substance that we do not sell."[359] The CDC and US FDA recommend that people not use THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online dealers, as of February 18, 2020.[29] The US FDA considers it prudent to avoid inhaling vitamin E acetate.[347] On September 6, 2019, the US FDA stated that because consumers cannot be sure whether any THC vaping products may contain vitamin E acetate, consumers are urged to avoid buying vaping products on the street, and to refrain from using THC oil or modifying/adding any substances to products purchased in stores.[347] The Public Health Agency of Canada recommends for adults and parents or guardians who are smoking or vaping to contact a health care provider for guidance on ways to stop.[30] The vaping-induced lung injuries has led to concern around the world.[275] In 2020, the first uptick in vaping-induced lung injury cases had occurred in Utah since the decline of 2019.[34]

Cardiovascular effects

Overview

Figure shows a cartoon-style comic illustrating the aerosolization process of e-cigarette and its relation to cardiovascular diseases. This comic provides a visual narrative, starting from the use of an e-cigarette to the potential harmful effects on the cardiovascular system. In the upper left part of the cartoon, it can be seen that e-cigarette aerosol contains many substances such as nicotine, flavorings, aldehydes, and metals, which may be harmful to human. In the upper right part of the cartoon is the design of an e-cigarette device. On the right side of the cartoon is the adverse effects of e-cigarette aerosol on blood vessels and heart. Through mechanisms such as oxidative stress, inflammation, and endothelial dysfunction, e-cigarette aerosol can increase heart rate, blood pressure, and clog blood vessels.
Figure shows a cartoon-style comic illustrating the aerosolization process of an e-cigarette and its relation to cardiovascular diseases.[360] This comic provides a visual narrative, starting from the use of an e-cigarette to the potential harmful effects on the cardiovascular system.[360] In the upper left part of the cartoon, it can be seen that e-cigarette aerosol contains many substances such as nicotine, flavorings, aldehydes, and metals, which may be harmful to human.[360] In the upper right part of the cartoon is the design of an e-cigarette device.[360] On the right side of the cartoon is the adverse effects of e-cigarette aerosol on blood vessels and heart.[360] Through mechanisms such as oxidative stress, inflammation, and endothelial dysfunction, e-cigarette aerosol can increase heart rate, blood pressure, and clog blood vessels.[360]
Diagram shows potential adverse cardiovascular effects induced by various constituents of e-cigarette aerosol.
Diagram shows potential adverse cardiovascular effects induced by various constituents of e-cigarette aerosol.[360]
Figure shows summary of pulmonary and cardiovascular dysfunction and their cellular basis. (a) E-cigarette use has been linked to disease and dysfunction in the heart and lungs. (b) i. Platelets are activated towards a pro-thrombotic phenotype in the vessel; ii. E-cigarette aerosol exposure promotes endothelial cell death and compromised barrier function, which facilitates immune cell extravasation into the surrounding tissue. Endothelial cells release inflammatory cytokines that enhance neutrophil recruitment; iii. Monocytes differentiate into macrophages upon extravasation. Neutrophils and macrophages remodel extracellular matrix in the interstitium as an inflammatory response, promoting compromise of the epithelium and endothelium; iv. Epithelial permeability is compromised and e-cigarette aerosol exposure is associated with epithelial cell apoptosis and necrosis; v. e-cigarette aerosol exposed macrophages and neutrophils enter the lung tissue and promote inflammation. Macrophages take up e-cigarette-associated lipids. Not to scale.
Figure shows summary of pulmonary and cardiovascular dysfunction and their cellular basis.[13] (a) E-cigarette use has been linked to disease and dysfunction in the heart and lungs.[13] (b) i. Platelets are activated towards a pro-thrombotic phenotype in the vessel; ii. E-cigarette aerosol exposure promotes endothelial cell death and compromised barrier function, which facilitates immune cell extravasation into the surrounding tissue.[13] Endothelial cells release inflammatory cytokines that enhance neutrophil recruitment; iii. Monocytes differentiate into macrophages upon extravasation.[13] Neutrophils and macrophages remodel extracellular matrix in the interstitium as an inflammatory response, promoting compromise of the epithelium and endothelium; iv. Epithelial permeability is compromised and e-cigarette aerosol exposure is associated with epithelial cell apoptosis and necrosis; v. e-cigarette aerosol exposed macrophages and neutrophils enter the lung tissue and promote inflammation.[13] Macrophages take up e-cigarette-associated lipids.[13] Not to scale.[13]
Figure shows testing outcomes for acute heart rate. Eight acute studies found no significant increase in heart rate with e-cigarette use within subject or compared to tobacco cigarettes. Three acute tests found a significant increase in heart rate for nicotine e-cigarettes, but in one test, the increase was not significantly different than tobacco cigarettes, and in another, it was a significantly lower increase than tobacco cigarettes. One additional acute study finding an increase in heart rate was seriously compromised due to excessive e-cigarette exposure. One study reported that acute non-nicotine e-cigarette use significantly raised heart rate compared to sham vaping; it conducted excessive e-cigarette exposure. Another study on non-nicotine e-cigarettes found that tobacco cigarettes significantly raised heart rate in comparison.
Eight acute studies found no significant increase in heart rate with e-cigarette use within subject or compared to tobacco cigarettes.[361] Three acute tests found a significant increase in heart rate for nicotine e-cigarettes, but in one test, the increase was not significantly different than tobacco cigarettes, and in another, it was a significantly lower increase than tobacco cigarettes.[361] One additional acute study finding an increase in heart rate was seriously compromised due to excessive e-cigarette exposure.[361] One study reported that acute non-nicotine e-cigarette use significantly raised heart rate compared to sham vaping; it conducted excessive e-cigarette exposure.[361] Another study on non-nicotine e-cigarettes found that tobacco cigarettes significantly raised heart rate in comparison.[361]

There is limited available evidence on their long-term cardiovascular effects.[362] No data is available on their effects in individuals with cardiovascular disease, as of 2016.[247] Their cardiovascular effects in individuals who do not have cardiovascular disease is uncertain.[363] Although limited, there is supportive evidence that vaping adversely impacts endothelial function and arterial hardening.[362] Most of the cardiovascular effects of vaping are consistent with those of nicotine.[91] E-cigarettes may lead to adverse effects on the cardiovascular system through various mechanisms, such as oxidative stress, inflammation, endothelial dysfunction, atherosclerosis, hemodynamic effects, and platelet activity.[360]

Effects

A 2023 systematic review and meta-analysis finds that nicotine-containing e-cigarettes cause a substantial, potentially harmful effect on several short-term cardiovascular parameters.[364] Their short-term use may result in adverse effects in vascular endothelial function.[98] Vaping might bring about some adverse cardiovascular effects to users, especially those who already have cardiovascular disease.[91] However, the risk is believed to be lower than that of cigarette smoking based on research comparing e-cigarette aerosol in contrast to cigarette smoke chemicals.[91] Compared to non-users, e-cigarette use increases the chance of experiencing a heart attack by 33%.[365]

There is a substantial amount of evidence that e-cigarettes can be equally (if not even more) harmful to the cardiovascular system than traditional tobacco.[366] Like classic tobacco smoking, e-cigarettes can also increase sympathetic nervous system activity, oxidative stress and inflammation, endothelial dysfunction, and platelet activation, leading to cardiac arrhythmias, atherosclerosis and plaque instability, thrombosis and acute ischemia, etc.[366] The effects of e‐cigarettes on RAAS activity and specifically on aldosterone levels are presently not known.[366]

Given the similarity between their cardiovascular effects and those of traditional tobacco smoking, it is quite plausible that e-cigarette–derived nicotine also activates the RAAS axis and elevates circulating aldosterone levels, exactly as the nicotine delivered by traditional tobacco products does.[366] Nicotine has systemic hemodynamic effects that are mediated by the activation of the sympathetic nervous system.[71] Thus, acute nicotine treatment can stimulate cardiac output by producing systemic vasoconstriction and increasing heart rate.[71]

The effects of aldehydes, particulates, and flavorings used in vaping devices on cardiovascular health is not clear.[91] Low amounts of aldehydes can still be a health concern, particularly among individuals with cardiovascular disease.[209] E-cigarettes reduce cardiac muscle function and increase inflammation, but these changes were only substantial with traditional cigarettes.[28] No published research is available on vaping and thrombosis, platelet reactivity, atherosclerosis, or blood vessel function.[45] The small particles generated from e-cigarette use have the ability to get through airways and enter circulation, which pose a potential risk to cardiovascular systems.[209]

The minute nicotine particles in the e-cigarette vapor could increase the risk of cardiac arrhythmias and hypertension which may put some users, particularly those with atherosclerosis or other cardiovascular risk factors, at significant risk of acute coronary syndrome.[269] There are many compounds in the e-cigarette vapor that have an impact on the onset and advancement of atherosclerosis.[367] Some case reports documented the possible cardiovascular adverse effects from using e-cigarettes, the majority associated was with improper use.[269] Even though e-cigarettes are anticipated to produce fewer harmful substances than traditional cigarettes, limited evidence recognizes they comparatively have a lowered raised cardiovascular risk.[269]

Preliminary studies have shown that using a nicotine containing e-cigarette for just five minutes causes similar lung irritation, inflammation, and effect on blood vessels as smoking a traditional cigarette, which may increase the risk of a heart attack.[368] E-cigarette use leads to sympathomimetic effects because of nicotine intake.[369] The evidence suggests that vaping may induce tachycardia-induced cardiomyopathy.[369] E-cigarettes containing nicotine may have a lower cardiovascular effect than traditional cigarettes containing nicotine.[247] Research on the consequences of vaping on blood pressure is limited.[370] Short-term physiological effects include increases in blood pressure and heart rate.[45] The increased blood pressure and heart rate among smokers who vaped was lower than with cigarette smoking.[209]

A 2016 study found vaping increases aortic stiffness in people who did not have cardiovascular risk factors, an effect that was lower than with cigarette smoking.[91] A 30-minute vaping session seems to induce an unfavorable effect on aortic stiffness similar to traditional smoking.[70] Habitual vaping was associated with oxidative stress and a shift towards cardiac sympathetic activity, which are both associated with a risk of developing cardiovascular disease.[215] A 2012 case report found a correlation between paroxysmal atrial fibrillation and vaping.[45] Research indicates a relationship between exposure to particulate matter with a diameter of 2.5 μm and the chance of developing cardiovascular disease.[209]

E-cigarettes adversely impact the cardiovascular system.[112] Although the specific role of nicotine in cardiovascular disease remains debated, nicotine is not the only biologically active component in e-cigarette aerosol.[112] E-cigarettes work by creating an aerosol of ultrafine particles to carry nicotine deep into the lungs.[112] These particles are as small as—and sometimes smaller than—those in traditional cigarettes.[112] These ultrafine particles are themselves biologically active, trigger inflammatory processes, and are directly implicated in causing cardiovascular disease and acute cardiovascular events.[112] The dose-response effect for exposure to particles is nonlinear, with substantial increases in cardiovascular risk with even low levels of exposure to ultrafine particles.[112] For example, exposure to second-hand cigarette smoke has nearly as large an effect on many risk factors for cardiovascular disease and the risk of acute myocardial infarction as does being an active smoker.[112] Like traditional cigarette smokers, e-cigarette users experience increased oxidative stress and increases in the release of inflammatory mediators.[112] E-cigarette aerosol also induces platelet activation, aggregation, and adhesion.[112] All these changes are associated with an increased risk of cardiovascular disease.[112] These physiological changes are manifest in rapid deterioration of vascular function following use of e-cigarettes.[112]

E-cigarette and traditional cigarette smoking in healthy individuals with no known cardiovascular disease exhibit similar inhibition of the ability of arteries to dilate in response to the need for more blood flow.[112] This change reflects damage to the lining of the arteries (the vascular endothelium), which increases both the risk of long-term heart disease and an acute event such as a myocardial infarction (heart attack).[112] Using e-cigarettes is also accompanied by a shift in balance of the autonomic (reflex) nervous system toward sympathetic predominance, which is also associated with increased cardiac risk.[112]

The biological stresses that e-cigarette use impose on the cardiovascular system are manifest as an increase in risk of acute myocardial infarction.[112] A cross-sectional analysis of data in the US 2014 and 2016 National Health Interview Surveys showed that daily e-cigarette use was associated with increased odds of having suffered a myocardial infarction, controlling for traditional cigarette smoking, demographic characteristics (age, gender, body mass index, family income) and health characteristics (hypertension, diabetes, and hypercholesterolemia).[112] Significantly, the effect of using e-cigarettes on the odds of myocardial infarction approached what was found with traditional cigarette smoking.[112] Daily vaping represents an independent risk factor for myocardial infarction, synergically amplified by exposure to nicotine, a parasympathomimetic alkaloid increasing heart rate and blood pressure.[70]

Hypertension effects

The research conducted by Farsalinos et al. in 2014 demonstrated that short-term e-cigarette using caused a fractional increase in diastolic blood pressure.[88] In the study conducted by Yan et al. in 2015, a lower nicotine content was reported in the blood of persons vaping e-cigarettes than in the case of people smoking traditional cigarettes, which contributed to a smaller increase in arterial pressure and heart rate in this group.[88] Research by Vlachopoulos et al. in 2016 was conducted among people of 30 ± 8 years of age without cardiovascular risk.[88] The subject of analysis was arterial pressure measured in 4 sessions: smoking traditional cigarettes and e-cigarettes for 5 minutes, 30 minutes of vaping e-cigarettes, and sham procedure that lasted 60 minutes .[88] The analysis of the obtained results did not show any differences in all the readings between the sessions, while the systolic and diastolic arterial pressure values as well as the heart rate increased both during smoking traditional cigarettes and e-cigarettes.[88]

Very significant results were obtained in the research conducted by Polosa et al. in 2017.[88] During a 3.5 years' observation of a group of young people (29.7 ± 6 years of age), daily e-cigarette users, who had never smoked before, no significant changes in the heart rate and arterial pressure values were demonstrated in comparison with the control group, who had never smoked any kind of cigarettes.[88] In turn, in a study conducted by Franzen et al. in 2018, persons vaping e-cigarettes and traditional cigarettes were subjected to a 2 hour observation immediately after having smoked a cigarette.[88] The analysis of the obtained results demonstrated that systolic blood pressure increased for up to 45 minutes after the person had stopped using an e-cigarette containing nicotine and for about 15 minutes in the case of normal cigarettes.[88] No significant changes in arterial pressure values in the first hour of observation were reported for e-cigarettes.[88] A similar correlation was demonstrated for heart rate readings.[88] Research in that field was also conducted by Antoniewicz et al. in 2019 to assess acute influence of inhaling e-cigarettes with nicotine and without it within the period of 0, 2, and 4 hours after exposure.[88] A significant increase in heart rate was reported in the case of vaping e-cigarettes containing nicotine and an increase in arterial blood pressure in both analyzed cases.[88]

In the study of Arastoo et al. in 2020 among 100 electronic and traditional smokers, including chronic smokers, the baseline heart rate variability as well as hemodynamics (blood pressure and heart rate) were analyzed.[88] In this research, the authors hypothesized that the changes in these parameters are caused by nicotine, and not by the non-nicotine components of the e-cigarette aerosol.[88] Based on the conducted research, it was shown that people who were chronic smokers of both types of cigarettes had a similar level of heart rate variability.[88] When assessing the effect of vaping e-cigarettes, a sharp increase in blood pressure and heart rate was noticed only after the use of e-cigarettes with nicotine, which confirmed the hypothesis.[88]

An interesting study was also conducted by George et al. in 2019 on a group of people of 18 of age or older, who had been smoking ≥15 cigarettes for ≥2 years.[88] During the study, the examined persons changed to using e-cigarettes with or without nicotine.[88] The analysis of the obtained results demonstrated that once both groups of e-cigarette vapers had been combined, a greater decrease in systolic blood pressure was reported than in the group of traditional smokers.[88] Abnormalities in heart rate during vaping e-cigarettes in comparison with nonsmokers were also demonstrated by Moheimani et al. in 2017.[88] Moreover, the authors indicate that it was not caused by the nicotine content in the e-cigarette liquid, because it was untraceable in the plasma of the examined persons.[88] At the same time, they emphasize that it is nicotine metabolites that can produce adverse effects leading to a greater risk of cardiovascular diseases among people using this type of cigarettes.[88]

E-cigarettes are very often chosen when a person wants to quit smoking traditional cigarettes.[88] In a 12-month prospective randomized research conducted by Caponetto et al. in 2013, the researchers subjected 300 participants divided into 3 groups to an analysis.[88] Study groups were given nicotine refill cartridges: 7.2 mg for 12 weeks; 7.2 mg for 6 weeks and 5.4 mg for another 6 weeks.[88] The control one was given cartridges without nicotine for 12 weeks.[88] The analysis of the obtained results demonstrated a decrease in the frequency of smoking in each group.[88] However, what is important is the fact that within the duration of the study, no significant changes in systolic and diastolic pressure or heart rate were demonstrated.[88] Moreover, no differences between the analyzed groups were revealed.[88] In turn, in a continuation of that study, conducted by Farsalinos et al. in 2017, an additional classification of constant smoking phenotype was made, in which people were divided into those who quitted smoking in full, those who limited the number of smoked cigarettes and those in whose case quitting ended in failure.[88] It was demonstrated that persons who limited or quitted smoking and changed to e-cigarettes were characterized by lower systolic arterial blood pressure.[88] This effect was especially visible in persons with elevated values at the beginning of the examination.[88]

In the context of e-cigarettes, by contributing to an increased sympathetic heart activity, can be also responsible for increased oxidative stress, which will cause an increased cardiovascular risk.[88] Moreover, the increased oxidative stress and inflammatory conditions can induce the development of atherosclerosis.[88]

Alzheimer's disease effects

Nicotine independently promotes the development of neurodegenerative disorders,[215] induces oxidative stress, and inhibits the process of autophagy.[215] Out of 28 e-liquids tested from seven companies in 2014, the four most commonly found flavor additives were vanillin, ethyl maltol, ethyl vanillin, and menthol.[215] They are carcinogenic or toxic, which may contribute to causing cardiopulmonary diseases such as chronic obstructive pulmonary disease and neurodegenerative disorders such as Alzheimer's disease.[215] E-cigarette use results in oxidize stress, which play a role in contributing to cardiopulmonary diseases and neurodegenerative disorders.[215]

Brain effects

The long-term effects of e-cigarette use on the brain is unknown.[4] With long-term nicotine use, cellular adaptations (as the brain reacts to recurring periods of uptake and withdrawal) within the brain may result in almost permanent alterations in neurons and neural circuits.[10] While a clear positive correlation between e-cigarette use and depression has been established, the causality and mitigating factors affecting this relationship are largely undetermined.[4] There is growing evidence that vaping is hazardous to one's health including risk of depression which increases the risk of suicidal thoughts and suicide.[337]

Chronic farnesol administration increases the firing rate of nicotinic acetylcholine receptor-expressing neurons in the ventral tegmental area.[4] Thus, the addition of the green apple flavorant, which is acquired by adding the chemical farnesol, induces neurobiological changes in the brain’s reward-related circuitry, which enhances nicotine’s rewarding properties to reinforce continued product use.[4]

E-cigarette-emitted metal particulates have been shown to readily cross the blood–brain barrier, as evidenced by metal accumulation in the mouse brain.[4] Moreover, following e-cigarette exposure, arsenic, chromium, copper, iron, manganese, nickel, lead, selenium, strontium, and zinc were found to accumulate across different regions of the mouse brain, with the greatest accumulation observed in the anterior frontal cortex and striatum.[4] Specifically, in the anterior frontal cortex, copper and strontium were enriched, whereas arsenic, chromium, copper, iron, lead, and selenium were enriched in the striatum.[4] Like other types of e-cigarette emissions, the type and relative proportion of metals that might accumulate in the brain are expected to vary among commercially available brands due to differences in the vape liquid constituents and electronic cigarette device characteristics.[4]

Cerebrovascular disease effects

Adequate research is not available to ascertain the risk of long-term harm resulting in cerebrovascular disease.[371]

Effects on COVID-19

Figure shows the effects of e-cigarette use on lung and immune function in response to COVID-19 virus and similarities of pathogenicity.
Figure shows the effects of e-cigarette use on lung and immune function in response to COVID-19 virus and similarities of pathogenicity.[372]
Figure shows factors responsible for higher susceptibility of smokers or vapers against COVID-19. In normal individuals, the muco-ciliary epithelium and the mucous layers act as the first line of defense against the foreign pathogen (in this case SARS-CoV2). On smoking, this layer is damaged and so is the flow of the peri-ciliary fluid (mucous; indicated by arrows) which makes them more prone to infections. Smokers are also shown to have higher surface expression of ACE2 receptors (binding sites for SARS-CoV2) which allows the entry of pathogens into the host cell and protects the virus against the host surveillance. In normal individuals, the viral infection could be checked by the, (a) cytokine release from the type II pneumocytes, goblet, nasal epithelial/ciliated and oral mucosal cells and (b) immune cell (macrophages, neutrophils and lymphocytes) infiltration at the site of infection, to contain further spread. Smoking weakens the immune system enabling easy entry into the host cell, rapid multiplication of the virus followed by hyperinflammatory response triggered by 'cytokine storm' in the host body eventually leading to damaged lung tissue.
Figure shows factors responsible for higher susceptibility of smokers or vapers against COVID-19.[373] In normal individuals, the muco-ciliary epithelium and the mucous layers act as the first line of defense against the foreign pathogen (in this case SARS-CoV2).[373] On smoking, this layer is damaged and so is the flow of the peri-ciliary fluid (mucous; indicated by arrows) which makes them more prone to infections.[373] Smokers are also shown to have higher surface expression of ACE2 receptors (binding sites for SARS-CoV2) which allows the entry of pathogens into the host cell and protects the virus against the host surveillance.[373] In normal individuals, the viral infection could be checked by the, (a) cytokine release from the type II pneumocytes, goblet, nasal epithelial/ciliated and oral mucosal cells and (b) immune cell (macrophages, neutrophils and lymphocytes) infiltration at the site of infection, to contain further spread.[373] Smoking weakens the immune system enabling easy entry into the host cell, rapid multiplication of the virus followed by hyperinflammatory response triggered by 'cytokine storm' in the host body eventually leading to damaged lung tissue.[373]

Because of their possible acute lung and cardiovascular toxicity, vaping may pose a greater risk of severe sickness for individuals with COVID-19.[77] The impact of vaping on being more susceptible to being diagnosed with COVID-19 is unknown.[374] A 2020 study found a clear link between vaping and various COVID-19 cases and fatalities.[375]

Vaping habits, such as the hand-to-mouth actions as well as touching the face, could increase the chance of COVID-19 infection and spread of the virus.[158] Through the transmission of asymptomatic carriers, sharing vaping devices could contribute to the spread of the virus.[158] It is possible the surface of a vaping device can be a vehicle for the transmission of the virus.[376] This is because the virus can survive on surfaces for a few hours to days.[376] Due to their design, e-cigarettes devices are brought to the mouth and face to inhale repeatedly, and many users have an increased urge to cough or expectorate which can increase the transmission of COVID-19.[100] In addition, the aerosols generated by these devices could contribute to SARS-CoV-2 transmission.[100]

E-cigarettes which contain high amount of nicotine might contribute to overexpression of ACE2 and contribute in the serious COVID 19 associated complications.[372] Moreover, ACE2 is linked to nicotinic acetylcholine receptors (nAChRs), particularly alpha7nAChR receptors, further supporting the notion that vaping (nicotine) might be playing a significant role in the pathophysiology of COVID-19.[372] Furthermore, TMPRSS2 protease important in the virus entry into the host cells are is suggested to be altered by ACE2 in vapers.[372]

E-cigarette use impair mucociliary clearance, increased mucosal permeability, promote peribronchial inflammation, and fibrosis.[372] It is well-established that the mucociliary epithelium and the mucous layers act as the primary line of defense against pathogens.[372] Further, vaping induces oxidative stress and inflammatory responses which may further contribute to COVID-19 related complication in vapers.[372]

A 2020 analysis showed that the occurrence of COVID-19 was associated with the use of e-cigarettes or the use of e-cigarettes and cigarettes together.[372] COVID-19 diagnosis was five times more likely among e-cigarettes users and seven times more likely among ever-dual-users.[372] Further, the testing was nine times more likely among past 30-day dual-users and 2.6 times more likely among past 30-day e-cigarette only users.[372] A 2021 review speculates that dual users of e-cigarettes and alcohol may be at higher risk to complications of COVID-19.[220] Higher odds of COVID-19 symptoms and higher odds of confirmed/suspected COVID-19 diagnosis were found in dual users than in exclusive smoking of conventional cigarettes.[79]

A 2020 study showed that while the use of nicotine or flavor-containing e-cigarettes led to significant cytokine dysregulation and potential inflammasome activation, none of these effects were detected in non-flavored and non-nicotine-containing e-cigarettes.[82] Therefore, taking together these observations, e-cigarette use may still be a potent risk factor for severe COVID-19 development depending on the flavor and nicotine content.[82] While smoking is linked with progression to more dire cases of COVID-19, a 2020 review recommends to give up vaping to minimize the chance of developing a severe case of COVID-19.[377]

Vaping websites inquired abouts the risks related to e-cigarette use and COVID-19, and unverified statements that vaping and nicotine can be used to guard against COVID-19 spread across social media.[378] The use of-cigarettes and the possible greater chance of transmission and susceptibility to COVID-19, as well as the possible greater chance of severity to this illness is a public health concern.[379] Medical organizations and public health professional across the globe have voiced their concern that e-cigarette use may increase the likelihood for COVID-19 susceptibility, severity, and negative consequences.[379]

Erectile dysfunction effects

Vaping may cause oxidative stress, such as the creation of reactive oxygen species and hydroxyl radicals.[380] This can lead to endothelial dysfunction, which in turn may lead to erectile dysfunction.[380] Nicotine causes dysfunction of nitric oxide synthesis.[48] This may result in an inability to get penile erections, resulting in erectile dysfunction.[48] Mutiple studies have shown endothelial dysfunction from vaping, from nicotine itself as well as additives and flavors in e-cigarette emissions.[380] No study has conclusively demonstrated vaping causes erectile dysfunction, although nicotine use has been demonstrated to cause erectile dysfunction.[380]

Esophagitis effects

E-cigarettes are potential triggers of esophagitis exacerbations.[70]

Effects on eye health

Limited research is available on the consequences of vaping on eye health, though chemicals such as nicotine and aldehydes are possibly harmful to the eyes.[381] Exposure to toxic chemicals from e-liquid or its vapor may result in dry eye and tear film break-up.[381]

Reproductive effects

Male

Diagram explaining the effects of e-cigarette-mediated reproductive disruption.
Effects of e-cigarette-mediated reproductive disruption[67]

While studies on the effect of e-cigarettes on human male reproduction are limited, numerous studies have investigated their effect in animal models.[67]

Exposure to e-cigarettes was reported to disturb the hypothalamo-pituitary axis, resulting in altered gonadal function and semen quality.[67] Wawryk-Gawda and collaborators in 2019 showed that in male rats exposed to e-cigarette vapor had increased apoptosis in spermatogonia and spermatocyte, an alteration of the morphology and function of the seminiferous epithelium, as well as unica albuginea malformations.[67] Other studies linked e-cigarette utilization with steroidogenesis disruption and global disorganisation of the testes, accompanied by significant desquamation of germ cells.[67]

Moreover, low testicular weight and a higher apoptotic cell number in the testis was observed in the context of e-cigarette exposure.[67] Intraperitoneal injection of e-cigarette liquid in male rats induced toxicity and testicular inflammation, which, in turn, affected sperm production and sperm quality with lower sperm density, reduction of epididymal sperm number, and lower sperm viability.[67] When inhaled for 4 weeks by male rats, the same flavoring induced apoptosis in testes.[67] The sperm of rats exposed to e-cigarette vapor showed increased teratozoospermia (looped tail, flagellar angulation, and complete absence of flagellum).[67] Studies showed that sperm chromatin integrity could also be affected by e-cigarette exposure.[67] In fact, higher DNA damage was observed in both testis and sperm of exposed rats.[67] These findings suggest potential mutagenic effects of e-cigarettes on sperm.[67]

Little to no studies have corroborated these findings in humans.[67] A preliminary study, presented at the British Fertility Society Conference in 2017, investigating the effect of e-cigarette flavoring on human sperm, showed a significant decrease in motility in specimen cultured with e-liquid flavoring.[67] This study and the results obtained in animal models all suggest that vaping could have pathogenic effects on male reproduction and caution should be used when vaping and trying to conceive.[67]

Female

Evidence of the impact of e-cigarettes on female reproduction suggests that the female reproductive system is not left unaffected by exposure to e-cigarettes.[67] Unlike sperm, there is no evidence linking the impact of e-cigarette utilization on intrinsic oocyte quality and oocyte genome integrity.[67] However, some data suggests that ovarian function is impaired in animal models exposed to e-cigarettes.[67] A decreased percentage of normal follicles was described in the ovaries of female rats exposed to e-cigarette fluid.[67] Hormone levels were also affected in these animals, where a reduction in estrogen secretion was observed.[67] Implantation and pregnancy outcomes were also affected in mice exposed to e-cigarette vapor.[67] Microarray analysis showed an alteration in uterine receptivity transcripts in e-cigarette exposed mice.[67] These females experienced a delay in embryo implantation, although the animals showed high progesterone levels, resulting in a decreased offspring number.[67]

Although reproductive trials have demonstrated that e-cigarettes can be responsible for embryo implantation and development impairments in mice, studies have not yet been performed specifically regarding e-cigarette-associated exposure in mammal granulosa cells.[382] In a 2017 study carried out in pregnant smokers, it was observed that the use of e-cigarettes as a way to quit tobacco smoking was consideerably more common than any other US FDA-approved smoking cessation tool.[382] For this reason, both fertility and embryo implantation trials in 2019 have been performed in mice following exposure of the animals to e-cigarette-produced aerosol for 4 months.[382] Exposed dams showed a significant delay in the onset of the first litter and a noticeable impaired embryo implantation despite the detection of high progesterone levels, a known pregnancy indicator.[382] As a consequence, existing studies could indicate that e-cigarettes are capable of impairing pregnancy initiation and fetal health, further suggesting that their use on behalf of reproductive-aged women or during pregnancy should be considered with extreme caution, a 2020 review states.[382]

Effects on gastrointestinal system

The most common gastrointestinal symptoms associated with vaping were epigastric pain, nausea and vomiting, followed by diarrhea and hemorrhage, which Gaur et al. attributed to the trace metals copper and chromium in the aerosol if exposed to high levels.[383] Further reports have documented relapsed ulcerative colitis in two unrelated cases of heavy cigarette smokers after having stopped cigarette smoking and starting e‑cigarette use.[383] In these cases, either the continued use of e‑cigarettes or switching back to cigarette smoking helped alleviate the symptoms.[383]

In another case report of a pregnancy health effect linked to e‑cigarette use, a one-day-old infant suffered gastrointestinal bleeding with abdominal distension and respiratory distress.[383] The infant recovered at six months, after having undergone double barrel ileostomy and subsequent surgical procedures.[383] Vaping might induce recurring ulcerative colitis.[129]

Effects on immunology

Concern exists regarding the immunological effects of e-liquid, and analysis on animals demonstrate that nicotine as well as e-liquid vapor, appear to have adverse effects on the immune system.[129] The health consequences of smoking are widely documented, but the immunological effects of e-cigarette use is not well understood.[90] The finding of the limited available research on the immunological effects appear to be contradictory.[90] There is a small amount of research available that is related to gastrointestinal and neurological health risks.[90] There were reports of e-cigarettes causing an immune system reaction involving inflammation of the gastrointestinal system.[87]

Insulin resistance effects

Studies have shown that nicotine causes decreased sensitivity of tissues to insulin, thus increasing the risk of developing type 2 diabetes.[88] Nicotine contributes to an increase in the level of hormones antagonistic to insulin, i.e, catecholamines and cortisol.[88] In turn, research studies conducted on animals have shown a direct influence of nicotine on activation of protein kinase dependent on AMP in adipose tissue.[88] It increased the speed of lipolysis and promoted insulin resistance.[88] Insulin resistance, which causes the development of diabetes, is connected with prothrombotic inflammatory conditions and provokes atherogenic changes in blood lipids.[88] It increases the risk of ischemic heart disease, diseases of peripheral arteries, and brain stroke.[88]

Research on the influence of nicotine on the organism has demonstrated its ability to induce hyperglycemia by activating glycogenesis and gluconeogenesis.[88] El Golli et al. in 2016 conducted experiment on rats administered intraperitoneally exposed to pure nicotine (0.5 mg/kg of body weight), e-liquid with or without nicotine for 28 days, and a significant increase in the level of blood glucose was reported.[88] Additionally, a reduced level of liver proteins and increased transaminase activity were detected in all the examined groups, yet it was the rats exposed to e-cigarettes which achieved worse results than the rats exposed to pure nicotine.[88] This can suggest that the mechanism of disorders of glucose metabolism induced by e-cigarettes is different than in the case of nicotine alone.[88] A 2019 study demonstrated that e-cigarettes users were at a greater risk of being diagnosed with prediabetes than those who had never used this kind of cigarettes.[88]

Kidney effects

A 2016 study regarding e-liquid exposure in adults rats showed e-cigarettes have an adverse impact on the kidneys.[249]

Liver effects

Animal studies have shown that vaping can induce hepatic steatosis through heterogeneous mechanisms, involving oxidative stress, hepatocytes apoptosis and impairment of cholesterol and lipid metabolism.[70] A 2020 case report documented e-cigarettes-induced hepatic injury even in humans, describing an increase of liver enzymes in a young vaper presenting to the emergency department for fever, abdominal pain, vomiting, and diarrhea.[70]

Effects on medication

Two cases highlighted that the use of the e-cigarette increased their clozapine levels and one publication presenting a patient with epilepsy for whom it increased their seizure frequency.[150] Two of the patients were 16 years old and 23 years old females and there was one 52-year-old male.[150] The increased clozapine levels reported cases, demonstrate the effect of nicotine on medication plasma levels and raise wider concerns regarding potential interactions with other medications as well.[150] Switching between different e-cigarette products and vice versa, or planning on quitting smoking, might alter the serum levels of a person's medication.[150]

Thromboembolism

There is scarce information on the health effects of using oral contraceptive in conjunction with e-cigarettes.[384] The available research indicates that e-cigarettes can lead to thrombosis.[384] As a result, people with other hypercoagulability triggers who also use e-cigarettes may face an increased risk of thromboembolism.[384] Additionally, oral contraceptive use in young adolescents can induce a hypercoagulable state and thrombosis.[384] This serves as an independent risk factor for thromboembolism, even in women without genetic predispositions or other common risk factors.[384] The estrogen component of oral contraceptives alters hemostasis by boosting the plasma levels and activities of coagulation factors while reducing coagulation inhibitors.[384]

Metabolism

Metabolic effects

There is a limited amount of research available on the metabolic effects of vaping.[385] It has not been fully studied in humans as to whether vaping has the same negative effects on metabolic processes as cigarette smoking.[385] Though, animal studies show similar effects of vaping, even without being exposed to nicotine, on weight and metabolic processes, comparing cigarette smoking.[385] This shows other things are responsible for the metabolic effects than just nicotine.[385] Animal studies indicate that vaping has similar negative effects on weight, body fat, glucose and lipid profiles and other cardiovascular potential dangers as traditional cigarettes, but they may be less prominent.[385] A lot of these cardiometabolic effects happen even without nicotine being present.[385]

Metabolic syndrome effects

As of 2020, there have been very few publications demonstrating the influence of e-cigarettes on the risk of occurrence of metabolic syndrome in people.[88] Research on a group of 18,300 volunteers was conducted by Lequy et al. 2018.[88] The obtained results allowed the researchers to claim that the occurrence of metabolic syndrome was connected with using e-cigarettes, whenever patients were not on a diet.[88] Another study in 2020 has been conducted on a group of 7505 Korean males over 19 years of age to compare the frequency of occurrence of cardiovascular risk factors among: males smoking conventional cigarettes, dual users (e-cigarettes and traditional cigarettes users) and never-smokers.[88] The multivariate logistic regression analysis showed that, in the adjusted model, the odds ratio (OR) for the prevalence of metabolic syndrome equaled 2.79 (p  <  0.001) in comparison with never-smokers and 1.57 (p  =  0.038) in relation to cigarette-only smokers.[88] In this model, dual users were characterized by an increased waist circumference and triglycerides level, as well as reduced high-density lipoproteins (HDL) in comparison with both the people who had never smoked and those who smoked only traditional cigarettes; therefore, it may be concluded that dual users are more vulnerable to cardiovascular risk factors.[88]

Blood lipids

High levels of triglycerides and low levels of HDL are risk factors for cardiovascular disease.[71] Nicotine promotes loss of body weight and the disturbance of lipoprotein metabolism through the secretion of catecholamines, such as norepinephrine.[71] Catecholamine secretion favors the elevation of low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) and is also associated with decreased HDL levels.[71] Higher levels of LDL and VLDL are also known risk factors for cardiovascular diseases.[71] A health survey in Korean men showed significantly elevated triglyceride levels in dual users of conventional cigarettes and e-cigarettes compared to non-smokers.[71]

In addition, there was no significant difference in triglyceride levels between dual users and conventional cigarette-only smokers.[71] However, another work has shown that e-cigarette users have higher triglycerides and lower HDL than never users.[71] HDL cholesterol was significantly lower in both dual users and conventional cigarette only smokers compared to those who never have smoked.[71] E-cigarette vapers had increased levels of LDL and VLDL compared to nonsmokers.[71] Habitual e-cigarette users had increased oxidized LDL levels compared with non-user control individuals.[71] Oxidized LDL can lead to atherosclerosis as it can contribute to the buildup of atherosclerotic plaques.[71]

A 2019 study shows that e-cigarettes influence the lipid profile.[88] A comparison between nonsmokers, people smoking traditional cigarettes, and those using e-cigarettes demonstrated that the LDL fraction concentration was significantly higher in the group vaping e-cigarettes than in the control group, as opposed to those smoking traditional cigarettes, in whose case a negligible increase was reported.[88] In both groups also a slight decrease in the HDL fraction cholesterol was reported in comparison with the nonsmoking group, yet this decrease was greater in the group of people vaping e-cigarettes.[88] In turn, in the case of VLDL, the group of e-cigarettes users demonstrated a smaller increase in its concentration in blood serum.[88]

Effects on microbial pathogens

Vaping may weaken the body's ability to get rid of microbial pathogens, resulting in greater vulnerability to viral, fungal, or bacterial infections.[386] However, the effects of such findings continue to be unclear.[386]

Effects on multisystem inflammatory syndrome

Studies have shown an association between multisystem inflammatory syndrome and vaping, and a 2021 review speculates that adolescents who vape might be especially vulnerable to serious respiratory symptoms if they develop a hyper-inflammatory state multisystem inflammatory syndrome.[372]

Effects on nasal tissues

Research has been conducted on nasal tissues, partly due to a great number of e-cigarette users exhale via the nose.[375] There is a noticeable decline in gene expression associated with the immune system in the nasal epithelium, which suggests the immune genes had been impaired, and as consequence e-cigarette users may be more prone to infections.[375]

Effects on neuropsychiatric disorders

There is scant evidence on the neuropathological effects induced by nicotine exposure on the developing brain.[387] Due to this lack of knowledge, there is a rising public health concern when taking into account the surge in teen nicotine use and the emergence of innovative nicotine delivery devices like e-cigarettes.[387] There is persuasive evidence implying that teen nicotine exposure raises the likelihood of anxiety-associated behavior in the near term.[388] There is an association between teen nicotine exposure and a higher susceptibility of developing mood and anxiety-associated disorders in adulthood.[387] No effect has been observed on symptoms of schizophrenia from e-cigarette use.[129] Given the lack of data, there is currently no recommendation regarding dose adjustment of antipsychotics in the context of e-cigarette use.[389]

Data from rodents support findings from human studies associating e-cigarette exposure with anxiety- and depression-associated behaviors.[4] Specifically, withdrawal from nicotine was shown to induce persistent changes in anxiety-, depression- and compulsive-like behaviors following seven weeks of e-cigarette exposure, and surprisingly, these behavioral changes persisted 90 days following the last e-cigarette exposure in male mice.[4] Behavioral changes have also been observed even in the absence of nicotine, as nicotine-free e-cigarette vapor exposure was shown to result in anxiogenic phenotypes in both male and female mice.[4]

Abdominal obesity effects

Research conducted on rats demonstrated that exposure to nicotine contributes to significant adipocytes hypertrophy with increased expression of transcription factors of proadipogenic genes.[88] Such factors include the peroxisome proliferator activated receptor γ (PPAR-γ).[88] The result of the aforementioned situation is an increase in body weight and accumulation of adipose tissue.[88] The creation of mature adipocytes is also influenced by oxidative stress.[88]

So far not much has been learnt about the influence of e-cigarettes on adipose tissue and adipocyte functions.[88] The first such research was conducted by Zagoriti et al. in 2020.[88] It compared the influence of traditional cigarettes, e-cigarettes, and heated tobacco products on the differentiation of preadipocytes into beige adipocytes.[88] The increased activity of this kind of adipocytes (so-called thermogenic ones) was suggested as a means of reducing obesity and metabolic disorders.[88]

It was demonstrated that the extract of traditional cigarettes, as opposed to the other two extracts, significantly disrupted the differentiation of preadipocytes into beige adipocytes, which can influence the metabolic function of adipose tissue.[88] In turn, the results of research on e-cigarettes conducted on mice demonstrated that pure nicotine did not fully answer for lower body weight.[88] Further studies involving exposure of mice to equivalent nicotine doses, through inhaling e-cigarette or traditional cigarette fumes, did not show any influence on the body weight reduction in those exposed to e-cigarettes.[88] It can suggest that it is other compounds in cigarettes that can participate in reducing body weight while smoking traditional cigarettes.[88] On the other hand, opposite results were obtained by El Goli et al. in 2001 and Werley et al. in 2016 in their research on rats.[88]

Effects on oral health

The tissues of the oral cavity are those first exposed to the inhaled e-aerosol and they interact directly with its toxicants and chemical components.[390] Nicotine can cause vasoconstriction and decreased blood flow, which results in a reduced oxygen and blood supply to the gums and a reduction in the ability of the gums to remain healthy.[183] Research on potential oral health changes following e-cigarette exposure is limited and daily vaping is associated with poor oral health.[390]

A 2020 pilot cross-sectional study was performed with volunteers to assess the effect of e-cigarette use on biomarkers of inflammation, oxidative stress, anti-inflammatory lipid mediators, tissue injury and repair and growth factors in saliva and gingival crevicular fluid. The obtained results were compared between four groups of participants as e-cigarette users, non-smokers, cigarette smokers and both e-cigarette and cigarette (dual) smokers.[390] There was significant increase between levels of myeloperoxidase and matrix metaloproteinase-9 in e-cigarette users vs. non-smokers, and between dual smokers and e-cigarette users in inflammatory mediators as receptor for advanced glycation end products, myeloperoxidase and recombinant human uteroglobin/CC10.[390]

The changes in antioxidant capacity of saliva in e-cigarette users and cigarette smokers comparing to non-smokers were observed in a study by in 2021.[390] The uric acid, hypoxanthine, xanthine, TAOS (total antioxidant status) and TEAC (Trolox equivalent antioxidant capacity) were determined in the samples of saliva patients.[390] The antioxidant capacity of saliva was affected in the e-cigarette users in a similar degree as in cigarette smokers when compared to the saliva of non-smokers.[390] The impaired antioxidant function of saliva can stimulate the formation of free radicals and reactive oxygen species (ROS), which play a role in the progression of periodontitis and destruction of tissue.[390]

The microorganisms, harboring over 700 species, that reside in the human oral cavity are described as the oral microbiome, oral microflora or oral microbiota.[390] The microorganisms play an important role in the maintenance of the proper environment in the oral cavity and encompasses oral niches, such as teeth surface, tongue, cheeks, subgingival and supragingival plaque, palates, tonsils and salivary.[390] A dysbiosis, an imbalance in the microbial ecosystem, can produce changes in their functional composition and can result in pathological conditions.[390] The flavoring compounds of e-liquids have various aromas and tastes, and some chemical components, such as saccharides and sucralose are added to provide a sweet taste, they may selectively disrupt the homeostasis of the oral microbiome and can be associated with a variety of oral diseases, such as periodontitis and caries.[390]

There is evidence that e-cigarette use is associated with a compositional and functional shift in the oral microbiome, with an increase in opportunistic pathogens and virulence traits.[390] Preliminary research indicates that the health risks of e-cigarettes to the oral microbiome may be comparable to or more than smoking.[9] The combination of glycerin and flavoring agent in e-liquid pods may be associated with a four-fold increase in microbial adhesion and a two-fold increase in biofilm formation.[183] Sticky aerosols produced by heated e-liquid encourage the caries-causing bacterium Streptococcus mutans to adhere to tooth enamel, leading to demineralization and caries.[183]

There is little evidence indicating that using e-cigarettes rather than continue to smoke will help with periodontal disease.[391] Vaping may be equally as dangerous or possibly more dangerous to oral health than tobacco smoking.[392] Vaping with or without nicotine or flavoring may help cause periodontal disease.[393] Nicotine as well as their flavoring may be damaging to periodontal ligament, stem cells, and gingival fibroblasts in cultures as a result of creation of aldehydes and/or carbonyls from e-cigarette vapor.[393] It is possible that e-cigarettes could harm the periodontium because of the effects of nicotine on gum tissues and the immune system.[144] A 2023 review found every study demonstrated an increased marginal bone loss, probing depth, and plaque index, as well as decreased bleeding on probing in e-cigarette users as opposed to non-smokers who had an implant-supported prosthesis with over a year in use.[394] Early research suggests that e-cigarettes have an adverse effect on the results of dental implants in males.[395] A 2016 study found 6.9-8.1% of e-cigarette users had a toothache compared with 3.9-16.7% in traditional cigarette users.[396]

The potential connection of e-cigarette use with dry mouth has not been fully investigated.[397] Dry mouth is one of the oral complaints related to e-cigarettes and the oral diagnoses related to their use include nicotine stomatitis, black hairy tongue, and angular cheilitis.[210] Dry mouth from using e-cigarette affects adults and youth.[397] E-cigarette users were more likely to have dry mouth than tobacco users.[397] Vaping can increase the risk of developing oral mucosal lesions, nicotine stomatitis, hyperplastic candidiasis, and black hairy tongue.[398] The oral mucosal lesions nicotine stomatitis, hyperplastic candidiasis, and black hairy tongue are more frequent in vapers than in previous smokers.[398] In 2015, after an individual was diagnosed with black hairy tongue they quit vaping and started smoking again, which cured her discolored tongue.[398] When she started vaping again, the discoloration came back.[398]

Otology effects

Although little is known about the effects of e-cigarettes in otology, preliminary in vitro studies have shown middle-ear epithelial cell cytotoxicity is associated with nicotine and propylene glycol.[399] A 2014 study on guinea pigs showed that nicotine causes injury at the cochlear outer hair cells, which were deformed in shape with vacuolated cytoplasm and heterochromatic nuclei.[399]

Effects on sleep health

A 2020 study reported that similar to conventional cigarettes, e-cigarettes were associated with worse sleep health in young adults.[400] A 2019 study showed a significant association between e-cigarettes use and higher odds of sleep-related problems in adolescents.[400]

Effects on reversible cerebral vasoconstriction syndrome

A 2015 case report found that vaping might trigger the onset of reversible cerebral vasoconstriction syndrome.[129]

Effects on spine health

Due to the growing worldwide popularity of e-cigarette products advertised as a healthier alternative to tobacco, there is an increasing concern over health risks that are linked to vape use and how it affects bone health.[401] There is evidence that many of the major constituents of e-cigarettes, such as nicotine and carbonyl compounds can significantly impair osteoblast function, suggesting e-cigarette use may be detrimental to bone health.[402]

A 1995 study demonstrated systemic nicotine significantly increased pseudoarthrosis rate to 100% compared to 44% in control animals in a rabbit model of posterolateral spine fusion.[401] A 2000 study showed nicotine alone inhibits the expression of multiple cytokines with a variety of functions during spine fusion.[401] An e-cigarette solution containing nicotine can impact intervertebral disc health through the degeneration of both vasculature and nucleus pulposus and annulus fibrosus cells.[401]

Stroke effects

A 2021 observational study found an association between e-cigarette use and stroke.[403] The role of e-cigarette use in the development of stroke is inconclusive, due to the strong effect of prior tobacco use as a risk factor for stroke.[134]

Effects on surgical outcomes

There is limited information on the physiologic effect of nicotine vaping on surgical outcomes.[404] Nicotine can induce vasoconstriction while in otologic surgery.[280] It is not known whether there is a benefit for vaping to aid with quitting smoking before surgery.[404] Vaping may have a considerable negative effect on wound healing[404] and may hamper tissue regeneration.[405]

Effects on tuberculosis

Long-term e-cigarette use could increase the chance of developing tuberculosis.[68]

Effects on urologic health

Data on the impact of vaping on urologic health is not available.[232]

Vascular disease effects

The detrimental effects of aerosols associated with e-cigarettes start at the endothelial level.[135] The oxidative stress reduces the bioavailability of nitric oxide which in turn plays a key role in endothelium dysfunction alongside peroxynitrite (produced by superoxide) which causes low-density lipoprotein oxidation and inflammatory cytokines.[135] A healthy endothelium is responsible for the production of vasodilators; however this function becomes impaired when the endothelium is injured (e.g., by cigarette smoke or toxic compounds found in e-cigarettes) leading to an imbalance between vasoconstrictors and vasodilators.[135] The damaged cells from the endothelium must be replaced in order to maintain vascular tone, an ability that is reduced in users of e-cigarettes.[135] Platelet activation, coagulation cascade stimulation, and impairment of anticoagulative fibrinolysis leads to vascular disease.[135]

Tooth discoloration

Little evidence is present for the exact mechanisms of how tobacco and nicotine products may discolor teeth.[406] Cigarette smoke considerably impacts the color stability of dental composites, the existing evidence indicates.[407] Although data is limited, e-cigarettes induce a decrease in color variation of dental composites compared to cigarette smoke.[407] There is some evidence to suggest that the e‐liquid composition has some influence on staining.[406] Repolishing or whitening procedures can help with the changes in color to dental composites caused by vaping.[407]

Researchers used spectrophotometry to compare enamel specimens after exposure to e-liquid aerosol according to flavor and nicotine content and found discoloration of enamel in vitro.[183] The chemical substances used to flavor e-liquids, such as menthol, may be the reason behind the color alteration of enamel.[183] A 2020 study reported that exposure to e-cigarettes produced discoloration levels on prosthodontic materials that was similar to that associated with the smoking of tobacco products.[183] In their study, which included ceramics and resin materials with different surface properties, discoloration caused by both e-cigarettes and conventional tobacco cigarettes was below clinically perceptible levels for ceramic materials but was visually perceptible for composite resins.[183]

Although the effect of e-cigarettes on tooth color may be less pronounced than that of traditional cigarettes, long-term, high-dose exposure to e-cigarettes does cause tooth discoloration.[183] The rate of color change varies between natural tooth enamel and restoration materials composed of resin or ceramics.[183] The rate of color change may also be affected by the brand and flavor of the e-liquid.[183]

Effects on skin

Dermal exposure

The first case of contact dermatitis linked to vaping was reported in 2015.[398] Over the last three years leading up to 2019, there has been a rise in cases of contact dermatitis from e-cigarette nickel exposure.[398]

Contact dermatitis from nickel exposure has been reported, following e-cigarette use.[329] The nickel from the heating coil leaches out of the device, resulting in irritation to the hand from holding the device.[398] Cases of contact dermatitis have been treated with the avoidance of the e-cigarette.[150]

E-cigarette aerosol exposure

Little is known regarding the impacts of e-cigarette aerosol on the skin.[241] A 2014 study found HaCaT skin cells were injuried after directly being exposed to aerosolized Balsamic flavored e-liquid.[241] The aerosolized flavor free e-liquid did not exhibit any effects.[241]

E-cigarette aerosol

Composition

The chemical composition of the electronic cigarette aerosol varies significantly across and within brands.[note 9][54] Limited data exists regarding their chemistry.[54] The aerosol of e-cigarettes is generated when the e-liquid comes in contact with a coil heated to a temperature of roughly 100–250 °C (212–482 °F) within a chamber, which is thought to cause pyrolysis of the e-liquid and could also lead to decomposition of other liquid ingredients.[note 10][41] The aerosol (mist[43]) produced by an e-cigarette is commonly but inaccurately called vapor.[note 11][54] The e‑cigarette aerosol is absorbed through the lungs, and at this point it rapidly travels through the heart and subsequently delivers nicotine to the brain within a matter of a few seconds.[383] Nicotine in the brain of e-cigarette users is typically between 0.05 and 0.5 μM.[191] The use of an e-cigarette simulates the action of smoking,[40] but without tobacco combustion.[408] The e-cigarette aerosol somewhat resembles cigarette smoke.[409] E-cigarettes do not produce aerosol between puffs.[410] Both smoke and carbon monoxide are not generated,[157] although insignificant quantities of incomplete combustion products are produced.[180]

The e-cigarette aerosol usually contains propylene glycol, glycerin, nicotine, flavors, aroma transporters, and other substances.[note 12][36] The levels of nicotine, tobacco-specific nitrosamines, aldehydes, metals, volatile organic compounds, flavors, and tobacco alkaloids in e-cigarette aerosols vary greatly.[54] The yield of chemicals found in the e-cigarette aerosol varies depending on, several factors, including the e-liquid contents, puffing rate, and the battery voltage.[note 13][193] About 250 chemicals have been found in e-cigarette vapors.[411] There is emerging evidence indicating that over a thousand chemicals can be present in the e-liquid and aerosol.[412] There is also a variety of unknown chemicals in the e-cigarette aerosol.[56]

Metal parts of e-cigarettes in contact with the e-liquid can contaminate it with metal particles.[16] Heavy metals and metal nanoparticles have been found in tiny amounts in the e-cigarette aerosol.[note 14][16] Once aerosolized, the ingredients in the e-liquid go through chemical reactions that form new compounds not previously found in the liquid.[42] Many chemicals including carbonyl compounds such as formaldehyde can inadvertently be produced when the nichrome wire (heating element) that touches the e-liquid is heated and chemically reacted with the liquid.[44] Propylene glycol-containing liquids produced the most amounts of carbonyls in e-cigarette vapors.[44] In 2015, e-cigarettes companies attempted to reduce the formation of formaldehyde and metal substances of the e-cigarette vapor by producing an e-liquid in which propylene glycol is replaced by glycerin.[413]

Propylene glycol and glycerin are oxidized to create aldehydes that are also found in cigarette smoke when e-liquids are heated and aerosolized at a voltage higher than 3 V.[54] Depending on the heating temperature, the carcinogens in the e-cigarette aerosol may surpass the levels of cigarette smoke.[42] Reduced voltage e-cigarettes generate very low levels of formaldehyde.[44] Initial studies reported that formaldehyde was formed during the vaping process under high heat conditions.[1] Although some of the more recent e-cigarette devices limit temperature in an attempt to minimize this, multiple reports have documented the formation of acetaldehyde, acrolein, diacetyl, and formaldehyde under a wide range of conditions.[1] As e-cigarette engineering evolves, the later-generation and "hotter" devices could expose users to greater amounts of carcinogens.[45]

Second-hand exposure

Aerosol (vapor) exhaled by an e-cigarette user may expose non-users to second-hand vapor.
Aerosol (vapor) exhaled by an e-cigarette user may expose non-users to second-hand vapor.[414]

Since e-cigarettes have not been in widespread use for a significant amount of time, the long-term biological effects are currently unknown.[7] The short-term health effects from the second-hand vapor is also not known.[57] There are limited information on the health effects for children inhaling second-hand vapor.[240] The long-term effects for children inhaling second-hand vapor is not known.[240]

E-cigarettes are marketed as "free of primary and second-hand smoke risk" due to no carbon monoxide or tar is expected to be generated during use.[310] However, there is a concern for the health impact of nicotine and other ingredients.[310] The available evidence demonstrates that the e-cigarette vapor emitted from e-cigarettes is not just "harmless water vapor" as is repeatedly stated in the advertising of e-cigarettes, and they can cause indoor air pollution.[7]

Some non-users have reported adverse effects from the second-hand vapor.[129] Exhaled vapor consists of nicotine and some other particles, primarily consisting of propylene glycol, glycerin, flavors, and aroma transporters.[36] Bystanders are exposed to these particles from exhaled e-cigarette vapor.[7] The exhaled vapor may involuntarily expose bystanders to toxicants that are in the range as some cigarettes.[19] This is due to the fact that some vaping devices generate toxicants in the range as some cigarettes do.[19] E-cigarette vapor has notably fewer toxicants than cigarette smoke.[7]

There are benefits to banning vaping indoors in public and working areas, since there is a potential harm of renormalizing tobacco use in smoke-free areas, in addition to, vaping may result in spread of nicotine and other chemicals indoors.[415] Concerns exist that the increased rates of e-cigarette users who have never smoked could cause harms to public health from the increased nicotine addiction.[160] Vaping in areas where smoking is banned indoors could be a move in the wrong direction for public health when considering air quality in addition to being unfavorable for an individual who may have quit nicotine use if they did not vape.[224]

Third-hand exposure

Third-hand exposure happens when nicotine and other substances from exhaled e-cigarette aerosol settle on surfaces, which then exposes people by way of touching, ingesting, or inhaling.[37] E‐cigarettes can be unsafe to non-users via third-hand exposure, including children, pregnant women, casino employees, housekeeping employees, and vulnerable groups.[209] E-cigarette use by a parent might lead to inadvertent health risks to offspring.[255] E-cigarettes pose many safety concerns to children.[255] For example, indoor surfaces can accumulate nicotine where e-cigarettes were used, which may be inhaled by children, particularly youngsters, long after they were used.[255]

There are no published studies of third-hand exposure from e-cigarettes, however initial data suggests that nicotine from e-cigarettes may stick to surfaces and would be hard to remove.[37] The extent of third-hand contamination indoors from e-cigarettes in real-world settings has not been established but would be of particular concern for children living in homes of e-cigarette users, as they spend more time indoors, are in proximity to and engage in greater activity in areas where dust collects and may be resuspended (e.g., carpets on the floor), and insert nonfood items in their mouths more frequently.[162]

Effects on pregnancy and infants

The following information is presented by the Centers for Disease Control and Prevention on e-cigarettes and pregnancy. It reads: Are e-cigarettes safer than regular cigarettes in pregnancy? Although the aerosol of e-cigarettes generally has fewer harmful substances than cigarette smoke, e-cigarettes and other products containing nicotine are not safe to use during pregnancy. Nicotine is a health danger for pregnant women and developing babies and can damage a developing baby’s brain and lungs. Also, some of the flavorings used in e-cigarettes may be harmful to a developing baby.
Information presented by the Centers for Disease Control and Prevention on e-cigarettes and pregnancy[416]

No evidence have shown that e-cigarettes are safe to use for pregnant women.[417] No amount of nicotine is safe for pregnant women.[417] The risks of vaping e-cigarettes during pregnancy are largely unknown.[340] E-cigarette use during pregnancy can be harmful to the fetus.[418] Several ingredients used in e-liquids have not been studied for use during pregnancy for safety.[417]

Nicotine exposure during pregnancy is extremely harmful to the fetus.[419] Nicotine is also a health danger for pregnant people.[420] Prenatal nicotine exposure is associated with adverse effects on the growing fetus, including effects to normal growth of the endocrine, reproductive, respiratory, cardiovascular, and neurologic systems.[417] Nicotine has been found in breast milk.[421] Nicotine-free e-cigarette aerosols may cause harm to the fetus.[340]

The belief that e-cigarettes are safer than traditional cigarettes could increase their use in pregnant women.[40] Concerns exist regarding pregnant women exposure to e-cigarette vapor through direct use or via exhaled vapor.[7] According to a 2017 review, the evidence that nicotine harms infant development justifies the need for public health initiatives to shield pregnant women from being exposed to nicotine.[261]

Multigenerational effects

The multigenerational epigenetic effect of nicotine on lung function has been demonstrated.[422] Vaping or the use of any nicotine-based product during pregnancy or during pregnancy and during the breastfeeding, postpartum period causes the "concurrent exposure of three generations to nicotine".[423]

Environmental impact

A discarded Puff Bar and a discarded traditional cigarette.
E-cigarette and traditional cigarette product waste
Cigarette butt waste from a Parliament cigarette.
Cigarette butt waste
Diagram shows potential environmental impacts related to e-cigarettes.
Diagram shows potential environmental impacts related to e-cigarettes.[59]

There are a range of consequences for the environment surrounding the use of e-cigarettes, such as air quality effects, energy and materials used, issues related to environmentally responsible disposal, and land-use decisions.[424]

There is limited information available on any environmental issues connected to the production, usage, and disposal of e-cigarette models that use cartridges.[59] Studies directly describing environmental exposure to chemicals from e-cigarette waste on minorities and low-income populations are limited.[425] As of 2014, no formal studies have been done to evaluate the environmental effects of making or disposing of any part of e-cigarettes including the batteries or nicotine production.[59] As of 2014, it is uncertain if the nicotine in e-liquid is United States Pharmacopeia-grade nicotine, a tobacco extract, or synthetic nicotine when questioning the environmental impact of how it is made.[59] It is not clear which manufacturing methods are used to make the nicotine used in e-cigarettes.[59] The emissions from making nicotine could be considerable from manufacturing if not appropriately controlled.[59] Some e-cigarette brands that use cartridges state their products are 'eco-friendly' or 'green', despite the absence of any supporting studies.[59] Some writers contend that such marketing may raise sales and increase e-cigarette interest, particularly among minors.[59]

E-cigarettes that are thrown away that end up in landfills is a rising public health concern.[17] A July 2018–April 2019 garbology study found e-cigarette products composed 19% of the waste from all traditional and electronic tobacco and cannabis products collected at 12 public high schools in the San Francisco Bay Area.[426] It is unclear how many traditional cigarettes are comparable to using one e-cigarette that uses a cartridge for the average user.[59] Information is limited on energy and materials used for production of e-cigarettes versus traditional cigarettes, for comparable use.[59] E-cigarettes can be made manually put together in small factories, or they can be made in automated lines on a much bigger scale.[59] Larger plants will produce greater emissions to the surrounding environment, and thus will have a greater environmental impact.[59] Tobacco factories create toxic nicotine waste from the manufacturing of tobacco products.[427] While cigarettes still comprise almost 90% of all tobacco sales globally as of 2020 (except for South Asia), other tobacco products, especially e-cigarettes, also weigh heavily on the environment.[428] The rise of e-cigarettes in industrialized countries is changing the composition of the environmental harms of tobacco.[428] Because these products are composed of low-value but sophisticated electronics, the environmental costs from manufacturing e-cigarettes may be substantially more severe than cigarettes per unit.[428] The tobacco industry is aware of the new scope of environmental harms e-cigarettes pose.[428]

Although some brands have begun recycling services for their e-cigarette cartridges and batteries, the prevalence of recycling is unknown, as is the prevalence of information provided by manufacturers on how to recycle disposable parts.[59] E-cigarettes that are not reusable may contribute to the problem of electronic waste.[60] When non-reusable e-cigarettes are discarded, heavy metals may be leached into the environment.[193] E-cigarettes batteries contaminate the land and water and may release lead into the environment.[17] E-liquids that are not entirely used up could contain nicotine and heavy metals.[17] This is another risk for the environment.[17] Littered or improperly discarded e-cigarettes can leach heavy metals, battery acids, and organic chemicals, potentially affecting humans and other organisms.[425] Small components (e.g., pods, cartridges) may be eaten by birds and other animals.[425] Since the majority of e-cigarettes are reusable they are possibly more environmentally friendly than using single-use devices.[429] Compared to traditional cigarettes, e-cigarettes do not create litter in the form of discarded cigarette butts.[429] Tobacco cigarette waste can be seen on city sidewalks and public beaches.[430] Traditional cigarettes tend to end up in the ocean where they cause pollution.[429]

According to the US FDA, e-cigarettes, including rechargeable batteries and the cartridges and bottles that contain e-liquids (liquid nicotine mixtures), can pose a threat to the environment if they are not disposed of properly.[431] E-cigarette and e-liquid waste should not be thrown in the regular trash or flushed down a sink.[431] Instead, these items should be taken safely to a hazardous waste facility, the US FDA states.[431] Improper disposal of e-cigarettes and e-liquid products can hurt the environment.[431] If thrown in the trash or flushed into the sewer system, the nicotine solution in an e-liquid product can seep into the ground or water and become a danger for wildlife and humans.[431]

As e-cigarette batteries degrade, the compounds in them can also seep into nearby water.[431] Additionally, lithium ion batteries have been linked to explosions in recycling trucks when batteries are not properly disposed of.[431] As sales of e-cigarettes have increased significantly in the past few years leading up to 2020, institutions face a burden to dispose of e-cigarette waste in a way that protects the environment.[431] Schools face challenges with waste littered by students on school property.[431] According to the Minnesota Pollution Control Agency, products that contain nicotine including e-liquids and e-cigarettes, pose a threat to the environment if they are not discarded of properly.[432]

History of e-cigarette research and vaping industry strategies

External video
1994 - Tobacco Company CEOs Testify Before Congress

For over 50 years, there has been a compelling assemblance of irrefutable evidence demonstrating that smoking cigarettes leads to disease in nearly every human organ.[157] At least as early as the 1950s the tobacco industry has intentionally mislead the public regarding the health risks of smoking.[433] Big Tobacco has partnered with firms, including the Electronic Cigarette Association, Consumer Advocates for Smoke-Free Alternatives Association, and Vapers International, Inc., that were set up to promote the use of e-cigarettes.[8] These factions, coupled with other vested interested parties, have had taken steps to stall or abolish legislation targeted at curbing the sales and the use of e-cigarettes.[8]

Previous studies have identified several strategies used in tobacco and e-cigarette advertising that are particularly appealing to young individuals.[434] These include marketing flavors, especially fruity ones, offering price reductions and discounts, displaying product design, promoting harm reduction claims like e-cigarettes being less harmful than traditional cigarettes, incorporating activities and environments, highlighting sports events or bars, and utilizing emotional appeals and humor.[434]

While cigarettes have been the leading source of tobacco consumption, a diverse range and usage of more recently created products had been accelerating by 2021.[435] These newly created tobacco, nicotine, and other aerosolized products were perpetually being introduced into the marketplace and were vigorously being pushed both in affluent countries where cigarette consumption is descending and where people are able to pay for the latest products, in addition to less affluent countries, thus sidestepping laws prohibiting tobacco advertising or the importation of nicotine vaping devices.[435]

Their short as well as their long-term consequences, including their potential carcinogenicity, are actively being scientifically investigated.[436] Biased research paid for by the tobacco industry continues to be rampant in the e-cigarette topic area, as of 2019.[437] The tobacco companies have had an impact on research-based conclusions by providing funding for scientists.[438] The extent to which research related to e-cigarettes has ties to businesses and other special interests in this industry, is an area of concern.[439]

Public perception

Overview

Many teens have dangerous misperceptions that lead them to believe that vaping is harmless.
Many teens have dangerous misperceptions that lead them to believe that vaping is harmless.

Marketing and advertisement play a significant role in the public's perception of e-cigarettes.[160] E-cigarettes have been promoted as replacements for traditional tobacco products.[440] This has led to the creation of a misleading sense of safety among those who use them.[440] E-cigarette advertisements with warnings could strengthen e-cigarette harm perceptions, and lower the likelihood of buying e-cigarettes.[441]

The public generally thinks that vaping is correlated with few health risks.[167] Some tobacco users think vaping is safer than tobacco or other smoking cessation aids.[442] It is generally considered by users that e-cigarettes are safer than tobacco.[223] Emerging research indicates that vaping is not as safe as previously thought.[443] Many users think that e-cigarettes are healthier than traditional cigarettes for personal use or for other people.[213]

Perceived health risks

Studies have found that perceptions play a significant role in predicting e-cigarette use among young people.[265] Many youths believe vaping is a safe substitute to traditional cigarettes.[302] Youth exposed to mostly negative e-cigarette news were significantly more likely to increase their beliefs about e-cigarette harms compared with exposure to only positive news headlines.[265] The evidence suggests that the parental perception of a child's health risks connected to e-cigarette exposure during both prenatal and post-natal life is low.[340]

Adolescents may find e-cigarettes initially more enticing than traditional cigarettes due to perceived health risks, unique product traits (like taste, price, and discreetness), and the increased acceptance they receive from peers and others.[444] Youths who have lower harm perceptions may be particularly susceptible to e-cigarette and polytobacco use, conversely those who perceive e-cigarettes as more harmful would be less likely to use them.[445] Usually, only a small proportion of users are concerned about the potential adverse health effects or toxicity of e-cigarettes.[213] Research indicates that an individual's perception of a substance's potential harms and benefits and their behavior of use is influenced by the availability of information discussing the health effects of that substance.[446]

Perceived misconception regarding safety

There is a public misconception that vaping is safer than cigarette smoking.[404] The rise in e-cigarette usage may be due in part to the mistaken belief that they are a safer option compared to regular cigarettes.[447] Individuals who opt for non-cigarette tobacco products seem to not understand the full extent of the health risks involved.[258] Beliefs on vaping may be surpassing our scientific knowledge of these products.[448] Proponents of vaping have stated that nicotine is 'as safe as caffeine'.[449] E-cigarettes are believed to be considerably safer compared with smoking while nicotine is thought to be comparatively benign, except for its addiction potential.[450] Consequently, it is believed to be without risk to use them indoors or near babies.[450]

The vaping community’s apparent disregard for the potential negative impacts of e-cigarettes seems to have tarnished their reputation among many public health officials.[451] Persisting on this trajectory may foster the perception that they are indifferent to public health, they care more about selling their burgeoning businesses to the highest bidder from the tobacco industry, and will resist any sensible regulations on their products—thus mirroring the notorious tactics used by tobacco companies.[451] Initially, it was claimed that e-cigarettes were completely harmless.[209] However, they are generally viewed as 'reduced harm' alternatives to traditional cigarettes.[209] This latter viewpoint remains contentious and lacks definitive evidence, particularly given the significant differences among e-cigarette products.[209]

Perceived health risks in various countries

A 2014 worldwide survey found that 88% of respondents stated that vaping were less harmful than cigarette smoke and 11% believed that vaping were absolutely harmless.[452] A 2013 four-country survey found higher than 75% of current and former smokers think e-cigarettes are safer than traditional cigarettes.[40]

Among high income countries, compiled data from the International Tobacco Control project found that the percentage of respondents of adult smokers believing e-cigarette use is just as risky or riskier to health than cigarettes were: Republic of Korea in 2016 was 66%, the US in 2016 was 37%, Netherlands in 2015 was 32%, Canada in 2016 was 30%, the UK in 2016 was 24%, Australia in 2016 was 22%, Uruguay in 2014 was 19%, and among low income countries, Malaysia in 2013 was 70%, Zambia in 2014 was 57%, Thailand in 2012 was 54%, Mexico from 2014 to 2015 was 38%, Bangladesh from 2014 to 2015 was 37%, Brazil from 2012 to 2013 was 22%, and China from 2013 to 2015 was 15%.[453]

Among middle income countries, compiled data from the International Tobacco Control project found that the percentage of respondents of adult smokers believing e-cigarette use is just as risky or riskier to health than cigarettes were: Malaysia in 2013 was 70%, Zambia in 2014 was 57%, Thailand in 2012 was 54%, Mexico between 2014 to 2015 was 38%, Bangladesh between 2014 to 2015 was 37%, Brazil between 2012 to 2013 was 22%, and China between 2013 to 2015 was 15%.[453]

According to data from an International Tobacco Control Policy Evaluation survey, countries with more relaxed policies on the use and marketing of nicotine vaping products, such as the UK, have higher levels of awareness and usage.[454] Additionally, the perception that nicotine vaping products are less dangerous than traditional cigarettes is significantly greater in the UK compared to Australia, which is indicative of the UK's more lenient regulatory stance.[454]

Perceived health risks in adolescence in various countries

A 2015 study showed that 60% of all adolescence stated vaping were safe or a minor health risk and that 53.4% considered vaping safer than cigarette smoking.[108] In terms of harm perception, a 2016 study found that flavored e-cigarette use reduced the prevalence of perception of the dangers of tobacco use among youth.[233] Another 2016 study found more nuanced results, demonstrating that tobacco flavor increased harm perception while fruit and sweet flavors decreased harm perception among UK adolescents.[233]

A 2016 survey of people 14 years of age and up in Germany reported that 20.7% of participants consider e-cigarettes to be not as harmful as cigarettes, 46.3% just as harmful, and 16.1% thought they were more harmful, and 17.0% gave no answer.[455] Many adolescent asthmatics have a favorable view of vaping.[93]

Perceived health risks regarding pregnant women

Based on literature from January 2006 to October 2016, a 2017 review found, that examined the perceptions regarding vaping during pregnancy, that the majority of respondents perceived vaping can carry health risks to mother and child, but also thought they may be less harmful than traditional cigarettes.[456] A nation-wide US survey among adults found 11.1% thought vaping during pregnancy was not as harmful as smoking, 51.0% thought it was as harmful, 11.6% thought it would be an increased harm, and 26.2% were unsure.[457]

As a result of perceiving e-cigarettes as less of a health risk, their usage among pregnant women has grown, which has increased the exposure of unborn children to nicotine and other hazardous substances.[18]

Perceived health risks in the United States

A 2015 PHE report noted that in the US, 82% of respondents considered vaping was a safer option than smoking, but this number declined to 51% by 2014.[458]

Perceived health risks in adolescence in the United States

A 2016 study in the US found that, for US adolescents, fruit-flavored e-cigarettes were perceived to be less harmful than tobacco flavored ones.[233] A 2015 analysis reports that 34.20% (8,433/24,658) of American youth sampled believe that e-cigarettes are less harmful than cigarettes, and 45% (11,096/24,658) are not sure.[446]

Wait for review. See here.

Perceived health risks in the United Kingdom

Action on Smoking and Health in the UK found that in 2015, compared to the year before, more people thought that e-cigarettes are equally harmful or even more harmful than smoking, increased from 15% in 2014 to 22% in 2015.[459] Among smokers who are aware of e-cigarettes but have not tried them, that thought that e-cigarettes are equally harmful or even more harmful than smoking, almost increased by two-fold from 12% in 2014 to 22% in 2015.[459]

In 2018, under 50% of adults in the UK believe vaping is less harmful than smoking.[460] In 2021 in the UK, about 32% of adults of respondents believed that e-cigarettes were either equally or more harmful than smoking tobacco, an increase from 7% in 2013.[461] In 2021 in the UK, about 30% of respondents believed e-cigarettes to be less harmful than smoking and 12% thought they were a lot less harmful, whereas 24% expressed uncertainty.[461]

Perceived health risks in adolescence in the United Kingdom

Adolescence in the UK tend to think that e-cigarettes with fruity flavors are not as harmful as those with tobacco flavors.[462]

Related media

Notes

  1. A 2019 review concluded: "no long term vaping toxicological/safety studies have been done in humans; without these data, saying with certainty that e-cigarettes are safer than combustible cigarettes is impossible."[1] Early research seemed to indicate that vaping might be safer than traditional cigarettes and provide a different method to give up smoking, though mounting evidence does not substantiate this.[9] Evidence has not been presented to demonstrate that e-cigarettes are less dangerous than tobacco.[10] The short-term health effects of e-cigarettes can be severe[11] and the short-term harms of e-cigarettes is greater than tobacco products.[12] E-cigarettes are frequently viewed as a safer alternative to conventional cigarettes; however, evidence to support this perspective has not materialized.[13] This appears to be due to the presence of toxicants in e-liquid composition, their adverse effects in animal models, association with acute lung injury and cardiovascular disease, and ability to modulate different cell populations in the lung and blood towards pro-inflammatory phenotypes.[13] A 2020 review noted, "although there is overlap with the toxicity of tobacco, vaping introduces exposures and has effects which are not seen with tobacco. Thus the idea that vaping is a safer, watered-down version of smoking, is scientific nonsense."[12]
  2. While vitamin E acetate is strongly linked to this outbreak, evidence is not sufficient to rule out the contribution of other chemicals of concern, including chemicals in either THC or non-THC products, in some of the reported vaping-related lung injury cases.[29] There is likely more than one cause of the outbreak.[31] The majority of cases in Canada involving lung injuries do not seem to have been connected with the use of THC-infused products.[30] In 2019, some people diagnosed with a vaping-induced lung injury reported using only nicotine-containing products.[32] Nicotine e-cigarette use has been linked to the vaping-induced lung injury cases in a small subset of users.[33] In 2020, the first uptick in vaping-induced lung injury cases had occurred in Utah since the decline of 2019.[34] This research indicates the recurrent nature of the vaping-induced lung illness epidemic with new occurrences continuing to be reported.[34]
  3. A 2021 review found "Formaldehyde, acetaldehyde, acrolein, carcinogenic nitrosamines N'-nitrosonornicotine (NNN) and nicotine-derived nitrosamine ketones (NNK) were found in vapors of a variety of e-cigarette products and are all carcinogenic to humans."[53]
  4. The engineering designs, including the kind of the battery, heating temperature of the solution, and the style of heating element and storage for the solution, typically affects the nature, number, and size of particles generated.[7]
  5. E-cigarettes were initially marketed as a safe replacement for smoking, but clinical and experimental studies have observed the potentially, lethal consequences of these products.[95] The industry's marketing approach for these instruments of addiction has been to promote them as a safer alternative to tobacco, a behavioral choice supporting smoking cessation, and as the 'cool' appearance of vaping with flavored products (e.g. tutti frutti, bubble gum, and buttered popcorn etc.).[96]
  6. E-cigarette aerosol generally contains fewer toxic chemicals than the deadly mix of 7,000 chemicals in smoke from regular cigarettes.[102]
  7. Due to the subsequent identification of the primary cause of cases in the US, and the considerable decline in cases and deaths since a peak in September 2019, the CDC stopped collecting these data from states as of February 2020.[29]
  8. Vitamin E acetate is used as an additive, most notably in THCl-containing e-cigarette, or vaping, products.[29] Vitamin E acetate dilutes THC oil without altering the look or thickness.[72] Research suggests that when vitamin E acetate is inhaled, it may interfere with normal lung functioning.[29]
  9. A 2014 review found "Wide ranges in the levels of chemical substances such as tobacco-specific nitrosamines, aldehydes, metals, volatile organic compounds, phenolic compounds, polycyclic aromatic hydrocarbons, flavours, solvent carriers, tobacco alkaloids and drugs have been reported in e-cigarette refill solutions, cartridges, aerosols and environmental emissions."[54]
  10. A 2014 review found "there is enough heat generated during puffing to cause the fluid to decompose and/or components of the device to pyrolyze, whereby toxic/carcinogenic substances may be formed."[68]
  11. The term vapor is a misnomer due to the fact that the aerosol generated by e-cigarettes has both a particulate and gas phase.[45]
  12. E-cigarette aerosol is composed of droplets of e-liquids, which contain mainly propylene glycol, glycerin, nicotine, water, flavorings (if added to e-liquid), preservatives and also small amounts of by-products of thermal decomposition of some of these constituents.[92]
  13. A 2017 review found "The physical composition of the aerosol can be altered by many factors: the temperature of the metal coil, rate of e-liquid flow through the heated coil, chemical composition of the coil, the coil connection to the power source, the wicking material transporting e-liquid and the hot aerosol contacts."[221]
  14. A 2017 review found "As e-cig metal components undergo repeated cycles of heating and cooling, traces of these metal components can leech into the e-liquid, causing the device to emit metallic nanoparticles."[329]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Gotts, Jeffrey E; Jordt, Sven-Eric; McConnell, Rob; Tarran, Robert (30 September 2019). "What are the respiratory effects of e-cigarettes?". BMJ (Clinical research ed.). BMJ. 366: l5275. doi:10.1136/bmj.l5275. ISSN 1756-1833. PMC 7850161. PMID 31570493. This article incorporates text by Jeffrey E Gotts, Sven-Eric Jordt, Rob McConnel, and Robert Tarran available under the CC BY 4.0 license.
  2. 2.0 2.1 Pajai, Devanjali D; Paul, Priyanka; Reche, Amit (16 February 2023). "Pharmacotherapy in Tobacco Cessation: A Narrative Review". Cureus. doi:10.7759/cureus.35086. PMC 10023046. PMID 36938244. This article incorporates text by Devanjali D Pajai, Priyanka Paul, and Amit Reche available under the CC BY 4.0 license.
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Bracken-Clarke, Dara; Kapoor, Dhruv; Baird, Anne Marie; Buchanan, Paul James; Gately, Kathy; Cuffe, Sinead; Finn, Stephen P. (2021). "Vaping and lung cancer – A review of current data and recommendations". Lung Cancer. 153: 11–20. doi:10.1016/j.lungcan.2020.12.030. ISSN 0169-5002. PMID 33429159.
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 Bautista, Malia; Mogul, Allison S.; Fowler, Christie D. (14 August 2023). "Beyond the label: current evidence and future directions for the interrelationship between electronic cigarettes and mental health". Frontiers in Psychiatry. 14. doi:10.3389/fpsyt.2023.1134079. PMC 10460914. PMID 37645635. This article incorporates text available under the CC BY 4.0 license.
  5. "What Is in E-cigarette Aerosol?". Centers for Disease Control and Prevention. 2 November 2023.Public Domain This article incorporates text from this source, which is in the public domain.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 Travis, Nargiz; Knoll, Marie; Cadham, Christopher J.; Cook, Steven; Warner, Kenneth E.; Fleischer, Nancy L.; Douglas, Clifford E.; Sánchez-Romero, Luz María; Mistry, Ritesh; Meza, Rafael; Hirschtick, Jana L.; Levy, David T. (25 July 2022). "Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations". International Journal of Environmental Research and Public Health. 19 (15): 9054. doi:10.3390/ijerph19159054. PMC 9330875. PMID 35897421. This article incorporates text by Nargiz Travis, Marie Knoll, Christopher J. Cadham, Steven Cook, Kenneth E. Warner, Nancy L. Fleischer, Clifford E. Douglas, Luz María Sánchez-Romero, Ritesh Mistry, Rafael Meza, Jana L. Hirschtick, and David T. Levy available under the CC BY 4.0 license.
  7. 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 Grana, Rachel; Benowitz, Neal; Glantz, Stanton A. (13 May 2014). "E-Cigarettes: A Scientific Review". Circulation. 129 (19): 1972–1986. doi:10.1161/circulationaha.114.007667. PMC 4018182. PMID 24821826.
  8. 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 Drummond, MB; Upson, D (February 2014). "Electronic cigarettes. Potential harms and benefits". Annals of the American Thoracic Society. 11 (2): 236–42. doi:10.1513/annalsats.201311-391fr. PMC 5469426. PMID 24575993.
  9. 9.0 9.1 9.2 Kumar, P.S.; Clark, P.; Brinkman, M.C.; Saxena, D. (2019). "Novel Nicotine Delivery Systems". Advances in Dental Research. 30 (1): 11–15. doi:10.1177/0022034519872475. ISSN 0895-9374. PMID 31538804.
  10. 10.0 10.1 10.2 Herman, Melissa; Tarran, Robert (2020). "E‐cigarettes, nicotine, the lung and the brain: multi‐level cascading pathophysiology". The Journal of Physiology. 598 (22): 5063–5071. doi:10.1113/JP278388. ISSN 0022-3751. PMC 7721976. PMID 32515030.
  11. 11.0 11.1 11.2 11.3 Gilley, Meghan; Beno, Suzanne (June 2020). "Vaping implications for children and youth". Current Opinion in Pediatrics. 32 (3): 343–348. doi:10.1097/MOP.0000000000000889. ISSN 1040-8703. PMID 32332326.
  12. 12.00 12.01 12.02 12.03 12.04 12.05 12.06 12.07 12.08 12.09 12.10 Bhatt, Jayesh Mahendra; Ramphul, Manisha; Bush, Andrew (2020). "An update on controversies in e-cigarettes". Paediatric Respiratory Reviews. 36: 75–86. doi:10.1016/j.prrv.2020.09.003. ISSN 1526-0542. PMC 7518964. PMID 33071065.
  13. 13.00 13.01 13.02 13.03 13.04 13.05 13.06 13.07 13.08 13.09 13.10 13.11 13.12 13.13 13.14 13.15 13.16 Snoderly, Hunter T.; Nurkiewicz, Timothy R.; Bowdridge, Elizabeth C.; Bennewitz, Margaret F. (18 November 2021). "E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences". International Journal of Molecular Sciences. MDPI AG. 22 (22): 12452. doi:10.3390/ijms222212452. ISSN 1422-0067. PMC 8619996. PMID 34830344. This article incorporates text by Hunter T. Snoderly,Timothy R. Nurkiewicz, Elizabeth C. Bowdridge, and Margaret F. Bennewitz available under the CC BY 4.0 license.
  14. 14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 Mravec, Boris; Tibensky, Miroslav; Horvathova, Lubica; Babal, Pavel (2020). "E-Cigarettes and Cancer Risk". Cancer Prevention Research. 13 (2): 137–144. doi:10.1158/1940-6207.CAPR-19-0346. ISSN 1940-6207. PMID 31619443.
  15. 15.0 15.1 15.2 15.3 Knorst, Marli Maria; Benedetto, Igor Gorski; Hoffmeister, Mariana Costa; Gazzana, Marcelo Basso (2014). "The electronic cigarette: the new cigarette of the 21st century?". Jornal Brasileiro de Pneumologia. 40 (5): 564–572. doi:10.1590/S1806-37132014000500013. ISSN 1806-3713. PMC 4263338. PMID 25410845.
  16. 16.00 16.01 16.02 16.03 16.04 16.05 16.06 16.07 16.08 16.09 16.10 16.11 Farsalinos, K. E.; Polosa, R. (2014). "Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review". Therapeutic Advances in Drug Safety. 5 (2): 67–86. doi:10.1177/2042098614524430. ISSN 2042-0986. PMC 4110871. PMID 25083263.
  17. 17.0 17.1 17.2 17.3 17.4 17.5 17.6 17.7 Smith, L; Brar, K; Srinivasan, K; Enja, M; Lippmann, S (June 2016). "E-cigarettes: How "safe" are they?". J Fam Pract. 65 (6): 380–5. PMID 27474819.
  18. 18.0 18.1 Bush, Andrew; Ferkol, Thomas; Valiulis, Algirdas; Mazur, Artur; Chkhaidze, Ivane; Maglakelidze, Tamaz; Sargsyan, Sergey; Boyajyan, Gevorg; Cirstea, Olga; Doan, Svitlana; Katilov, Oleksandr; Pokhylko, Valeriy; Dubey, Leonid; Poluziorovienė, Edita; Prokopčiuk, Nina; Taminskienė, Vaida; Valiulis, Arūnas (8 February 2021). "Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children". Acta medica Lituanica. 28 (1): 6–18. doi:10.15388/Amed.2020.28.1.6. PMC 8311841. PMID 34393624.
  19. 19.0 19.1 19.2 19.3 "Electronic nicotine delivery systems" (PDF). World Health Organization. 21 July 2014. pp. 1–13.
  20. 20.0 20.1 20.2 Glover, Marewa; Breier, Bernhard H.; Bauld, Linda (2016). "Could Vaping be a New Weapon in the Battle of the Bulge?". Nicotine & Tobacco Research. 19 (12): 1536–1540. doi:10.1093/ntr/ntw278. hdl:1893/26149. ISSN 1462-2203. PMID 27798086.
  21. 21.0 21.1 21.2 21.3 21.4 Jimenez Ruiz, CA; Solano Reina, S; de Granda Orive, JI; Signes-Costa Minaya, J; de Higes Martinez, E; Riesco Miranda, JA; Altet Gómez, N; Lorza Blasco, JJ; Barrueco Ferrero, M; de Lucas Ramos, P (August 2014). "The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes". Archivos de Bronconeumologia. 50 (8): 362–7. doi:10.1016/j.arbres.2014.02.006. PMID 24684764.
  22. 22.0 22.1 Brady, Benjamin R.; De La Rosa, Jennifer S.; Nair, Uma S.; Leischow, Scott J. (2019). "Electronic Cigarette Policy Recommendations: A Scoping Review". American Journal of Health Behavior. 43 (1): 88–104. doi:10.5993/AJHB.43.1.8. ISSN 1087-3244. PMID 30522569.
  23. Bals, Robert; Boyd, Jeanette; Esposito, Susanna; Foronjy, Robert; Hiemstra, Pieter S.; Jiménez-Ruiz, Carlos A.; Katsaounou, Paraskevi; Lindberg, Anne; Metz, Carlos; Schober, Wolfgang; Spira, Avrum; Blasi, Francesco (2019). "Electronic cigarettes: a task force report from the European Respiratory Society". European Respiratory Journal. 53 (2): 1801151. doi:10.1183/13993003.01151-2018. ISSN 0903-1936. PMID 30464018.
  24. 24.0 24.1 Tsai, MuChun; Byun, Min Kwang; Shin, John; Crotty Alexander, Laura E. (2020). "Effects of e‐cigarettes and vaping devices on cardiac and pulmonary physiology". The Journal of Physiology. 598 (22): 5039–5062. doi:10.1113/JP279754. ISSN 0022-3751. PMID 32975834.
  25. 25.0 25.1 25.2 25.3 Riwu Bara, Roy Pefi; McCausland, Kahlia; Swanson, Maurice; Scott, Lucy; Jancey, Jonine (February 2023). ""They're sleek, stylish and sexy:" selling e-cigarettes online". Australian and New Zealand Journal of Public Health. 47 (1): 100013. doi:10.1016/j.anzjph.2022.100013. PMID 36641959.
  26. 26.0 26.1 26.2 26.3 26.4 Breland, Alison B.; Spindle, Tory; Weaver, Michael; Eissenberg, Thomas (2014). "Science and Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 223–233. doi:10.1097/ADM.0000000000000049. ISSN 1932-0620. PMC 4122311. PMID 25089952.
  27. 27.0 27.1 27.2 Gaur, Sumit; Agnihotri, Rupali (2018). "Health Effects of Trace Metals in Electronic Cigarette Aerosols—a Systematic Review". Biological Trace Element Research. 188 (2): 295–315. doi:10.1007/s12011-018-1423-x. ISSN 0163-4984. PMID 29974385.
  28. 28.0 28.1 28.2 Harrell, PT; Simmons, VN; Correa, JB; Padhya, TA; Brandon, TH (4 June 2014). "Electronic Nicotine Delivery Systems ("E-cigarettes"): Review of Safety and Smoking Cessation Efficacy". Otolaryngology–Head and Neck Surgery. 151 (3): 381–393. doi:10.1177/0194599814536847. PMC 4376316. PMID 24898072.
  29. 29.00 29.01 29.02 29.03 29.04 29.05 29.06 29.07 29.08 29.09 29.10 29.11 29.12 29.13 29.14 "Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products". Centers for Disease Control and Prevention. 3 August 2021.Public Domain This article incorporates text from this source, which is in the public domain.
  30. 30.0 30.1 30.2 30.3 30.4 30.5 "Vaping-associated lung illness". Public Health Agency of Canada. 20 August 2020.
  31. 31.0 31.1 King, Brian A.; Jones, Christopher M.; Baldwin, Grant T.; Briss, Peter A. (2020). "The EVALI and Youth Vaping Epidemics — Implications for Public Health". New England Journal of Medicine. 382 (8): 689–691. doi:10.1056/NEJMp1916171. ISSN 0028-4793. PMID 31951683.
  32. Ghinai, Isaac; Navon, Livia; Gunn, Jayleen K.L.; Duca, Lindsey M.; Brister, Sarah; Love, Sarah; Brink, Rachel; Fajardo, Geroncio; Johnson, Jona; Saathoff-Huber, Lori; King, Brian A.; Jones, Christopher M.; Krishnasamy, Vikram P.; Layden, Jennifer E. (24 January 2020). "Characteristics of Persons Who Report Using Only Nicotine-Containing Products Among Interviewed Patients with E-cigarette, or Vaping, Product Use–Associated Lung Injury — Illinois, August–December 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 84–89. doi:10.15585/mmwr.mm6903e1. PMC 7367041. PMID 31971930.Public Domain This article incorporates text from this source, which is in the public domain.
  33. 33.0 33.1 Marrocco, Antonella; Singh, Dilpreet; Christiani, David C.; Demokritou, Philip (16 March 2022). "E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs". Critical Reviews in Toxicology. 52 (3): 188–220. doi:10.1080/10408444.2022.2082918. PMC 9716650. PMID 35822508.
  34. 34.0 34.1 34.2 Smith, Maxwell L.; Gotway, Michael B.; Crotty Alexander, Laura E.; Hariri, Lida P. (2020). "Vaping-related lung injury". Virchows Archiv. 478 (1): 81–88. doi:10.1007/s00428-020-02943-0. ISSN 0945-6317. PMC 7590536. PMID 33106908.
  35. Zulfiqar, Hassam; Sankari, Abdulghani; Rahman, Omar (January 2024). "Vaping-Associated Pulmonary Injury". StatPearls. StatPearls Publishing.
  36. 36.0 36.1 36.2 36.3 36.4 36.5 36.6 36.7 36.8 Hajek, P; Etter, JF; Benowitz, N; Eissenberg, T; McRobbie, H (31 July 2014). "Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit". Addiction. 109 (11): 1801–10. doi:10.1111/add.12659. PMC 4487785. PMID 25078252.
  37. 37.00 37.01 37.02 37.03 37.04 37.05 37.06 37.07 37.08 37.09 37.10 37.11 Brandon, T. H.; Goniewicz, M. L.; Hanna, N. H.; Hatsukami, D. K.; Herbst, R. S.; Hobin, J. A.; Ostroff, J. S.; Shields, P. G.; Toll, B. A.; Tyne, C. A.; Viswanath, K.; Warren, G. W. (2015). "Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology". Clinical Cancer Research. 21 (3): 514–525. doi:10.1158/1078-0432.CCR-14-2544. ISSN 1078-0432. PMID 25573384.
  38. 38.0 38.1 Durmowicz, E. L. (2014). "The impact of electronic cigarettes on the paediatric population". Tobacco Control. 23 (Supplement 2): ii41–ii46. doi:10.1136/tobaccocontrol-2013-051468. ISSN 0964-4563. PMC 3995262. PMID 24732163.
  39. 39.0 39.1 Weaver, Michael; Breland, Alison; Spindle, Tory; Eissenberg, Thomas (2014). "Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 234–240. doi:10.1097/ADM.0000000000000043. ISSN 1932-0620. PMC 4123220. PMID 25089953.
  40. 40.0 40.1 40.2 40.3 40.4 40.5 40.6 40.7 40.8 Ebbert, Jon O.; Agunwamba, Amenah A.; Rutten, Lila J. (2015). "Counseling Patients on the Use of Electronic Cigarettes". Mayo Clinic Proceedings. 90 (1): 128–134. doi:10.1016/j.mayocp.2014.11.004. ISSN 0025-6196. PMID 25572196.
  41. 41.00 41.01 41.02 41.03 41.04 41.05 41.06 41.07 41.08 41.09 41.10 41.11 41.12 41.13 41.14 Rowell, Temperance R.; Tarran, Robert (15 December 2015). "Will chronic e-cigarette use cause lung disease?". American Journal of Physiology. Lung Cellular and Molecular Physiology. 309 (12): L1398–L1409. doi:10.1152/ajplung.00272.2015. ISSN 1040-0605. PMC 4683316. PMID 26408554.
  42. 42.0 42.1 42.2 42.3 42.4 42.5 42.6 42.7 42.8 42.9 Cooke, Andrew; Fergeson, Jennifer; Bulkhi, Adeeb; Casale, Thomas B. (July 2015). "The Electronic Cigarette: The Good, the Bad, and the Ugly". The Journal of Allergy and Clinical Immunology: In Practice. 3 (4): 498–505. doi:10.1016/j.jaip.2015.05.022. ISSN 2213-2198. PMID 26164573.
  43. 43.00 43.01 43.02 43.03 43.04 43.05 43.06 43.07 43.08 43.09 43.10 43.11 43.12 Bertholon, J.F.; Becquemin, M.H.; Annesi-Maesano, I.; Dautzenberg, B. (2013). "Electronic Cigarettes: A Short Review". Respiration. 86 (5): 433–8. doi:10.1159/000353253. ISSN 1423-0356. PMID 24080743.
  44. 44.00 44.01 44.02 44.03 44.04 44.05 44.06 44.07 44.08 44.09 44.10 44.11 44.12 44.13 Bekki, Kanae; Uchiyama, Shigehisa; Ohta, Kazushi; Inaba, Yohei; Nakagome, Hideki; Kunugita, Naoki (2014). "Carbonyl Compounds Generated from Electronic Cigarettes". International Journal of Environmental Research and Public Health. 11 (11): 11192–11200. doi:10.3390/ijerph111111192. ISSN 1660-4601. PMC 4245608. PMID 25353061.
  45. 45.00 45.01 45.02 45.03 45.04 45.05 45.06 45.07 45.08 45.09 45.10 45.11 45.12 Orellana-Barrios, Menfil A.; Payne, Drew; Mulkey, Zachary; Nugent, Kenneth (2015). "Electronic cigarettes-a narrative review for clinicians". The American Journal of Medicine. 128 (7): 674–81. doi:10.1016/j.amjmed.2015.01.033. ISSN 0002-9343. PMID 25731134.
  46. 46.0 46.1 46.2 46.3 46.4 Jerry, Jason M.; Collins, Gregory B.; Streem, David (August 2015). "E-cigarettes: Safe to recommend to patients?". Cleveland Clinic Journal of Medicine. 82 (8): 521–526. doi:10.3949/ccjm.82a.14054. PMID 26270431.
  47. 47.0 47.1 Dinardo, Perry; Rome, Ellen S. (2019). "Vaping: The new wave of nicotine addiction". Cleveland Clinic Journal of Medicine. 86 (12): 789–798. doi:10.3949/ccjm.86a.19118. ISSN 0891-1150. PMID 31821136.
  48. 48.0 48.1 48.2 48.3 48.4 Chaturvedi, Pankaj; Mishra, Aseem; Datta, Sourav; Sinukumar, Snita; Joshi, Poonam; Garg, Apurva (2015). "Harmful effects of nicotine". Indian Journal of Medical and Paediatric Oncology. 36 (1): 24. doi:10.4103/0971-5851.151771. ISSN 0971-5851. PMC 4363846. PMID 25810571.
  49. 49.0 49.1 McNeill 2018, p. 58.
  50. 50.0 50.1 Shinbashi, Meagan; Rubin, Bruce K. (2020). "Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI)". Paediatric Respiratory Reviews. 36: 87–91. doi:10.1016/j.prrv.2020.06.003. ISSN 1526-0542. PMID 32653465.
  51. 51.0 51.1 51.2 51.3 WHO 2016, p. 3.
  52. 52.0 52.1 52.2 52.3 52.4 Eltorai, Adam EM; Choi, Ariel R; Eltorai, Ashley Szabo (2018). "Impact of Electronic Cigarettes on Various Organ Systems". Respiratory Care. 64 (3): 328–336. doi:10.4187/respcare.06300. ISSN 0020-1324. PMID 30401756.
  53. 53.0 53.1 Famiglietti, Amber; Memoli, Jessica Wang; Khaitan, Puja Gaur (2021). "Are electronic cigarettes and vaping effective tools for smoking cessation? Limited evidence on surgical outcomes: a narrative review". Journal of Thoracic Disease. 13 (1): 384–395. doi:10.21037/jtd-20-2529. ISSN 2072-1439. PMC 7867832. PMID 33569219.
  54. 54.00 54.01 54.02 54.03 54.04 54.05 54.06 54.07 54.08 54.09 54.10 Cheng, T. (2014). "Chemical evaluation of electronic cigarettes". Tobacco Control. 23 (Supplement 2): ii11–ii17. doi:10.1136/tobaccocontrol-2013-051482. ISSN 0964-4563. PMC 3995255. PMID 24732157.
  55. 55.0 55.1 55.2 55.3 55.4 55.5 Hildick-Smith, Gordon J.; Pesko, Michael F.; Shearer, Lee; Hughes, Jenna M.; Chang, Jane; Loughlin, Gerald M.; Ipp, Lisa S. (2015). "A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population". Journal of Adolescent Health. 57 (6): 574–9. doi:10.1016/j.jadohealth.2015.07.020. ISSN 1054-139X. PMID 26422289.
  56. 56.0 56.1 56.2 Lai, Lo; Qiu, Hongyu (April 2021). "Biological Toxicity of the Compositions in Electronic-Cigarette on Cardiovascular System". Journal of Cardiovascular Translational Research. 14 (2): 371–376. doi:10.1007/s12265-020-10060-1. ISSN 1937-5387. PMC 7855637. PMID 32748205.
  57. 57.0 57.1 Fernández, Esteve; Ballbè, Montse; Sureda, Xisca; Fu, Marcela; Saltó, Esteve; Martínez-Sánchez, Jose M. (2015). "Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study". Current Environmental Health Reports. 2 (4): 423–429. doi:10.1007/s40572-015-0072-x. ISSN 2196-5412. PMID 26452675.
  58. 58.0 58.1 Li, Liqiao; Lin, Yan; Xia, Tian; Zhu, Yifang (2020). "Effects of Electronic Cigarettes on Indoor Air Quality and Health". Annual Review of Public Health. 41 (1): 363–380. doi:10.1146/annurev-publhealth-040119-094043. ISSN 0163-7525. PMC 7346849. PMID 31910714. This article incorporates text by Liqiao Li, Yan Lin, Tian Xia, and Yifang Zhu1 available under the CC BY 4.0 license.
  59. 59.00 59.01 59.02 59.03 59.04 59.05 59.06 59.07 59.08 59.09 59.10 59.11 59.12 59.13 Chang, H. (May 2014). "Research gaps related to the environmental impacts of electronic cigarettes". Tobacco Control. 23 (Supplement 2): ii54–ii58. doi:10.1136/tobaccocontrol-2013-051480. ISSN 0964-4563. PMC 3995274. PMID 24732165.
  60. 60.0 60.1 60.2 Nowak, Dennis; Jörres, Rudolf A.; Rüther, Tobias (16 May 2014). "E-cigarettes--prevention, pulmonary health, and addiction". Deutsches Ärzteblatt International. 111 (20): 349–55. doi:10.3238/arztebl.2014.0349. PMC 4047602. PMID 24882626.
  61. Chapman 2015, p. 15.
  62. "E-cigarettes: An Emerging Public Health Challenge". Centers for Disease Control and Prevention. 20 October 2015.
  63. Caplan, David (22 December 2016). "Man Suffers 3rd-Degree Burns After E-Cigarette Explodes in His Pocket While Riding Bus". ABC News.
  64. 64.0 64.1 "Electronic cigarettes : what's the bottom line?". Centers for Disease Control and Prevention. 21 February 2018.
  65. 65.0 65.1 65.2 65.3 Farsalinos, Konstantinos; LeHouezec, Jacques (2015). "Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes)". Risk Management and Healthcare Policy. 8: 157–167. doi:10.2147/RMHP.S62116. ISSN 1179-1594. PMC 4598199. PMID 26457058.
  66. Baraona, L. Kim; Lovelace, Dawn; Daniels, Julie L.; McDaniel, Linda (2017). "Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women". Journal of Midwifery & Women's Health. 62 (3): 253–269. doi:10.1111/jmwh.12616. ISSN 1526-9523. PMID 28556464.
  67. 67.00 67.01 67.02 67.03 67.04 67.05 67.06 67.07 67.08 67.09 67.10 67.11 67.12 67.13 67.14 67.15 67.16 67.17 67.18 67.19 67.20 67.21 67.22 67.23 Montjean, Debbie; Godin Pagé, Marie-Hélène; Bélanger, Marie-Claire; Benkhalifa, Moncef; Miron, Pierre (18 March 2023). "An Overview of E-Cigarette Impact on Reproductive Health". Life. 13 (3): 827. doi:10.3390/life13030827. PMID 36983982. This article incorporates text by Debbie Montjean, Marie-Hélène Godin Pagé, Marie-Claire Bélanger, Moncef Benkhalifa, and Pierre Miron available under the CC BY 4.0 license.
  68. 68.0 68.1 68.2 68.3 Pisinger, Charlotta; Døssing, Martin (December 2014). "A systematic review of health effects of electronic cigarettes". Preventive Medicine. 69: 248–260. doi:10.1016/j.ypmed.2014.10.009. PMID 25456810.
  69. Cahn, Z.; Siegel, M. (February 2011). "Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?". Journal of Public Health Policy. 32 (1): 16–31. doi:10.1057/jphp.2010.41. PMID 21150942.
  70. 70.0 70.1 70.2 70.3 70.4 70.5 70.6 70.7 Virgili, Fabrizio; Nenna, Raffaella; Ben David, Shira; Mancino, Enrica; Di Mattia, Greta; Matera, Luigi; Petrarca, Laura; Midulla, Fabio (December 2022). "E-cigarettes and youth: an unresolved Public Health concern". Italian Journal of Pediatrics. 48 (1): 97. doi:10.1186/s13052-022-01286-7. PMC 9194784. PMID 35701844. This article incorporates text by Fabrizio Virgili, Raffaella Nenna, Shira Ben David, Enrica Mancino, Greta Di Mattia, Luigi Matera, Laura Petrarca, and Fabio Midulla available under the CC BY 4.0 license.
  71. 71.00 71.01 71.02 71.03 71.04 71.05 71.06 71.07 71.08 71.09 71.10 71.11 71.12 71.13 71.14 Espinoza-Derout, Jorge; Shao, Xuesi M.; Lao, Candice J.; Hasan, Kamrul M.; Rivera, Juan Carlos; Jordan, Maria C.; Echeverria, Valentina; Roos, Kenneth P.; Sinha-Hikim, Amiya P.; Friedman, Theodore C. (7 April 2022). "Electronic Cigarette Use and the Risk of Cardiovascular Diseases". Frontiers in Cardiovascular Medicine. 9: 879726. doi:10.3389/fcvm.2022.879726. PMC 9021536. PMID 35463745. This article incorporates text by Jorge Espinoza-Derout, Xuesi M. Shao, Candice J. Lao, Kamrul M. Hasan, Juan Carlos Rivera, Maria C. Jordan, Valentina Echeverria, Kenneth P. Roos, Amiya P. Sinha-Hikim, and Theodore C. Friedman available under the CC BY 4.0 license.
  72. 72.0 72.1 72.2 Cao, Dazhe James; Aldy, Kim; Hsu, Stephanie; McGetrick, Molly; Verbeck, Guido; De Silva, Imesha; Feng, Sing-yi (2020). "Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury". Journal of Medical Toxicology. 16 (3): 295–310. doi:10.1007/s13181-020-00772-w. ISSN 1556-9039. PMC 7320089. PMID 32301069.
  73. Marcham, Cheryl L.; Springston, John P. (2019). "Electronic cigarettes in the indoor environment". Reviews on Environmental Health. 34 (2): 105–124. doi:10.1515/reveh-2019-0012. ISSN 2191-0308. PMID 31112510. S2CID 135122336.
  74. Bonner, Emily; Chang, Yvonne; Christie, Emerson; Colvin, Victoria; Cunningham, Brittany; Elson, Daniel; Ghetu, Christine; Huizenga, Juliana; Hutton, Sara J.; Kolluri, Siva K.; Maggio, Stephanie; Moran, Ian; Parker, Bethany; Rericha, Yvonne; Rivera, Brianna N.; Samon, Samantha; Schwichtenberg, Trever; Shankar, Prarthana; Simonich, Michael T.; Wilson, Lindsay B.; Tanguay, Robyn L. (September 2021). "The chemistry and toxicology of vaping". Pharmacology & Therapeutics. 225: 107837. doi:10.1016/j.pharmthera.2021.107837. ISSN 0163-7258. PMC 8263470. PMID 33753133.
  75. Ren, Michelle; Lotfipour, Shahrdad; Leslie, Frances (March 2022). "Unique effects of nicotine across the lifespan". Pharmacology Biochemistry and Behavior. 214: 173343. doi:10.1016/j.pbb.2022.173343. PMC 8904294. PMID 35122768.
  76. Cite error: Invalid <ref> tag; no text was provided for refs named Seiler-RamadasSandner2020
  77. 77.0 77.1 77.2 77.3 Münzel, Thomas; Hahad, Omar; Kuntic, Marin; Keaney, John F; Deanfield, John E; Daiber, Andreas (2020). "Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes". European Heart Journal. 41 (41): 4057–4070. doi:10.1093/eurheartj/ehaa460. ISSN 0195-668X. PMC 7454514. PMID 32585699.
  78. Bhatnagar, Aruni; Whitsel, Laurie P.; Blaha, Michael J.; Huffman, Mark D.; Krishan-Sarin, Suchitra; Maa, John; Rigotti, Nancy; Robertson, Rose Marie; Warner, John J. (2019). "New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association". Circulation. 139 (19). doi:10.1161/CIR.0000000000000669. ISSN 0009-7322. PMID 30862181.
  79. 79.00 79.01 79.02 79.03 79.04 79.05 79.06 79.07 79.08 79.09 79.10 79.11 79.12 Pisinger, Charlotta; Rasmussen, Sofie K. Bergman (21 October 2022). "The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review". International Journal of Environmental Research and Public Health. 19 (20): 13687. doi:10.3390/ijerph192013687. PMC 9603628. PMID 36294263. This article incorporates text by Charlotta Pisinger and Sofie K. Bergman Rasmussen available under the CC BY 4.0 license.
  80. National Academies of Sciences, Engineering, and Medicine 2018, p. 9, Summary.
  81. 81.0 81.1 Wilder 2016, p. 127.
  82. 82.00 82.01 82.02 82.03 82.04 82.05 82.06 82.07 82.08 82.09 82.10 82.11 82.12 82.13 82.14 Marques, P; Piqueras, L; Sanz, MJ (18 May 2021). "An updated overview of e-cigarette impact on human health". Respiratory research. 22 (1): 151. doi:10.1186/s12931-021-01737-5. ISSN 1465-9921. PMC 8129966. PMID 34006276. This article incorporates text by Patrice Marques, Laura Piqueras, and Maria-Jesus Sanz available under the CC BY 4.0 license.
  83. 83.0 83.1 83.2 83.3 83.4 83.5 Strongin, Robert M. (12 June 2019). "E-Cigarette Chemistry and Analytical Detection". Annual review of analytical chemistry (Palo Alto, Calif.). Annual Reviews. 12 (1): 23–39. doi:10.1146/annurev-anchem-061318-115329. ISSN 1936-1327. PMC 6565477. PMID 30848928.
  84. 84.0 84.1 84.2 84.3 "Alternative tobacco products use and its impact on urologic health – Will the lesser evil still be evil? A commentary and review of literature". Central European Journal of Urology. 74 (2). May 2021. doi:10.5173/ceju.2021.0110.
  85. Hamann, Stephen L.; Kungskulniti, Nipapun; Charoenca, Naowarut; Kasemsup, Vijj; Ruangkanchanasetr, Suwanna; Jongkhajornpong, Passara (22 September 2023). "Electronic Cigarette Harms: Aggregate Evidence Shows Damage to Biological Systems". International Journal of Environmental Research and Public Health. 20 (19): 6808. doi:10.3390/ijerph20196808. PMC 10572885. PMID 37835078. This article incorporates text by Stephen L Hamann, Nipapun Kungskulniti, Naowarut Charoenca, Vijj Kasemsup, Suwanna Ruangkanchanasetr, and Passara Jongkhajornpongs available under the CC BY 4.0 license.
  86. Vasiljevic, Milica; St John Wallis, Amelia; Codling, Saphsa; Couturier, Dominique-Laurent; Sutton, Stephen; Marteau, Theresa M (2018). "E-cigarette adverts and children's perceptions of tobacco smoking harms: an experimental study and meta-analysis". BMJ Open. 8 (7): e020247. doi:10.1136/bmjopen-2017-020247. ISSN 2044-6055. PMC 6082488. PMID 30012646. This article incorporates text by Milica Vasiljevic, Amelia St John Wallis, Saphsa Codlin, Dominique-Laurent Couturier, Stephen Sutton, and Theresa M Marteau available under the CC BY 4.0 license.
  87. 87.0 87.1 87.2 87.3 87.4 Hua, My; Talbot, Prue (2016). "Potential health effects of electronic cigarettes: A systematic review of case reports". Preventive Medicine Reports. 4: 169–178. doi:10.1016/j.pmedr.2016.06.002. ISSN 2211-3355. PMC 4929082. PMID 27413679. This article incorporates text by My Hua and Prue Talbot available under the CC BY 4.0 license.
  88. 88.00 88.01 88.02 88.03 88.04 88.05 88.06 88.07 88.08 88.09 88.10 88.11 88.12 88.13 88.14 88.15 88.16 88.17 88.18 88.19 88.20 88.21 88.22 88.23 88.24 88.25 88.26 88.27 88.28 88.29 88.30 88.31 88.32 88.33 88.34 88.35 88.36 88.37 88.38 88.39 88.40 88.41 88.42 88.43 88.44 88.45 88.46 88.47 88.48 88.49 88.50 88.51 88.52 88.53 88.54 88.55 88.56 88.57 88.58 88.59 88.60 88.61 88.62 88.63 88.64 88.65 88.66 88.67 88.68 88.69 88.70 88.71 Górna, Ilona; Napierala, Marta; Florek, Ewa (2020). "Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review". Toxics. 8 (4): 105. doi:10.3390/toxics8040105. ISSN 2305-6304. PMC 7711672. PMID 33212878. This article incorporates text by Ilona Górna, Marta Napierala, and Ewa Florek available under the CC BY 4.0 license.
  89. 89.0 89.1 Gorlova, Olga Y; Xu, Ying; Guo, Yanfang; Liu, Kaiqian; Liu, Zheng; Wang, Xiaobo (2016). "E-Cigarette Awareness, Use, and Harm Perception among Adults: A Meta-Analysis of Observational Studies". PLOS ONE. 11 (11): e0165938. Bibcode:2016PLoSO..1165938X. doi:10.1371/journal.pone.0165938. ISSN 1932-6203. PMC 5115669. PMID 27861501.
  90. 90.0 90.1 90.2 90.3 90.4 90.5 Kaur, Gagandeep; Pinkston, Rakeysha; Mclemore, Benathel; Dorsey, Waneene C.; Batra, Sanjay (2018). "Immunological and toxicological risk assessment of e-cigarettes". European Respiratory Review. 27 (147): 170119. doi:10.1183/16000617.0119-2017. ISSN 0905-9180. PMC 9489161. PMID 29491036.
  91. 91.0 91.1 91.2 91.3 91.4 91.5 91.6 91.7 Benowitz, Neal L.; Fraiman, Joseph B. (2017). "Cardiovascular effects of electronic cigarettes". Nature Reviews Cardiology. 14 (8): 447–456. doi:10.1038/nrcardio.2017.36. ISSN 1759-5002. PMC 5519136. PMID 28332500.
  92. 92.0 92.1 Sosnowski, Tomasz R.; Odziomek, Marcin (2018). "Particle Size Dynamics: Toward a Better Understanding of Electronic Cigarette Aerosol Interactions With the Respiratory System". Frontiers in Physiology. 9: 853. doi:10.3389/fphys.2018.00853. ISSN 1664-042X. PMC 6046408. PMID 30038580. This article incorporates text by Tomasz R. Sosnowski and Marcin Odziomek available under the CC BY 4.0 license.
  93. 93.00 93.01 93.02 93.03 93.04 93.05 93.06 93.07 93.08 93.09 93.10 93.11 Clapp, Phillip W.; Jaspers, Ilona (November 2017). "Electronic Cigarettes: Their Constituents and Potential Links to Asthma". Current Allergy and Asthma Reports. 17 (11): 79. doi:10.1007/s11882-017-0747-5. ISSN 1529-7322. PMC 5995565. PMID 28983782.
  94. Detailed reference list is located at a separate image page.
  95. Pham, Kien; DeFina, Sam; Wang, He (24 February 2021). "E-Cigarettes Promote Macrophage-Tumor Cells Crosstalk: Focus on Breast Carcinoma Progression and Lung Metastasis". Exploratory Research and Hypothesis in Medicine. 000 (000): 000–000. doi:10.14218/erhm.2021.00002. PMC 9005083. PMID 35419501.
  96. Ebersole, Jeffrey; Samburova, Vera; Son, Yeongkwon; Cappelli, David; Demopoulos, Christina; Capurro, Antonina; Pinto, Andres; Chrzan, Brian; Kingsley, Karl; Howard, Katherine; Clark, Nathaniel; Khlystov, Andrey (8 May 2020). "Harmful chemicals emitted from electronic cigarettes and potential deleterious effects in the oral cavity". Tobacco Induced Diseases. 18 (May). doi:10.18332/tid/116988. ISSN 1617-9625. PMC 7233525. PMID 32435175. This article incorporates text by Jeffrey Ebersole, Vera Samburova, Yeongkwon Son, David Cappelli, Christina Demopoulos, Antonina Capurro, Andres Pinto, Brian Chrzan, Karl Kingsley, Katherine Howard, Nathaniel Clark, and Andrey Khlystov available under the CC BY 4.0 license.
  97. 97.0 97.1 97.2 97.3 Hendlin, Yogi H.; Vora, Manali; Elias, Jesse; Ling, Pamela M. (2019). "Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review". American Journal of Public Health. 109 (7): e1–e8. doi:10.2105/AJPH.2019.305106. ISSN 0090-0036. PMC 6603486. PMID 31095414.
  98. 98.0 98.1 Meng, Xing-chen; Guo, Xin-xin; Peng, Zhen-yan; Wang, Chun; Liu, Ran (27 March 2023). "Acute effects of electronic cigarettes on vascular endothelial function: a systematic review and meta-analysis of randomized controlled trials". European Journal of Preventive Cardiology. 30 (5): 425–435. doi:10.1093/eurjpc/zwac248. PMID 36316290.
  99. 99.0 99.1 99.2 Sobczak, Andrzej; Kosmider, Leon; Koszowski, Bartosz; Goniewicz, Maciej Ł. (2020). "E-cigarettes and their impact on health: from pharmacology to clinical implications". Polish Archives of Internal Medicine. doi:10.20452/pamw.15229. ISSN 1897-9483. PMC 7685201. PMID 32155137.
  100. 100.0 100.1 100.2 Kashyap, Vivek K.; Dhasmana, Anupam; Massey, Andrew; Kotnala, Sudhir; Zafar, Nadeem; Jaggi, Meena; Yallapu, Murali M.; Chauhan, Subhash C. (9 September 2020). "Smoking and COVID-19: Adding Fuel to the Flame". International Journal of Molecular Sciences. 21 (18): 6581. doi:10.3390/ijms21186581. PMC 7555793. PMID 32916821. This article incorporates text by Vivek K. Kashyap, Anupam Dhasmana, Andrew Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, Murali M. Yallapu, and Subhash C. Chauhan available under the CC BY 4.0 license.
  101. 101.0 101.1 101.2 101.3 Walley, Susan C.; Wilson, Karen M.; Winickoff, Jonathan P.; Groner, Judith (2019). "A Public Health Crisis: Electronic Cigarettes, Vape, and JUUL". Pediatrics. 143 (6): e20182741. doi:10.1542/peds.2018-2741. ISSN 0031-4005. PMID 31122947.
  102. "Health Effects of Vaping". Centers for Disease Control and Prevention. 31 January 2025.Public Domain This article incorporates text from this source, which is in the public domain.
  103. 103.0 103.1 103.2 MacDonald, Marjorie; O'Leary, Renee; Stockwell, Tim; Reist, Dan (2016). "Clearing the air: protocol for a systematic meta-narrative review on the harms and benefits of e-cigarettes and vapour devices". Systematic Reviews. 5 (1): 85. doi:10.1186/s13643-016-0264-y. ISSN 2046-4053. PMC 4875675. PMID 27209032. This article incorporates text by Marjorie MacDonald, Renee O'Leary, Tim Stockwell, and Dan Reist available under the CC BY 4.0 license.
  104. 104.0 104.1 104.2 104.3 Dagaonkar RS, R.S.; Udwadi, Z.F. (2014). "Water pipes and E-cigarettes: new faces of an ancient enemy" (PDF). Journal of the Association of Physicians of India. 62 (4): 324–328. PMID 25327035.
  105. 105.0 105.1 Burstyn, Igor (9 January 2014). "Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks". BMC Public Health. 14 (1): 18. doi:10.1186/1471-2458-14-18. ISSN 1471-2458. PMC 3937158. PMID 24406205.
  106. McCausland, Kahlia; Maycock, Bruce; Jancey, Jonine (2017). "The messages presented in online electronic cigarette promotions and discussions: a scoping review protocol". BMJ Open. 7 (11): e018633. doi:10.1136/bmjopen-2017-018633. ISSN 2044-6055. PMC 5695349. PMID 29122804.
  107. Smith, Nikki (20 January 2016). "Headlines about e-cigarettes don't mean they're 'not safer than tobacco'". Cancer Research UK.
  108. 108.0 108.1 Greenhill, Richard; Dawkins, Lynne; Notley, Caitlin; Finn, Mark D.; Turner, John J.D. (2016). "Adolescent Awareness and Use of Electronic Cigarettes: A Review of Emerging Trends and Findings". Journal of Adolescent Health. 59 (6): 612–619. doi:10.1016/j.jadohealth.2016.08.005. ISSN 1054-139X. PMID 27693128.
  109. 109.0 109.1 109.2 Palazzolo, Dominic L. (November 2013). "Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review". Frontiers in Public Health. 1 (56): 56. doi:10.3389/fpubh.2013.00056. PMC 3859972. PMID 24350225. This article incorporates text by Dominic L. Palazzolo available under the CC BY 3.0 license.
  110. Nansseu, Jobert Richie N.; Bigna, Jean Joel R. (2016). "Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa". Pulmonary Medicine. 2016: 1–9. doi:10.1155/2016/4894352. ISSN 2090-1836. PMC 5220510. PMID 28116156. This article incorporates text by Jobert Richie N. Nansseu and Jean Joel R. Bigna available under the CC BY 4.0 license.
  111. 111.0 111.1 111.2 111.3 111.4 111.5 111.6 Drope, Jeffrey; Cahn, Zachary; Kennedy, Rosemary; Liber, Alex C.; Stoklosa, Michal; Henson, Rosemarie; Douglas, Clifford E.; Drope, Jacqui (2017). "Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine". CA: A Cancer Journal for Clinicians. 67 (6): 449–471. doi:10.3322/caac.21413. ISSN 0007-9235. PMID 28961314.
  112. 112.00 112.01 112.02 112.03 112.04 112.05 112.06 112.07 112.08 112.09 112.10 112.11 112.12 112.13 112.14 112.15 112.16 112.17 112.18 112.19 112.20 112.21 112.22 112.23 112.24 112.25 112.26 112.27 112.28 112.29 112.30 112.31 112.32 112.33 112.34 112.35 112.36 112.37 112.38 112.39 112.40 112.41 112.42 112.43 112.44 112.45 Glantz, Stanton A.; Bareham, David W. (January 2018). "E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications". Annual Review of Public Health. 39 (1): 215–235. doi:10.1146/annurev-publhealth-040617-013757. ISSN 0163-7525. PMC 6251310. PMID 29323609. This article incorporates text by Stanton A. Glantz and David W. Bareham available under the CC BY 4.0 license.
  113. Bush, Ashley M.; Holsinger, James W.; Prybil, Lawrence D. (2016). "Employing the Precautionary Principle to Evaluate the Use of E-Cigarettes". Frontiers in Public Health. 4: 5. doi:10.3389/fpubh.2016.00005. ISSN 2296-2565. PMC 4740382. PMID 26870723.
  114. 114.0 114.1 114.2 114.3 Traboulsi, Hussein; Cherian, Mathew; Abou Rjeili, Mira; Preteroti, Matthew; Bourbeau, Jean; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J. (15 May 2020). "Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health". International Journal of Molecular Sciences. 21 (10): 3495. doi:10.3390/ijms21103495. ISSN 1422-0067. PMC 7278963. PMID 32429092. This article incorporates text by Hussein Traboulsi, Mathew Cherian, Mira Abou Rjeili, Matthew Preteroti, Jean Bourbeau, Benjamin M. Smith, David H. Eidelman, and Carolyn J. Baglole available under the CC BY 4.0 license.
  115. 115.0 115.1 Banks, Emily; Yazidjoglou, Amelia; Brown, Sinan; Nguyen, Mai; Martin, Melonie; Beckwith, Katie; Daluwatta, Amanda; Campbell, Sai; Joshy, Grace (3 April 2023). "Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence". Medical Journal of Australia. 218 (6): 267–275. doi:10.5694/mja2.51890. PMC 10952413. PMID 36939271. This article incorporates text available under the CC BY 4.0 license.
  116. 116.0 116.1 116.2 116.3 116.4 116.5 116.6 116.7 116.8 Bhatnagar, A.; Whitsel, L. P.; Ribisl, K. M.; Bullen, C.; Chaloupka, F.; Piano, M. R.; Robertson, R. M.; McAuley, T.; Goff, D.; Benowitz, N. (24 August 2014). "Electronic Cigarettes: A Policy Statement From the American Heart Association". Circulation. 130 (16): 1418–1436. doi:10.1161/CIR.0000000000000107. PMID 25156991.
  117. Bullen, Chris; Knight-West, Oliver (2016). "E-cigarettes for the management of nicotine addiction". Substance Abuse and Rehabilitation. 7: 111–118. doi:10.2147/SAR.S94264. ISSN 1179-8467. PMC 4993405. PMID 27574480.
  118. Hartmann-Boyce, Jamie; Begh, Rachna; Aveyard, Paul (2018). "Electronic cigarettes for smoking cessation". BMJ. 360: j5543. doi:10.1136/bmj.j5543. ISSN 0959-8138. PMID 29343486.
  119. 119.0 119.1 119.2 119.3 Smith, L; Brar, K; Srinivasan, K; Enja, M; Lippmann, S (June 2016). "E-cigarettes: How "safe" are they?". The Journal of Family Practice. 65 (6): 380–385. PMID 27474819.
  120. 120.0 120.1 120.2 120.3 120.4 Zborovskaya, Y (2017). "E-Cigarettes and Smoking Cessation: A Primer for Oncology Clinicians". Clinical Journal of Oncology Nursing. 21 (1): 54–63. doi:10.1188/17.CJON.54-63. PMID 28107337.
  121. 121.0 121.1 Wang, Richard J.; Bhadriraju, Sudhamayi; Glantz, Stanton A. (February 2021). "E-Cigarette Use and Adult Cigarette Smoking Cessation: A Meta-Analysis". American Journal of Public Health. 111 (2): 230–246. doi:10.2105/AJPH.2020.305999. ISSN 0090-0036. PMC 7811087. PMID 33351653.
  122. 122.0 122.1 122.2 Kim, Jinyung; Lee, Serim; Chun, JongSerl (14 September 2022). "An International Systematic Review of Prevalence, Risk, and Protective Factors Associated with Young People's E-Cigarette Use". International journal of environmental research and public health. MDPI AG. 19 (18): 11570. doi:10.3390/ijerph191811570. ISSN 1660-4601. PMC 9517489. PMID 36141845. This article incorporates text by Jinyung Kim, Serim Lee, and JongSerl Chun available under the CC BY 4.0 license.
  123. Vajdi, Borna; Tuktamyshov, Rasikh (2020). "Electronic cigarettes — myocardial infarction, hemodynamic compromise during pregnancy, and systolic and diastolic dysfunction: Minireview". World Journal of Cardiology. 12 (10): 475–483. doi:10.4330/wjc.v12.i10.475. ISSN 1949-8462. PMC 7596422. PMID 33173566.
  124. 124.0 124.1 124.2 124.3 Sapru, Sakshi; Vardhan, Mridula; Li, Qianhao; Guo, Yuqi; Li, Xin; Saxena, Deepak (December 2020). "E-cigarettes use in the United States: reasons for use, perceptions, and effects on health". BMC Public Health. 20 (1). doi:10.1186/s12889-020-09572-x. PMC 7545933. PMID 33032554. This article incorporates text by Sakshi Sapru, Mridula Vardhan, Qianhao Li, Yuqi Guo, Xin Li, and Deepak Saxena available under the CC BY 4.0 license.
  125. 125.0 125.1 125.2 Oh, Anne Y.; Kacker, Ashutosh (December 2014). "Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes?: Review on e-cigarette vapor versus tobacco smoke". The Laryngoscope. 124 (12): 2702–2706. doi:10.1002/lary.24750. PMID 25302452.
  126. 126.0 126.1 "Electronic Cigarettes – An Overview" (PDF). German Cancer Research Center. 2013.
  127. 127.0 127.1 127.2 Evans, S. E.; Hoffman, A. C. (2014). "Electronic cigarettes: abuse liability, topography and subjective effects". Tobacco Control. 23 (Supplement 2): ii23–ii29. doi:10.1136/tobaccocontrol-2013-051489. ISSN 0964-4563. PMC 3995256. PMID 24732159.
  128. 128.0 128.1 Sanford, Sanford; Goebel, Lynne (2014). "E-cigarettes: an up to date review and discussion of the controversy". W V Med J. 110 (4): 10–5. PMID 25322582.
  129. 129.00 129.01 129.02 129.03 129.04 129.05 129.06 129.07 129.08 129.09 129.10 Breland, Alison; Soule, Eric; Lopez, Alexa; Ramôa, Carolina; El-Hellani, Ahmad; Eissenberg, Thomas (2017). "Electronic cigarettes: what are they and what do they do?". Annals of the New York Academy of Sciences. 1394 (1): 5–30. Bibcode:2017NYASA1394....5B. doi:10.1111/nyas.12977. ISSN 0077-8923. PMC 4947026. PMID 26774031.
  130. Bullen, Christopher (2014). "Electronic Cigarettes for Smoking Cessation". Current Cardiology Reports. 16 (11): 538. doi:10.1007/s11886-014-0538-8. ISSN 1523-3782. PMID 25303892.
  131. Caponnetto, P.; Russo, C.; Bruno, C.M.; Alamo, A.; Amaradio, M.D.; Polosa, R. (March 2013). "Electronic cigarette: a possible substitute for cigarette dependence". Monaldi Archives for Chest Disease. 79 (1): 12–19. doi:10.4081/monaldi.2013.104. ISSN 1122-0643. PMID 23741941.
  132. Wilder 2016, p. 87.
  133. Li, Gerard; Saad, Sonia; Oliver, Brian; Chen, Hui (2018). "Heat or Burn? Impacts of Intrauterine Tobacco Smoke and E-Cigarette Vapor Exposure on the Offspring's Health Outcome". Toxics. 6 (3): 43. doi:10.3390/toxics6030043. ISSN 2305-6304. PMC 6160993. PMID 30071638. This article incorporates text by Gerard Li, Sonia Saad, Brian G. Oliver, and Hui Chen available under the CC BY 4.0 license.
  134. 134.0 134.1 Zhao, Kai; Li, Jing; Zhou, Ping; Xu, Ling; Yang, Mingfei (14 November 2022). "Is electronic cigarette use a risk factor for stroke? A systematic review and meta-analysis". Tobacco Induced Diseases. 20 (November): 1–8. doi:10.18332/tid/154364. PMC 9661377. PMID 36447455. This article incorporates text by Kai Zhao, Jing Li, Ping Zhou, Ling Xu, and Mingfei Yang available under the CC BY 4.0 license.
  135. 135.0 135.1 135.2 135.3 135.4 135.5 135.6 Luca, Alina-Costina; Curpăn, Alexandrina-Ștefania; Iordache, Alin-Constantin; Mîndru, Dana Elena; Țarcă, Elena; Luca, Florin-Alexandru; Pădureț, Ioana-Alexandra (8 February 2023). "Cardiotoxicity of Electronic Cigarettes and Heat-Not-Burn Tobacco Products—A Problem for the Modern Pediatric Cardiologist". Healthcare. 11 (4): 491. doi:10.3390/healthcare11040491. PMC 9957306. PMID 36833024. This article incorporates text by Alina-Costina Luca, Alexandrina-Ștefania Curpăn, Alin-Constantin Iordache, Dana Elena Mîndru, Elena Țarcă, Florin-Alexandru Luca, and Ioana-Alexandra Pădureț available under the CC BY 4.0 license.
  136. 136.00 136.01 136.02 136.03 136.04 136.05 136.06 136.07 136.08 136.09 136.10 Lyzwinski, Lynnette Nathalie; Naslund, John A.; Miller, Christopher J.; Eisenberg, Mark J. (11 April 2022). "Global youth vaping and respiratory health: epidemiology, interventions, and policies". npj Primary Care Respiratory Medicine. 32 (1): 14. doi:10.1038/s41533-022-00277-9. PMC 9001701. PMID 35410990. This article incorporates text by Lynnette Nathalie Lyzwinski, John A. Naslund, Christopher J. Miller, and Mark J. Eisenberg available under the CC BY 4.0 license.
  137. McNeill 2018, p. 175.
  138. McNeill 2015, p. 76.
  139. 139.0 139.1 Couch, Elizabeth T.; Chaffee, Benjamin W.; Gansky, Stuart A.; Walsh, Margaret M. (July 2016). "The changing tobacco landscape". The Journal of the American Dental Association. 147 (7): 561–569. doi:10.1016/j.adaj.2016.01.008. ISSN 0002-8177. PMC 4925234. PMID 26988178.
  140. Camenga, Deepa R.; Tindle, Hilary A. (2018). "Weighing the Risks and Benefits of Electronic Cigarette Use in High-Risk Populations". Medical Clinics of North America. 102 (4): 765–779. doi:10.1016/j.mcna.2018.03.002. ISSN 0025-7125. PMID 29933828.
  141. 141.0 141.1 141.2 141.3 Armendáriz-Castillo, Isaac; Guerrero, Santiago; Vera-Guapi, Antonella; Cevallos-Vilatuña, Tiffany; García-Cárdenas, Jennyfer M.; Guevara-Ramírez, Patricia; López-Cortés, Andrés; Pérez-Villa, Andy; Yumiceba, Verónica; Zambrano, Ana K.; Leone, Paola E.; Paz-y-Miño, César (23 December 2019). "Genotoxic and Carcinogenic Potential of Compounds Associated with Electronic Cigarettes: A Systematic Review". BioMed Research International. 2019: 1–8. doi:10.1155/2019/1386710. PMC 6948324. PMID 31950030.} This article incorporates text by Isaac Armendáriz-Castillo, Santiago Guerrero, Antonella Vera-Guapi, Tiffany Cevallos-Vilatuña, Jennyfer M García-Cárdenas, Patricia Guevara-Ramírez, Andrés López-Cortés, Andy Pérez-Villa, Verónica Yumiceba, Ana K Zambrano, Paola E Leone, and César Paz-Y-Miño available under the CC BY 4.0 license.
  142. Legg, Tess; Legendre, Michél; Gilmore, Anna B (November 2021). "Paying lip service to publication ethics: scientific publishing practices and the Foundation for a Smoke-Free World". Tobacco Control. 30 (e1): e65–e72. doi:10.1136/tobaccocontrol-2020-056003. PMC 8606453. PMID 33911028.
  143. 143.0 143.1 Burki, Talha Khan (June 2021). "Conflicts of interest in tobacco industry-funded research". The Lancet Oncology. 22 (6): 758. doi:10.1016/S1470-2045(21)00281-3. PMID 33965060.
  144. 144.0 144.1 Chaffee, Benjamin W.; Couch, Elizabeth T.; Ryder, Mark I. (2016). "The tobacco-using periodontal patient: role of the dental practitioner in tobacco cessation and periodontal disease management". Periodontology 2000. 71 (1): 52–64. doi:10.1111/prd.12120. ISSN 0906-6713. PMC 4842013. PMID 27045430.
  145. 145.0 145.1 Bhatnagar, Aruni (2016). "Cardiovascular Perspective of the Promises and Perils of E-Cigarettes". Circulation Research. 118 (12): 1872–1875. doi:10.1161/CIRCRESAHA.116.308723. ISSN 0009-7330. PMC 5505630. PMID 27283531.
  146. Chen, Jinsong; Bullen, Chris; Dirks, Kim (2017). "A Comparative Health Risk Assessment of Electronic Cigarettes and Conventional Cigarettes". International Journal of Environmental Research and Public Health. 14 (4): 382. doi:10.3390/ijerph14040382. ISSN 1660-4601. PMC 5409583. PMID 28379177. This article incorporates text by Jinsong Chen, Chris Bullen, and Kim Dirks available under the CC BY 4.0 license.
  147. 147.0 147.1 Sharma, H; Ruikar, M (April 2023). "Electronic cigarettes: Ally or an enemy in combating tobacco-use-associated diseases - An integrative review". Indian journal of dental research : official publication of Indian Society for Dental Research. 34 (2): 216–222. doi:10.4103/ijdr.ijdr_890_21. PMID 37787216.
  148. Priemer, David S.; Gravenmier, Curtis; Batouli, Amir; Hooper, Jody E. (1 November 2020). "Overview of Pathologic Findings of Vaping in the Context of an Autopsy Patient With Chronic Injury". Archives of Pathology & Laboratory Medicine. 144 (11): 1408–1413. doi:10.5858/arpa.2019-0637-RA. PMID 32383974.
  149. 149.0 149.1 Serror, K.; Chaouat, M.; Legrand, Matthieu M.; Depret, F.; Haddad, J.; Malca, N.; Mimoun, M.; Boccara, D. (2018). "Burns caused by electronic vaping devices (e-cigarettes): A new classification proposal based on mechanisms". Burns. 44 (3): 544–548. doi:10.1016/j.burns.2017.09.005. ISSN 0305-4179. PMID 29056367.
  150. 150.0 150.1 150.2 150.3 150.4 150.5 Tzortzi, Anna; Kapetanstrataki, Melpo; Evangelopoulou, Vaso; Behrakis, Panagiotis (2020). "A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist". International Journal of Environmental Research and Public Health. 17 (7): 2248. doi:10.3390/ijerph17072248. ISSN 1660-4601. PMC 7177608. PMID 32230711. This article incorporates text by Anna Tzortzi, Melpo Kapetanstrataki, Vaso Evangelopoulou, and Panagiotis Behrakis available under the CC BY 4.0 license.
  151. 151.0 151.1 151.2 Saitta, D; Ferro, GA; Polosa, R (Mar 2014). "Achieving appropriate regulations for electronic cigarettes". Therapeutic Advances in Chronic Disease. 5 (2): 50–61. doi:10.1177/2040622314521271. PMC 3926346. PMID 24587890.
  152. 152.0 152.1 152.2 152.3 152.4 152.5 152.6 Zhao, Di; Aravindakshan, Atul; Hilpert, Markus; Olmedo, Pablo; Rule, Ana M.; Navas-Acien, Ana; Aherrera, Angela (2020). "Metal/Metalloid Levels in Electronic Cigarette Liquids, Aerosols, and Human Biosamples: A Systematic Review". Environmental Health Perspectives. 128 (3): 036001. doi:10.1289/EHP5686. ISSN 0091-6765. PMC 7137911. PMID 32186411.Public Domain This article incorporates text from this source, which is in the public domain.
  153. 153.0 153.1 Reiter, Anna; Hébert-Losier, Andréa; Mylocopos, Genevieve; Filion, Kristian B.; Windle, Sarah B.; O'Loughlin, Jennifer L.; Grad, Roland; Eisenberg, Mark J. (January 2024). "Regulatory Strategies for Preventing and Reducing Nicotine Vaping Among Youth: A Systematic Review". American Journal of Preventive Medicine. 66 (1): 169–181. doi:10.1016/j.amepre.2023.08.002. PMID 37553038.
  154. 154.00 154.01 154.02 154.03 154.04 154.05 154.06 154.07 154.08 154.09 154.10 Rom, Oren; Pecorelli, Alessandra; Valacchi, Giuseppe; Reznick, Abraham Z. (2014). "Are E-cigarettes a safe and good alternative to cigarette smoking?". Annals of the New York Academy of Sciences. 1340 (1): 65–74. doi:10.1111/nyas.12609. ISSN 0077-8923. PMID 25557889.
  155. 155.0 155.1 "E-Cigarettes". Tobacco Control Research Branch of the National Cancer Institute. 2023.
  156. 156.0 156.1 Jenssen, Brian P.; Boykan, Rachel (2019). "Electronic Cigarettes and Youth in the United States: A Call to Action (at the Local, National and Global Levels)". Children. 6 (2): 30. doi:10.3390/children6020030. ISSN 2227-9067. PMC 6406299. PMID 30791645. This article incorporates text by Brian P. Jenssen and Rachel Boykan available under the CC BY 4.0 license.
  157. 157.0 157.1 157.2 157.3 157.4 Thirión-Romero, Ireri; Pérez-Padilla, Rogelio; Zabert, Gustavo; Barrientos-Gutiérrez, Inti (2019). "Respiratory Impact of Electronic Cigarettes and Low-Risk Tobacco". Revista de Investigación Clínica. 71 (1). doi:10.24875/RIC.18002616. ISSN 0034-8376. PMID 30810544.
  158. 158.0 158.1 158.2 Besaratinia, Ahmad; Tommasi, Stella (2021). "The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era". Preventive Medicine Reports. 22: 101374. doi:10.1016/j.pmedr.2021.101374. ISSN 2211-3355. PMC 8207461. PMID 34168950.
  159. 159.0 159.1 "Did You Know? – Public Health Impact". Surgeon General of the United States. 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  160. 160.0 160.1 160.2 160.3 160.4 Franck, Caroline; Filion, Kristian B.; Kimmelman, Jonathan; Grad, Roland; Eisenberg, Mark J. (2016). "Ethical considerations of e-cigarette use for tobacco harm reduction". Respiratory Research. 17 (1): 53. doi:10.1186/s12931-016-0370-3. ISSN 1465-993X. PMC 4869264. PMID 27184265. This article incorporates text by Caroline Franck, Kristian B. Filion, Jonathan Kimmelman, Roland Grad, and Mark J. Eisenberg available under the CC BY 4.0 license.
  161. Kumar, Navin; Hampsher, Sam; Walter, Nathan; Nyhan, Kate; De Choudhury, Munmun (9 October 2022). "Interventions to mitigate vaping misinformation: protocol for a scoping review". Systematic Reviews. 11 (1): 214. doi:10.1186/s13643-022-02094-0. PMC 9548303. PMID 36210470. This article incorporates text by Navin Kumar, Sam Hampsher, Nathan Walter, Kate Nyhan, and Munmun De Choudhury available under the CC BY 4.0 license.
  162. 162.00 162.01 162.02 162.03 162.04 162.05 162.06 162.07 162.08 162.09 162.10 162.11 162.12 162.13 162.14 162.15 162.16 U.S. Department of Health and Human Services (2016). E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General (PDF) (Report). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Surgeon General of the United States. pp. 1–298.